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ABSTRACT 
 
AADITYA DEVKOTA: An In Vitro Explant Model Of Overuse Tendinopathy. The Effects 
of Cyclic Loading And Inflammatory Mediators On Mechanical And Compositional 
Properties of Tendon. 
(Under the direction of Paul Weinhold) 
 
Overuse injuries are common clinical problems, athletically and occupationally, with 
estimates that nearly 50% of all injuries are overuse. Though a major clinical issue, the 
underlying etiology of tendon overuse injuries is unknown. Currently, the prevailing thought 
centers on microdamage accumulation. This is where loading (well below failure levels) 
causes damage at the fibrillar level. When this damage outpaces the tendon’s ability to repair 
itself, then tendinopathy is thought to occur.  
The elastic limit beyond which this microdamage occurs has long been accepted at 4% 
strain. The first objective was to examine this idea utilizing newer methodologies by first 
loading tendons to various subfailiure strain levels, then loading to failure after rest.  The 
elastic limit approached the failure strain limit (16%), implicating cellular responses as the 
driving factor in tendinopathy. 
To examine overuse tendinopathy, the next objective was to develop and characterize a 
model to apply and monitor complex, cyclic loadings to viable tendon. This device was able 
to significantly reduce the mechanical properties of loaded tendons (relative to control) as 
well as monitor this damage (strain accumulation). 
 ii 
With a model established, cyclic loadings were performed across varying periods to 
assess cellular responses’ role on tendon’s mechanical and biochemical characteristics. 
Compositional changes, as well as pronounced magnitude and duration dependant effects in 
collagenase, cellularity and the inflammatory mediator PGE2 were observed.  Significant loss 
of material properties were also observed with respect to loading magnitude. 
To determine the magnitude effect of these responses and separate it from duration 
dependence, an experiment with four levels of loading was performed across three days. This 
duration proved too short for compositional changes, however, significant magnitude 
dependant cellular responses were observed in regards to collagenase, cellularity and PGE2. 
PGE2, long hypothesized to contribute to tendinopathy development, was examined 
across cyclic loadings. PGE2 treatment caused decreased stiffness, resulting in increased 
strain and cellular responses. COX inhibitors were effective at reducing PGE2, as well as its 
responses.  This study suggests PGE2 may contribute in driving healthy tendons into 
tendinopathy, however this response is reducible with COX inhibitors which otherwise 
showed no negative effects in an explant model. 
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CHAPTER 1 
INTRODUCTION 
 
 Overuse injuries comprise a significant portion of tendon injuries, both athletically 
and occupationally.  Though overuse injuries account for nearly 50% of all injuries, the 
etiology of tendon overuse injuries is still poorly understood.  The issue is compounded with 
seemingly conflicting diagnosis. Clinical symptoms such as pain and swelling are 
inconsistent, but the diagnosis is often the same. Furthermore, nomenclature contradiction 
arises from diagnosis made to specify tendonitis (inflammation) or tendinosis (no 
inflammation), which is not suggested without a biopsy and histopathologic confirmation. To 
curtail further confusion, the general aetiologic term of overuse tendinopathy is advised until 
such confirmation. 
 The classical elucidation of the etiology centers on the concept of micro-damage to 
the collagen fibers with each loading.  The classic elastic limit, the strain level beyond which 
non-recoverable damage will occur, has long been accepted as 4%. The first objective 
showed no such limit at slow loading rates, implying an increased role of the cellular 
response in tendinopathies. The tendon is a robust biological tissue with adaptive responses 
that must also be considered when attempting to assess the damage source. Many studies 
have shown mechanical load to play a major role in the development of tendinopathic 
characteristics through such responses.  Responses to loading include an increase in the 
release of collagenases as well as various cytokines and inflammatory mediators.  
  
 The first overuse tendinopathy studies were expansions of general tendinopathy 
studies, performed across numerous cycles to determine the basic mechanical properties of 
tendon to repetitive loading.  While much was gained from this approach, it was performed 
on cadaver tendons and thus neglected a key component of overuse tendinopathy, the cellular 
response. The next line of studies took the opposite approach and loaded tendon fibroblasts 
on deformable substrates and observed a host of cellular responses to loading. The limitation 
of this type of study lies in the inability to account for the matrix and it’s interaction with the 
cells.  The latest approach, which brings the cells and the matrix together, is in vivo loading.  
Rabbit and rat models have been developed that have shown numerous cellular responses as 
well as matrix changes as a result of repetitive loading. An in vivo human model has also 
shown some cellular responses to loading. However, it has been suggested that due to the 
complexity of in vivo loading, it is necessary to develop in vitro models if one wants to 
determine precise causative loading effects on tendinopathy.  
 In order to determine how particular loading characteristics contribute to overuse 
injury, in vitro explant models can be used to apply controlled cyclic loads to tissue segments 
maintained in culture. Major deficiencies in the systems currently available necessitated the 
development of a new loading device and damage monitoring system. The next objective of 
this project was to fully develop and calibrate a novel device and assess its performance, 
while developing a video strain analysis system to monitor midsubstance strain.  
 After establishing the system’s ability to damage the tendon through cyclic loading 
while monitoring its deteriorating mechanical characteristics, the next major goal was to 
establish the ability of this device to damage the tendon through cyclic loading in a manner 
that establishes the damage to be more than would be expected with simple material fatigue. 
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Damage beyond fatigue was observed and was assumed to have been facilitated by the 
cellular responses of the tendon to the loading. Matrix ground substance turnover was noted, 
while matrix remodeling agents and inflammatory mediators were detected in load and 
duration dependant manners. The device had been established to not only damage the tendon 
through cyclic loading, but elicit various cellular responses that are consistent with past 
studies that likely damage the tissue further.  Next, it was necessary to determine the timing 
of these responses and determine their responses based on various loading levels. It was 
determined that many of these presumably causative cellular responses are elevated very 
quickly and that they are all very highly magnitude dependant. 
 Having established a cyclic loading model which produced fatigue damage, elicited 
various noxious cellular responses and saw interactions between the damage and cellular 
responses, a model sutiable for studying tendinopathy was created.  The final step was to 
isolate one of these responses, the inflammatory mediator Prostaglandin E2 (PGE2), which 
has been linked both directly and indirectly with various noxious responses in our previous 
experiments as well as in past studies.  This was done by both adding exogenous PGE2 and 
inhibiting it with non-steroidal anti-inflammatory drugs (NSAIDS). NSAIDS are a common 
treatment for overuse tendinopathy even though their full effects have not been completely 
established and recent studies have shown potential health hazards.  PGE2 treatment was seen 
to cause a decrease in stiffness, resulting in increased strains and increased cellular 
responses. Trends for collagen and GAG decreases were also seen.  COX inhibitors were 
found to be highly effective in reducing all of these responses, implying a potential 
therapeutic role for COX inhibitors in preventing repetitively loaded tendons from 
developing into overuse tendinopathy. 
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CHAPTER 2 
BACKGROUND REVIEW 
 
2.1 Tendon Anatomy & Physiology 
2.1.1 Function 
 Tendons are force transmitting connective tissues that attach muscles to bones and 
facilitate active joint motion.  Tendons are structurally and compositionally similar to 
ligaments, which connect bone to bone.  Each muscle has two tendons, one at the origin 
(proximal bone) and one at the insertion (distal bone). Consequently, each tendon has two 
attachments, one to the bone called the osteotendinous junction (OTJ) and one to the muscle 
called the myotendinous junction (MTJ). The main function of tendon is to transmit the force 
generated by the muscles across joints, thereby creating the angular motion that is 
responsible for all human motion.  
 The tendon also possesses many secondary functions such as making movement more 
energy efficient.  This is accomplished by limiting the lengthening of muscles, tissues with 
high energy demands.  Tendons also satisfy kinematic requirements by allowing muscles to 
be located further away from joints they cannot move across.  Furthermore, tendons allow 
single muscles to control multiple joints through pulleys.  They also absorb shock by 
damping sudden motion which limits damage to muscles and limits sudden, volatile motor 
stimuli (Jozsa and P. 1997).  A final role of the tendon is to store elastic energy, which can be 
  
converted to kinetic energy by elastic recoil, another key feature in energy conversation for 
movement.  
 
2.1.2 Structure and Organization 
 Tendons are bright white in color and fibroelastic in texture.  Inter-tendon size and 
shape variability is quite stark, with a range of sizes and possible shapes including rounded 
cords, strap-like bands, flattened ribbons and fan shaped.  Tendons used in powerful, 
resistive forces (quadriceps contractions) have short and broad tendons, while tendons used 
for subtle, delicate movements such as finger flexion are long and thin.  A host of structures 
are associated with tendon to facilitate motion in the intended path and reduce friction.  
These include fibrous sheaths, reflection pulleys, synovial sheaths, peritendinous sheets and 
bursae. Few tendons actually have a tendon sheath, most have only a paratenon. 
 
Figure 1: Hierarchal Structure of Tendon (Jozsa and P. 1997). 
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 Below the paratenon is a highly organized tendon assembly (Figure 1), whose 
outermost layer is called the epitenon, is contiguous with the paratenon. The epitenon is an 8-
10nm thick layer of dense collagen fibrils in various orientations. Contiguous with the 
epitenon, the next internal layer of tendon is the endotenon. The endotenon surrounds several 
fiber bundles (or fascicles) to form the tertiary fiber bundle which varies from a diameter of 
1mm to 3mm. These fascicles, average diameter 150µm to 1000µm, are also surrounded by 
the endotenon. Within these fascicles are numerous subfascicles, also surrounded by the 
endotenon. Within each subfascicle are the individual collagen fibers, the basic unit of the 
tendon (Jozsa and P. 1997).  
 The collagen fibrils are long rod shaped structures composed of numerous triple-helix 
polypeptide chains.  The chains are surrounded by a thin layer of proteoglycans (PGs) and 
glycosaminioglycans (GAGs).  The molecule is roughly 300nm long and 1 – 2nm wide. Each 
molecule overlaps its neighbors by 67nm or roughly 25% and is often referred to as the 
quarter-staggered array.  This 67nm region is comprised of an overlap region of 40% and a 
hole region of 60% (Silver et al. 2003).  Theses fibril are surrounded by more PGs and GAGs 
that are different from those surrounding the alpha chains (Jozsa and P. 1997). 
 
2.1.3 Composition 
 Tendons are primarily composed of type I collagen, with trace amounts of type III 
and V (Silver et al. 1992) and some elastin fibers.  The remaining components are the ground 
substances (proteoglycans, glycosaminoglycans and glycoproteins), fibroblasts and a few 
inorganic substances.  
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 Collagen comprises 90% of the total protein content and 60 – 75% of the tissue dry 
weight.  The other protein, elastin, comprises 2% of the tendon dry weight and its purpose is 
unknown.  It has been suggested to play a role in the recovery of the wavy fiber configuration 
after stretch (Butler et al. 1978).  Procollagen is the precursor to the main tendon component, 
collagen fibrils, and is synthesized in cells with non-helical amino and carboxyl terminals 
which are cleaved just prior to microfibril arrangement.  Type I collagen is composed of two 
α1 chains and one α2 chain.  The sequence of the alpha chains consists of a repeating series of 
glycine and two other amino acids (Gly-X-Y). Glycine, being the smallest amino acid, allows 
the helix to form by being placing it in the interior of the axis.  Proline, hydroxyproline and 
hydroxylysine are amino acids that predominately fill the remaining positions.  Proline and 
hydroxyproline give collagen fibrils their strength.  Consequently, regions devoid of these 
amino acids give collagen its flexibility. Regions with the sequence Gly-Pro-Hypro have the 
greatest rigidity (Silver et al. 2003) and are the basis for the great strength of the collagen 
fibril.  
 Each helix chain contains roughly 290 hydroxyproline residues which help stabilize 
the helix by forming water-bridges (Jozsa and P. 1997).  This regularity of hydroxyproline, 
coupled with the fact that it is found predominately in collagen, makes it a convenient marker 
for collagen content.  The stability of collagen makes it resistant against denaturing by all 
tissue proteases except for collagenase.  The other major amino acid, hydroxylysine, is 
essential in the formation of intermolecular cross-links, which along with the helix chain 
strength, is the basis for tendon strength (Jozsa and P. 1997). 
 The next major components of tendons are proteoglycans and matrix glycoproteins.  
Proteoglycans (PGs) are composed of a protein core and glycosaminoglycan (GAG) side 
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chains.  They are large, hydrophilic molecules that can hold water 50X their weight.  They 
provide the tendon with resistance to compressive forces.  Small PGs have short proteins 
with one or two GAG chains (dermatan sulfate) attached and are found predominately in 
tensional areas of tendons. Large PGs have longer core proteins with multiple GAGs 
(chondroitin sulfate) attached and are found predominately in pressure zones of tendon 
(Merrilees and Flint 1980).  Glycoproteins are smaller macromolecules with various 
functions, not all of which have been established (Jozsa and P. 1997).  Some established 
glycoproteins include, fibronectin, thrombospondin and laminin. Their roles include binding 
macromolecules such as calcium and cells together, as well as to each other.  
 The inorganic component of tendon, roughly 0.2% of the dry weight, include copper, 
manganese, magnesium, cadmium, cobalt, zinc, nickel, lithium, lead, fluoride, phosphor and 
silicon.  Their roles are various, some yet unknown, but some well defined ones include 
copper’s role in cross-linking, manganese’s role in molecule synthesis and calcium’s role in 
signaling (Minor 1980).  
 The final component of the tendon is the cell, or the internal fibroblast.  Fibroblasts 
comprise 95% of the total cellular component of tendons.  The remainders are chondrocytes 
at insertion sites, synovial cells in the tendon sheath, vascular cells and macrophages 
/inflammatory cells in other in some pathologic conditions.  Fibroblasts are long (80 - 
300µm) cells with numerous processes that attach to the extracellular matrix.  Originally 
thought to be inert, the fibroblasts’ oxygen requirements rival those of cardiac muscles cells 
on a per/cell basis (Peacock 1959).  
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2.1.3 Mechanical Properties 
 The basis for determining the material properties of tendons still remains in vitro 
failure tests.  This is performed at a constant deformation rate while monitoring the load and 
deformation levels.  The resulting force-elongation curve provides structural properties of the 
tendon such as stiffness, maximum load at failure, maximum strain at failure, etc.  However, 
to compare tendon properties one must normalize for specimen geometry, that is determine 
the material properties of the tendons.  This is achieved by dividing the force by the cross 
sectional area of the tendon and the elongation by the initial length, leaving a stress-strain 
curve ( ).  Mechanical properties of tendon can be determined after this.  Average 
maximum stress of tendons ranges from 45 – 125 MPa, while the average strain at failure 
ranges from 9 – 35% strain and elastic moduli of 1.2 – 1.8 GPa (Buckwalter et al. 2000). 
Figure 2
Figure 2: Typical Stress-Strain curve of tendons. 
  
 
 The classical stress-strain curve of tendon is divided into four distinct regions.  The 
first region, called the toe region, is the strain required to straighten the crimp pattern of 
resting tendons and orient the fibers to the loading direction.  This portion, roughly 0 – 2% 
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strain, is fully recoverable (Butler et al. 1978).  The second portion, the linear region, ranges 
from 1.5 – 4% strain (Viidik 1973; Butler et al. 1978).  This portion is equivalent to the 
elastic region of synthetic materials, meaning it is non-damaging and the strain is completely 
recoverable.  The next region, the failure region, is where non-recoverable damage to 
individual fibrils occurs as they begin to shear past each other and cross links break in an 
unpredictable fashion (Butler et al. 1978; O'Brien 1992; Buckwalter et al. 2000).  This 
continues until enough fibrils and cross-links are damaged to cause macroscopic failure, 
which commences around 8-10% stain (Butler et al. 1978; O'Brien 1992). 
 Along with the properties exhibited from a single loading, tendons display a host of 
time and history dependant properties (viscoelastic properties).  Tendon displays classic 
creep and stress relaxation properties.  Under constant load (well below failure level), tendon 
have been shown to fail by creep (Wang and Ker 1995).  Physiologic consideration for creep 
is applicable in events such as carpel tunnel syndrome (Smutz et al. 1995).  However, creep 
also has advantages as it decreases muscle fatigue by allowing the muscle to shorten during 
isometric contractions (Buckwalter et al. 2000).  Another viscoelastic behavior of tendon is 
that of preconditioning, a phenomenon where the first few cycles of load induce considerable 
hysteresis, relative to subsequent loading cycles and is the basis for warming-up before 
exercising (Buckwalter et al. 2000).  Another time dependant effect of tendons is that of 
strain-rate dependence.  Increasing the strain rate increases the stiffness and the failure 
strength of tendons (Standish et al. 2000). 
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 2.2 Tendon Loading & Injury 
 Various activities cause diverse stresses and strains on the tendon as they transfer the 
load generated by the muscle to move the bone and perform the activity.  The typical range 
of stresses seen by tendons is 1/3 - 1/2 of its failure strength (Buckwalter et al. 2000).  
Maximal tendon load is seen during eccentric muscle contraction and, in the case of the 
Achilles, can be to up to 15 times body weight.  Typical strains are in the range of 1-3% 
(Butler et al. 1978; Jozsa and P. 1997; Buckwalter et al. 2000).  These stresses and strains 
vary significantly by the tendon, the activity, predisposition and preparation.  Little data 
exists clinically of the tendon-muscle unit, but parallels can be drawn from the knowledge 
acquired from animal models.  The tendon is not an inert cable as originally thought. The 
adage that hyperfunction leads to hypertrophy and hypotrophy leads to atrophy exist in the 
tendon as well, however in a narrower scope than for bone and muscle (Jozsa and P. 1997).  
 
2.2.1 Disuse and Immobilization 
Disuse and immobilization are well studied aspects of tendon response. Animal 
studies of MTJ immobilization have demonstrated a significant decrease in muscle 
cell/tendon connections as well as decreased GAG content, increased collagen type III, 
resulting in decreased failure strength (Tidball 1991; Jozsa and P. 1997).  Similar 
compositional changes have also been observed in humans (decreased GAG and increased 
type III collagen), leading many to speculate decreased tendon strength in humans as well 
(Jozsa and P. 1997). 
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The tendon proper displays a variety of responses to load deprivation.  Tenocytes 
show signs of necrosis and hypoxia such as mitochondrial and nuclei shape alterations (Jozsa 
and P. 1997).  The enzymes that catalyze collagen and their mRNA decrease.  
Immobilization causes human tendons to exhibit decreased tensile strength, elastic stiffness, 
total weight and energy to failure (Amiel et al. 1982; Woo et al. 1982; Tipton et al. 1986; 
Jozsa and P. 1997; Maganaris et al. 2004).  Biochemically, immobilization causes increased 
collagen turnover, reduced cross-linking, collagen disorientation, reduction in cross-linking 
and decreased GAG content (Akeson 1961; Jozsa and P. 1997; Maganaris et al. 2004).  
Animal models have generally agreed with these results, showing decreased ultimate strength 
and modulus, however data on differences in collagen fibril size, diameter, density and 
organization is contradictory (Yamamoto et al. 1993; Hannafin et al. 1995; Yamamoto et al. 
2000; Lavagnino et al. 2005).  Increases in MMP-1 expression has also been shown to be 
significant with stress depervation in animals (Lavagnino et al. 2003).  
 Disuse causes many degenerative mechanical and biochemical changes in tendon. 
Comparing treatment groups to unloaded controls must first be carefully examined.  A more 
appropriate model for normalizing data may be untreated contra-lateral limbs with in vivo 
work, or moderately loaded controls with in vitro works. 
 
2.2.2 Regular Activity 
During regular activity, that is low loads within 1-3% strain with only a few 
repetitions, no changes are expected in tendon.  However, changes are possible through a 
host of intrinsic and extrinsic factors that can drastically alter the load/strain creating 
hypertrophic or atrophic conditions.  Even two individuals performing the same activity can 
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elicit varying loading conditions on the same tendon.  Some important intrinsic factors 
include malalignment, leg length discrepancy, muscle weakness, decreased flexibility, joint 
laxity, gender, age, weight as well as various predispositioning diseases (Jozsa and P. 1997).  
A common example is of malaligned loading caused by foot hyperpronation.  This is caused 
by excessive pronation of the subtalar joint in the stance phase, resulting in a whipping or 
bowstring action on the Achilles.  This not only leads to excessive loads on the Achilles, 
creating excessive stresses and strains there, but it can affect the lower leg and knee joints as 
well (Jozsa and P. 1997).  Extensor tendons of the hand are also more likely to rupture in 
patients with rheumatoid arthritis because of bone spurs that frequently form and the added 
friction associated with them (Standish et al. 2000).   
Extrinsic factors that can affect how load affects tendon includes excessive magnitude 
loads, types of movements, speed of movements, number of repetition, footwear, surface, 
training errors, environmental factors as well as poor equipment and technique.  All the 
factors indicated above can affect the loading on the tendon and cause an otherwise regular 
(or non-injuring activity) to turn into an injury even though it has been estimated that normal 
activities never exceed ¼ of the tendon’s ultimate tensile strength (Walker et al. 1964; Elliott 
1965). 
Regular use can include repetitions, provided they are accompanied with appropriate 
rest periods. No histological or cross-sectional area changes of Achilles tendon were seen in 
exercised rats, but the tensile strength was significantly increased (Jozsa and P. 1997).  
Exercising rabbits has shown the Achilles tendon to increase its CSA as much as 25% 
relative to unloaded controls.  These tendons also showed an increase in wet weight and fibril 
thickness (Jozsa and P. 1997).  Similar increases in the CSA have been shown by ultrasound 
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of race horses during training (Gillis et al. 1993).  However, 1/3 of the horses developed 
signs of tendonitis during this period.  Findings such as these demonstrate the difficulty in 
determining the proper level of exercise, even for well understood and meticulously 
monitored subjects such as racehorses.  The proper combination of loading and rest required 
for myotendinous hypertrophy, or regular loading, without developing degenerative 
conditions is not easily determinable and still requires considerable investigation. 
 
2.2.3 Strenuous Use 
 Beyond regular use, loading to levels that may cause damage is strenuous use.  This 
region does not have specific stress or strain limits and differs across individuals as well 
tendons.  It is the maximal level that individuals can voluntarily load their tendons. This is 
reached mainly in forced eccentric exercises against external loads or with fast aggressive 
movements. 
 Mechanical and biochemical data is scarce because subjects are not willing to donate 
otherwise healthy tendon, but few animal studies exist.  Maximally contracted rabbit 
fusiform muscles and pinnate muscles, showed stresses of 25 MPa and 15 MPa in their 
respective tendons (Elliott 1965).  Estimates made on patellar tendons of subjects in non-
injurious settings of kicking are 26 MPa (Standish et al. 2000), while estimates of 
weightlifters maximum stress at spontaneous PT rupture is 30 MPa (Standish et al. 2000).  
Spontaneous ruptures were rare before 1950, but are now common in many developed 
countries (Jozsa and P. 1997), likely because of the increase in recreational activity.  The 
most frequently rupturing tendon is the Achilles, and 75% of those are sports related, while 
only 2% of other tendon ruptures are sports related (Jozsa and P. 1997).  Classifying these 
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ruptures as spontaneous may be a little naive because histological assessment often displays 
considerable degenerative conditions that likely contributed to the failure (Jozsa and P. 1997; 
Buckwalter et al. 2000).   
No studies exist of otherwise normal tendons that have been aggressively loaded only 
a few times that exhibit biochemical or biomechanical changes.  Most of these injuries, as 
stated before, are athletic, which likely involves overuse and preexisting degenerative 
pathologies.  Furthermore, age has been shown to be a direct factor in ruptures (Jozsa and P. 
1997; Buckwalter et al. 2000), further enforcing the role of degenerative changes in 
otherwise spontaneous ruptures.  Ruptures that are not spontaneous or degeneration-induced 
have been observed, but in most cases they have been found to be a result of failures in the 
neuromuscular protective mechanisms (Jozsa and P. 1997). 
Given these findings, many researchers believe that even aggressive loadings 
(voluntary) are all well within the capacity of the tendon, and if given time before reapplying 
force, tendons will recover (Standish et al. 2000).  If the loadings are reapplied too quickly 
however (that is, overused), then degenerative conditions will ensue in the tendon and it will 
be more susceptible to failure, even at sub maximal loads.  
 
2.3 Response to Cyclic Load 
 It has been suggested that though the metabolic rate of the tendon is slow, repetitive 
loadings (or exercise) over an extended time period can cause degeneration and inflammation 
via biochemical, mechanical or most likely, a combination of the two pathways (Jozsa and P. 
1997; Khan et al. 2002; Wang 2005).  Up to a certain level this exercise can be beneficial, 
however if extended too long it begins to have negative effects on the tendon (Archambault 
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et al. 1995; Wang et al. 2006).  Given this difficulty in ascertaining the level at which 
exercise becomes detrimental, an examination of the response to cyclic loading is 
appropriate.  Various changes in the mechanical properties, cellular expressions and 
composition have been observed in response to cyclic load or exercise.  These responses 
have been obtained from in vivo and in vitro studies, as well as cadaveric tendons and 
fibroblasts.  These study designs are each unique in their advantages and limitations which 
must be considered when attempting to compare between the study designs. 
 
2.3.1 Mechanical Changes 
 Basic material properties of tendon are determined by in vitro ramp or cyclic loading.  
It has been suggested that tendons are similar to bones in that they have a complex 
breakdown and remodeling process (Archambault et al. 1995; Jozsa and P. 1997; Ker 2002). 
It must be noted that in vitro models do not accommodate the classic inflammatory repair 
process because they have no access to inflammatory cells usually supplied by vasculature.   
However, the repair process is slow and thus if the studies are not extended then they still 
provide invaluable information about the basic material properties of tendon.  
 Though tendon has a repair process that may potentially be similar to bone, it has 
some distinct differences. Endurance tests of human tendons have shown tendon to be devoid 
of an endurance limit, that is as stress decreases, the tendon always fails with more cycles 
(Schechtman and Bader 1997).  Utilizing a converse study design, frequency was found to be 
unrelated to failure time in human tendons (Schechtman and Bader 2002), however a similar 
study in wallaby tendon saw increases in frequency leading to shortened failure time (Wang 
et al. 1995).  A study of various wallaby hind limb tendons (Ker et al. 2000) showed the 
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fatigue life of the tendons to vary by orders of magnitude, however it is correlated with in 
vivo tissue stress.  When tendons were cyclically loaded at their mean isometric muscle 
contraction force, the fatigue life was similar for all of the tendons.  It was suggested that this 
is a tendon design criterion, that is, under stress conditions related to real life, the time to 
rupture is the same for all tendons (Ker 2002).  
 Because tendons are constantly undergoing remodeling, to fully understand the 
effects of cyclic load on tendon properties, exercise of healthy tissue is required.  Among the 
first animal exercise studies examining tendon showed rabbit Achilles tendon to increase in 
ultimate tensile stress after 40 weeks of training relative to control (Viidik 1967; Viidik 
1969).  A rat exercise study on treadmill showed decreases in the elastic modulus and 
ultimate tensile stress on the supraspianatus tendon after only 4 weeks (Soslowsky et al. 
2000).  After 8 weeks however, the ultimate tensile stress remained lower than control, but 
there was a significant increase in the cross sectional area.  Similar results were also observed 
in rat Achilles tendon exercised for 16 weeks (Sommer 1987).   
 The loss of ultimate tensile stress is either due to damage; that is, breaking of collagen 
fibrils or cross-links, or an artifact due to the increase in cross sectional area of the tendon.  
The artifact can exist if the failure load increases, but concurrent relative increase in cross 
sectional area occurs, resulting in lower ultimate stress.  This was seen in studies of exercised 
swine flexor and extensor tendons (Woo et al. 1980; Woo et al. 1981).  Their maximum 
failure load was increased significantly, but their cross sectional area increased much more 
(25% vs. 164%) causing a steep decrease in failure stress.  Functionally, if the area increase 
does not cause impingement or other gliding issues, then the stress decrease is functionally 
irrelevant if failure load increases.  Whether this is unintentional or part of normal 
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remodeling is unclear (Archambault et al. 1995; Ker 2002).  Specific analysis of the 
structural content and organization is required to assess whether this remodeling response to 
loading was beneficial or detrimental.  
 Conversely, the effects of stress deprivation are quite clear.  Stress deprivation in 
various animal studies has shown significant decreases in the weight, stiffness and the 
ultimate tensile strength of the tendon (Tipton et al. 1975; Amiel et al. 1982; Woo et al. 
1982; Tipton et al. 1986).  A final note when comparing the mechanical response to exercise 
is that of age.  Studies of mice have shown significant increases in fibril size, fibril packing 
density, ultimate strengths, cross sectional area and stiffness, (Michna 1984; Michna 1987; 
Michna and Hartmann 1989) however similar studies of rats have led authors to conclude 
that the differences are similar, but substantially less (Enwemeka et al. 1992; Archambault et 
al. 1995; Jozsa and P. 1997).  When exercising animals, loading is always external and 
difficult to control.  It has been suggested that, to understand tendinopathy, load itself must 
me more closely monitored (Archambault et al. 1995). 
  
2.3.3 Biochemical & Structural Changes 
 Histopathologic studies of tendons symptomatic for overuse tendinopathy have 
revealed various changes in the ultrastructure composition and organization.  Marked 
increases in vascularity with a lack of obvious organization of the blood vessels is often seen 
(Williams 1986; Nelen et al. 1989; Messner et al. 1999).  Most vascularity increases have 
been observed in tendon lesions and little data exists on their changes in overuse 
tendinopathies (Archambault et al. 1995).  The possible role of vascularity in tendinosis 
examined in horses (Kraus-Hansen et al. 1992), has shown tendinosis like degeneration to 
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develop with diminished blood supply.  This idea has been long postulated for the human 
Achilles tendon, which shows injury most often at the site with the most limited vascularity 
(Jozsa and P. 1997; Kjaer 2004).  
 This role of vascularity changes in tendinopathic conditions implies a critical role of 
cells, or more specifically, cellular responses in tendinopathy.  Cellular responses have been 
suggested to be the key factor that drives loading to cause tendinopathy (Leadbetter 1992).   
In preparation for this role, fibroblasts may proliferate slightly in response to strain (Yang et 
al. 2004).  More detailed analysis of tendon fibroblasts have shown them to not proliferate 
with load alone, but only when growth factors such as platelet derived growth factor (PDGF-
BB) or insulin-like growth factor-I (IGF-I) are combined with load (Banes et al. 1995).  IGF-
I, the aforementioned growth factor that increases cellular proliferation has also been shown 
to increase in exercised rats (Hansson et al. 1988).  Rats exercised into overuse show marked 
cellular proliferation (Soslowsky et al. 2000), however this increase was not normalized by 
the cross-sectional area increase of the tendon, so it is unclear whether the tendon has more 
cells relative to it’s size.  Finally, studies of exercised rats have shown quiescent tenocytes to 
turn into active fibroblasts (Zamora and Marini 1988). 
 Fibroblasts respond in a variety of ways to mechanical stimulus that could drive the 
tendon into tendinopathy like conditions.  A postmortem study of asymptomatic superficial 
digital flexor tendons (SDFT) of racehorses showed a significant increase of sulfated GAG in 
the portion of the tendon usually associated with damage, relative to other parts of the same 
tendon (Birch et al. 1998).  Also, separate studies have shown damaged and visibly 
degenerated horse SDFT to exhibit significant increases in GAG content (Kobayashi et al. 
1999).  Since GAGs, or specifically the proteoglycans they are a component of, also have a 
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role in fibril formation and organization, an abnormal GAG composition may be a good 
indicator of tendinopathy.  Along with PDGF-BB and IGF-I, other growth factors such as 
interleukin -1β (IL-1β) and transforming growth factor β1 (TGF-β) are load inducible in 
human fibroblasts (Jozsa and P. 1997; Archambault et al. 2002; Tsuzaki et al. 2003; Kjaer 
2004).  Growth factors have many roles in remodeling and if expressed excessively, could 
lead to tendinopathy. 
The cellular responses likely to have the greatest affect in driving the tendon towards 
tendinopathy are the expression, activation and synthesis of MMPs.  Immobilization results 
in pre- and post-translational decrease in MMP levels (Kjaer 2004).  However, cyclic loading 
has been shown to both induce (Archambault et al. 2001; Archambault et al. 2002; Tsuzaki 
et al. 2003) and inhibit (Lavagnino et al. 2003; Arnoczky et al. 2004) MMP expression.  The 
induction cyclic loading mechanism suggests that MMPs are released and activated due to 
loading, and then these MMPs break down the collagen, leading to tendinopathy.  This can 
be aided greatly by various cytokines and inflammatory mediators, which themselves 
increase with loading (Kjaer 2004; Sharma and Maffulli 2005; Wang et al. 2006).  
Conversely, the MMPs suppression mechanism suggests that loading collagen suppresses 
MMPs, but if that collagen is damaged then it no longer transmits load and thus acts like 
unloaded collagen and attached cells release MMPs, again leading to tendinopathy.  A study 
of rat tail tendons showed MMP expression to be dependant on very low levels of load 
magnitude and frequency (Lavagnino et al. 2003).  During short, non-damaging tests MMP 
expression was completely eliminated with only 1% strain at 0.17 Hz.  Furthermore, the 
addition of Cytochalasin D, an actin disruptor, completely eliminated all inhibitory effects 
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previously seen, implying MMP expression is modulated by a mechanotransduction pathway 
through the cytoskeleton. 
 The release of MMP through damaging loading, whether directly or indirectly, causes 
the degeneration of collagen, the main component of tendon.  Histopatholigic studies have 
shown collagen disorganization and disruption as a prevalent findings in overuse 
tendinopathies (Nelen et al. 1989; Enwemeka et al. 1992; Gillis et al. 1993; Astrom and 
Rausing 1995).  Because treatment and biopsies are not done prior to damage, the early 
stages of tendon degeneration have not been examined in human tendons.  However studies 
of over-exercised animals have shown performance decrease and frayed collagen (Barbe et 
al. 2003), as well as disorganized and damaged collagen consistent with human tendinopathy 
(Soslowsky et al. 2000), both by eight weeks.  A study of over-exercised avian tendon also 
found consistent increase of collagen disruption and turnover, as well as decreased amounts 
of pyridinoline cross links (Curwin et al. 1988).  Studies of positive exercise (those that 
caused increases in structural and material properties) show increase in collagen content 
(Woo et al. 1980; Woo et al. 1981; Michna 1984; Michna and Hartmann 1989).  Exercise in 
humans have also shown a significant increase in type-I collagen through microdialysis 
(Langberg et al. 1999; Langberg et al. 2001).  Also, positively exercised tendons show better 
alignment of collagen fibrils through birefringence (Jozsa and P. 1997).  Overall, studies that 
overload and damage tendons tend to exhibit decreased collagen content and organization, 
while those that are exercised but not overloaded tend to exhibit an increase in collagen 
content and show better organization.  Collagen, the most abundant protein in tendon, is 
modulated by load and is an important indicator of tendinopathy (Jozsa and P. 1997). 
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 Overloaded and damaged tendon can often exhibit infiltration of inflammatory cells, 
edema as well as fibrosis (Backman et al. 1990; Soslowsky et al. 2000; Wang 2005).  This is 
a common clinical observation, but again, it must be noted that clinical samples are from 
ruptured or damaged tendons.  The inflammatory cells and edema are usually a result of 
paratenonitis or rupture, as histopathologic studies have failed to find inflammatory cells in 
non-rupture tendinopathy (Astrom and Rausing 1995; Jozsa and P. 1997; Sharma and 
Maffulli 2005; Wang et al. 2006).   
 Though inflammatory cells are not found in tendinopathy, inflammatory mediators 
are frequently observed.  A microdialysis study of peritendinous space of the Achilles tendon 
showed significant increases of PGE2 in response to exercise (Langberg et al. 2003).   
Furthermore, this load induced PGE2 was inhibited with the administration of COX-2 
inhibitors. Though it is not determinable from this study what cells caused this response, 
studies of tendon fibroblasts in culture suggest their role.  Mechanically loading fibroblasts 
repeatedly has shown an increase in production of PGE2 as well as another inflammatory 
mediator, LTB4 (Almekinders et al. 1995; Wang et al. 2003; Li et al. 2004).  PGE2 has also 
been shown to be load inducible in a dose dependant manner in periodontal ligament 
fibroblasts (Yamaguchi et al. 1994).  Loading tendon fibroblasts has also shown the increase 
of COX-2 (Archambault et al. 2002; Tsuzaki et al. 2003).  PGE2 has been shown to cause 
localized degeneration as well as affect cellular proliferation and collagen synthesis, 
implicating it’s likely role in tendinopathy (Cilli et al. 2004; Khan et al. 2005).  In other 
tissue such as bone, these inflammatory mediators play a key role in general remodeling, as 
well as remodeling after damage (Radi and Khan 2005).  Their role in tendon is not currently 
known and needs to be further examined. 
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 Tendons respond robustly to cyclic loading by releasing cytokines, inflammatory 
mediators and matrix metalloproteinases which can modulate extra-cellular content, 
organization and composition.  Long term repetitive loading and the potential overproduction 
of such enzymes can cause the tendon to degenerate even if the loading level is well within 
the mechanical limit of tendon. Coupled with extrinsic factors such as age and genetics, over 
time this can manifest as tendon overuse injuries, even in sedentary people. 
 
2.4 Tendon Overuse Injuries (Clinical) 
 Tendons become overused when they are repeatedly loaded in the strenuous range (4-
8% strain). This level of loading causes microdamage, which by itself is insignificant, but if 
it accumulates because of repetitive loadings at a rate greater than the tendon’s ability to 
repair itself, it will cause a degenerative state and make the tendon susceptible to injury.  This 
damage can manifest itself as collagen fiber or cross-link damage, causing the fibers to slide 
past each other, denature, become enflamed and become painful.  Clinically, this could be 
diagnosed as tendonitis, peritendinitis, tenosynovitis, insertis, tendinous bursitis, 
apophystisis, or a combinitaion of these injuries (Hess et al. 1989).  It has been suggested 
that these terms are often contradictory and their pathogenesis poorly understood, possibly 
resulting in misdiagnosis (Wang et al. 2006).  These misdiagnoses occur because though 
there is swelling, histopathology often shows a lack of inflammatory cells that tendonitis 
implies (Astrom and Rausing 1995).  Therefore, it is suggested that these terms not be used 
until histopathological confirmation, and instead the general descriptor overuse tendinopathy 
be used (Maffulli et al. 1998; Paavola et al. 2000; Riley 2004; Wang et al. 2006).  The 
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epidemiology of overuse tendinopathies lends itself a good division between upper 
extremities and lower extremities, which are generally work and sports induced, respectively. 
 
2.4.1 Occupational Overuse  
Occupational overuse injuries focus mainly on the upper extremities, with the 
humeral epicondyles, wrist, forearm and hand common sites at greatest risk, mainly in 
manual workers who do repetitive motion.  A retrospective study (Kivi 1984) of nearly 3100 
Finnish laborers with repetitive occupational tasks observed 93% of all injuries to be on the 
upper limbs.  Peritendinitis, tenosynovitis and tendonitis were present in 58% and 
epicondylitis in 24% of all cases.  The majority of the cases were of females (69%) with the 
greatest relative risk (4-5x) of musculoskeletal disorders in the textile, leather and food 
industries relative to other industries.  The highest relative risk for musculoskeletal disorders 
came within the butchers, packers and workers of the food industry, who were 8 – 12 times 
more likely to have disorders relative to other occupations.  A review of the US Department 
of Labor, Bureau of Labor Statistics by (Gordon et al. 1995) showed 60% of all new 
occupational illnesses in 1992 were associated with repetitive motion.  Similar to the Finnish 
data, high incidence of injuries were observed in industries which require great manual labor 
such as meat packing plants (14% of all workers) and automobile plants (9% of all workers). 
An interesting note however, was that there was great increases in “safer” jobs as indicated 
by the early 10x increase in incidence of carpel tunnel syndrome over the previous 10 years.  
This is thought to be related to increased computer use, where across the same period, 
workers that used computers rose from 25% to nearly 50%.  In a separate study, of the 76% 
of musicians that have suffered performance-impairing medical problems, 2/3 were 
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musculotendinous (Jozsa and P. 1997).  These types of data provide direct evidence on the 
causative effects of repetitive occupational tasks on upper-extremity overuse injuries.  
However, whether it is an effect solely of repetitive mechanical load or whether it is due to 
chronic degenerative changes remains unclear and requires further investigation.  
 
2.4.2 Athletic Overuse 
Over the past 50 years, there has been a dramatic increase in the number of athletic 
overuse injuries treated, with some estimates now suggesting over 50% of all sports injuries 
being of this variety.  Though the increase in clinical treatment has been significantly greater, 
likely due to the increase of recreational activity in developed countries, direct scientific 
evidence of this increase is still inconclusive (Jozsa and P. 1997).  These injuries occur 
mainly in the lower extremity, because of the necessity of running, both as an exercise and as 
training in specific athletic events.  
Yearly incidence of running injuries is estimated at between 25-50%, and of these, 
50% - 75% are overuse injuries within the tendons of the knee extersor apparatus and the 
Achilles tendon, and less so posterior tibial tendonitis (Jozsa and P. 1997).  Furthermore age 
and gender play a significant role in the epidemiology of sports-induced overuse injuries.  
Age is a factor, not only because of degenerative changes in the tissue, but because of the 
nature of older patients to be more likely involved in endurance, rather than contact sports.  
Historically, men have shown more overuse injuries, however, the rise of incidence in 
women that has been seen lately leads to the suggestion that this is mainly because more men 
participate in athletic activities then women. 
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Sports related overuse injuries are numerous and often specific for certain sports. 
Soccer, long-distance running and volleyball are sports where the knee (patellar tendon 
insertion) is the major area of overuse, with Jumper’s knee and Osgood-Schlatter disease 
very common clinical issues (Jarvinen 1992).  Shin splints are a common overuse injury in 
long distance runners, tri-athletes, and cross country skiers.  Lateral epicondylitis of the 
humerus, or tennis elbow, has been reported to be the prevalent tennis injury, accounting for 
30-40% of all tennis injuries (Jarvinen 1992).  Injuries of the shoulder, most commonly 
impingement syndrome or rotator cuff tendonitis involving the supraspinatus tendon is most 
prevalent in swimming, baseball, volleyball and tennis.  It should be noted that because of the 
demand of winning on athletes, these injuries are often ignored or “played through” leading a 
predominance of the overuse injuries to be likely due to an accumulated degenerative 
condition. 
 
2.5 Etiology of Overuse Injury 
 As noted earlier, tendons display four distinct regions during loading.  The first two 
regions (toe and linear, up to 4% strain) are completely recoverable and thus no damage 
occurs.  The third region (4-8% strain) is the area of microdamage, while strain beyond that 
results in acute damage.  The microdamage, though insignificant by itself, can accumulate 
due to repetitive loadings at a rate greater than the tendon’s ability to repair itself.  However, 
how this microdamage actually occurs is debatable.  Most theories center on the cells 
reacting to collagen damage: 
The structure of the tendon is disrupted micro- or macroscopically by this 
repetitive strain (i.e., collagen fibers begin to slide past one another, causing breakage 
of their cross-linked structure, and denature, causing inflammation, edema, and pain.) 
(Josza, 1997, p164). 
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While this idea of cells reacting to the damage is likely the key contributor to the 
impending pathologic condition, it disregards the ability of the cells to cause the damage.  
Cells not only react to damage, but also react to the load itself.  Stretching of fibroblasts in 
culture has shown the release of various cytokines, inflammatory mediators and enzymes that 
potentially play a significant role in the pathology of overuse tendinopathy.  This leads to the 
possibility of the cells damaging the tendon with its response, if it is too great.  However, 
accurately translating tissue strain to cellular strain is not currently feasible, so the level of 
this cellular response cannot be directly compared to the in vivo condition.  
The clinical diagnosis of overuse injuries is usually only done after the patient has 
experienced pain or decreased function.  There is likely a long history in the tendon beyond 
the recent events that caused the pain when the patient first seeks help.  This history could 
include anything form localized degeneration to acute injuries.  Therefore the first clinical 
diagnosis can range from tendinosis to tendonitis, peritendonitis, tenosynovitis, insertitis, 
bursitis, apophysitis, or any combination of the above.   
A main distinction between the various diagnoses is the presence (or lack) of 
inflammatory cells.  Tendinosis (no inflammation) is the term used for general tendon 
degeneration.  It is this degeneration that leaves the tendon susceptible to the eventual 
damage.  Tendonitis (inflammation) is an inflammatory state with inflammatory cells, edema 
etc. associated with gross remodeling in response to severe, usually acute damage.  It is 
suggested that tendon overuse injuries are caused by tendinosis, but can be enhanced by 
tendonitis.  They are separate entities that can occur together (Backman et al. 1990; 
Leadbetter 1992; Jozsa and P. 1997) which has led to many misdiagnoses.  
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2.5.1 Tendon Degeneration (“-osis”) 
Though the prevalence of tendinosis is well known, the pathogenesis is not well 
understood.  In a retrospective study of healthy, urban Hungarians older than 35 with no prior 
evidence of tendon problems, signs of degeneration were seen in 1/3 of the patients (Jozsa 
and P. 1997).  This led the authors to conclude that tendon degeneration is very common, and 
is a function of age.  Furthermore, it is asymptomatic and no data exists to correlate 
degeneration versus previous occurrences of tendon disorders.  The asymptomatic nature of 
tendinosis is reiterated by a second study of nearly 900 spontaneous tendon ruptures, in 
which nearly 2/3 had no previous symptoms such as tenderness, stiffness or pain (Jozsa and 
P. 1997).  Furthermore, none of the spontaneous ruptures exhibited any inflammatory cell 
infiltration.  Tendinosis have a range of clinical classifications for the type of degeneration 
thought to be predominant: hypoxic, myoxid, hyaline, fibrinioid and fatty degenerations. 
Etiologically, the reason for tenocyte and collagen degeneration that leads to 
tendinosis is unknown.  Recent evidence suggests one reason may be tissue hypoxia as 
overuse is likely to damage blood vessels (Archambault et al. 1995).  Lesions, focal areas of 
concentrated growth, exhibit significant vascular proliferation.  Conversely, tendon 
degeneration regions often show empty spaces and reduced vascularity (Zamora and Marini 
1988).  In horses, tendinosis like conditions have been induced by limiting the blood supply 
(Kraus-Hansen et al. 1992).  A reduced blood supply is suspected to be the cause of the 
decrease in tenocyte viability, which in turn could initiate tendinosis (Kraus-Hansen et al. 
1992; Archambault et al. 1995; Jozsa and P. 1997).  Furthermore, the hypoxia could result 
from exercise-induced hyperthermia.  Intratendoinous temperatures of 45ºC have been 
measured in exercising horses, while in vitro fibroblast death is seen above 42.5ºC.  The 
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authors suggest that since blood often cools tissue, the lack of blood vessels could lead to 
tendinosis, especially when combined with exercise.  
Though repetitive motion induced cellular and molecular responses are thought to be 
important in the development of tendinosis, their underlying mechanisms remain unclear.  
Load inducible cellular responses that likely play a key role in driving tendon degeneration 
are cytokines, inflammatory mediators and MMPs (Leadbetter 1992; Wang et al. 2006).  
MMPs are the only proteins used to remodel the collagen matrix, and thus their potential role 
in tendinopathy is direct and obvious. MMPs are load and damage inducible, leading to the 
possibility of a positive feedback mechanism which would exacerbate the tendinopathy.  
Injection studies of collagenase have shown tendinosis like degeneration, similar to that 
observed during tendon injury, to ensue (Williams et al. 1984; Stone et al. 1999).  Cytokines 
and inflammatory mediators act indirectly through a host of cascades that can lead to 
tendinopathy.  These agents, which are load inducible, include IL-1β, PDGF-BB, IGF-I, 
TGF-β, LTB4 and PGE2.  Injection models of both cytokines and inflammatory mediators 
have shown tendinosis type degeneration (Stone et al. 1999; Khan et al. 2005).  Though their 
exact mechanism in tendinosis is unclear, it is evident that that these cytokines and 
inflammatory mediators (and possibly other markers) alter cellular signaling and induce 
tendon degeneration.  
 
2.5.1.1 Hypoxic Degeneration 
Hypoxic degeneration is defined as tendinosis caused by the lack of oxygen.  It is the 
most common form of tendinosis in all tendons except the Achilles, patellar and quadriceps 
tendons.  In a study of ruptured tendons that showed degeneration, hypoxic degeneration was 
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observed in 44%, while only 10% was observed in controls (Kannus and Jozsa 1991).  This 
type of degeneration is evident within the tenocytes and the collagen fibers. 
Microscopic observations note hypoxic degeneration to exhibit edema and small areas 
with no cells.  Larger patches with a complete loss of tendon structure and no cells 
stainability are also sometimes seen.  Metabolically, tenocytes show decreased oxidative 
enzyme activity and increased hydrolytic enzyme activity. Pyknosis of the nuclei is seen 
while the mitochondria swells (Jozsa and P. 1997).  Collagen organization shows decreased 
anisotropy, loss of periodicity and loss of birefringence.  Collagen fiber degeneration is also 
visible in the form of fragmentation, fraying and longitudinal splitting, giving the tissue a 
streaked, irregular appearance (Jozsa and P. 1997). 
2.5.1.2 Mucoid Degeneration 
Another common form of tendinosis is mucoid degeneration, where semisolid 
nodules are noted.  It is the most common form of degeneration in the Achilles tendon and 
was found in 21% of all tendon degeneration and only 9% of the controls (Kannus and Jozsa 
1991).  Visually, the tendon loses its bright white luster and has a soft grayish-white 
appearance.  Tenocytes change from their normal elongated shape and become more 
rounded, with decreased nucleus/cytoplasm ratios and increased number of vacuoles (Jozsa 
and P. 1997).  Collagen fibers are usually thin, frayed, longitudinally split and have lost their 
periodicity. The tendon also exhibits increased extracellular proteoglycan and 
glycosaminoglycan content.  
2.5.1.3 Hyaline, Fibrinoid & Fatty Degeneration 
The remaining three most common form of tendinosis are hyaline, fibrinoid and fatty 
degeneration.  Hyaline degeneration is charachterized by the appearance of nodules of 
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homogenous translucent material.  Macroscopically, tendons become yellowish, stiffer and 
less elastic.  The collagen fibers show increased thickness, fibril diameter variability is 
reduced and the cells-matrix ratio decreases.  Fibrinoid degeneration is charachterized by the 
appearance of a noticeable fibrous lesion.  The tissue becomes imbedded with fibrinogen, 
fibrin and fibronectin. Tenocytes become necrotic, collagen fibers denature and homogenate 
and the adjacent area can become surrounded by reactive cells (plasma cells, lymphocytes, 
etc.) (Jozsa and P. 1997).  The final form is fatty degeneration, characterized by lipid 
accumulation.  The various forms of this include fine droplet, masked lipidosis, lipid 
accumulation in tenocytes and tendolipomatosis.  In extreme cases the lipid cells can form 
long, complex three-dimensional chains between the collagen fibrils, whereas lipid cells are 
rarely found in healthy tendon (Jozsa and P. 1997). 
 
2.5.2 Tendon Inflammation (“-itis”) 
When patients seek treatment for their tendons, they sometimes exhibit the classic 
signs of inflammation: heat, redness, swelling and pain. This classic wound healing is a 
response to acute tissue loss or damage and results in inflammation, repair and remodeling.  
The inflammatory phase starts at day one and lasts four to seven days.  The repair phase lasts 
a further two weeks and the final phase, the remodeling lasts a further three plus weeks. 
Depending on the type of damage, the remodeling phase may last up to one year.   
The inflammation phase begins immediately as the surrounding fluids, blood and 
plasma from damaged vessels seep into the damaged area.  Platelets regulate clotting while 
fibrin and fibronectin create cross-links with collagen to control local bleeding.  Chemotatic 
agents such as histamines, fibronectin and bradykinin induce vascular permeability, 
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prostaglandin release and cellular infiltration by leukocytes, monocytes and macrophages 
ensues, usually within the first 24 hours.  Early in the response, PGE1 increases vascular 
permeability and PGE2 attracts leukocytes, while later they both may initiate early repair and 
ongoing inflammation (Jozsa and P. 1997).  As the inflammatory cells remove the injured 
area of necrotic tissue and debris, the repair stage begins. 
The repair phase begins with hypercellularity of fibroblasts, myo-fibroblasts and 
endothelial cells.  Growth factors release by macrophages and platelets stimulate cellular 
reproduction and migration.  Angiogenesis is seen and the cells begin to lay ground 
substance and extracellular matrix to replace the fibrin clot.  GAGs and type three collagen 
are present in the early stages, but collagen production soon switches to type I (Leadbetter 
1992), usually by the end of the second week and continues for about a week more. 
The remodeling phase begins by slowly decreasing the amount of inflammatory cells, 
decreasing angiogenesis rate and deceased matrix synthesis.  The scar density increases as 
fluids are slowly removed.  The amount of GAGs decrease and mainly type I collagen is left. 
Collagen maturation and alignment is seen by six months and fibroblasts revert to fibrocytes. 
As the response completes the newly formed section of tendon can have drastically different 
material composition and properties as the rest of the tendon and can be 30% weaker, 
depending on the healing response (Leadbetter 1992).   
This inflammatory response affects certain well-vascularized areas of certain tendons, 
but mostly it is seen in the peritendinous structures.  Actual tendonitis is rare and usually the 
observed inflammation is peritendonitis or tenosynovitis.  This peritendinous inflammation 
can become self-perpetuating and secondarily involve surrounding structures, that is cause 
tendonitis.  Peritendonitis and tendinosis have been shown to be separate entities (Backman 
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et al. 1990; Leadbetter 1992; Jozsa and P. 1997).  Tendonitis is rarely the cause of overuse 
tendinopathy though it can be seen in conjunction with tendinosis (Leadbetter 1992; Jozsa 
and P. 1997; Khan et al. 2002).  Though there is not inflammation in tendinosis, the release 
of load inducible inflammatory mediators such as prostaglandins, leutrokines and cytokines 
may drive the tendon into tendinosis (Khan et al. 2005; Wang et al. 2006). 
 
2.6 Arachidonic Acid Cascade 
 Arachidonic acid is an essential, polyunsaturated, 20-carbon omega-6 fatty acid.  The 
source of arachidonic acid is exogenous supply or dietary linoleic acid that is esterified into 
the phospholipids of the cell membrane.  Upon an external stimulation, such as an 
inflammatory response, G proteins initiate phospholipid hydrolysis to release arachidonic 
acid into the cytoplasm.  Phospholipase A2 (PLA) achieves this directly, while phospholipase 
C and phospholipase D require further enzymes to produce free arachidonic acid.  The 
amount of free arachidonic acid in resting conditions is very low and thus exogenous 
diffusion is negligible.  However, studies with artificially introduced exogenous arachidonic 
acid have shown that, if present, these will be absorbed and metabolized by the cells and that 
they will also inhibit any unnecessary phospholipid hydrolysis from the cell membrane 
(Brash and Ingram 1986).  Once free, the arachidonic acid in the cytoplasm has three fates: 
esterification into the cell membrane (storage), diffusion outside the cell or metabolism.  
Once outside the cell, newly freed arachidonic acid (and exogenous arachidonic acid) 
has been suggested to have several roles, even without enzymatic modifications.  One such 
role is to activate leukocyte NADPH oxidase, which reduces molecular oxygen to superoxide 
and induces respiratory bursts (Badwey et al. 1981).  Arachidonic acid has also been shown 
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to affect the activity of several ion channels such as mechanosensitive potassium, calcium 
and gap junctions (Brash 2001).  It has also been shown to block cellular proliferation and 
drive cells into apoptosis (Surette et al. 1996).  The lack of specificity of arachidonic acid is 
suggested to be a result of its simple structure and the existence of many close chemical 
analogues.  The effects of arachidonic acid are wide ranging, but the concentration levels 
required are 1000 – 100,000 times those of its metabolites such as prostaglandins and 
leukotrienes (Brash 2001).  Furthermore, platelets esterify arachidonic acid even in 
environments with metabolizing agents such as cyclooxygenase and lipoxygenase present 
suggesting that the role of free, unmetabolized arachidonic acid is very limited (Neufeld et al. 
1983). 
 
Figure 3: Arachadonic Acid Pathway 
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The final, and most important, fate of arachidonic acid is the metabolism of several  
hormones with wide ranging effects.  The metabolism pathway is driven by one of three main 
enzymes: cytochrome P450, lipoxygenase and cyclooxygenase.  The cytochrome P450 
enzyme produces epoxyeicosatrieonic fatty acids (EpETrEs) which have varied responses 
such as detoxification.  The lipoxygenase and cyclooxygenase enzymes produce eicosanoids 
such as leukotrienes, prostanoids and thromboxanes.  These are metabolites with a host of 
autocrine and paracrine responses in the management and regulation of inflammation and its 
symptoms. 
 
2.6.1 Lipoxygenase Pathway 
 Arachidonic acid is oxidized by one of three main isoforms of lipoxygenase: 5-
Lipoxygenase (5-LO), 12-Lipoxygenase (12-LO) and & 15-Lipoxygenase (15-LO), 
numbered for the steric position they oxidize to form 5, 12 or 15-
hydroperoxyeicosatetraenoic acid (HPETE).  HPETEs then are converted to lipoxins, 12-
HETEs and leukotrienes of the 4 series, which are both pro and anti-inflammatory. 
 There is limited knowledge about the 12-LO pathway, but it is primarily expressed in 
the pituitary gland, leukocytes, platelets and the lungs (Yoshimoto et al. 1990).  Fluctuations 
in the levels of 12-LO causes apoptosis and high levels have been observed in breast cancer 
(Natarajan et al. 1997).  Its main role lies in regulating cellular concentrations, either through 
apoptosis or through proliferation, during inflammation and normal maintenance for various 
tissues. 
 The 15-LO pathway produces the lipoxins (A4 and B4).  Lipoxins are anti-
inflammatory eicosanoids that signal the end of inflammation. They are known to inhibit 
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leukocyte-mediated injury, stimulate macrophage clearance of apoptotic neutrophils, 
suppress inflammatory cytokines, modulate cytokine regulated MMP activity, and inhibit 
cellular migration and proliferation (McMahon and Godson 2004).   A potential therupatic 
role of lipoxins is protecting from leukocyte-mediated tissue injury and is a large area of 
current research (McMahon and Godson 2004). 
 The most studied area of lipoxygenase is the 5-LO pathway that produces the 4 series 
leukotrienes.  5-LO is activated by a protein bound to the nuclear membrane, 5-lipoxygenase 
activating protein (FLAP).  The resulting leukotrienes act mainly on G protein coupled 
receptors and sometimes on peroxisome proliferator-activated receptors (PPARs).  They all 
play a role in the inflammatory process.  Leukotriene B4 (LTB4) stimulates aggregation and 
degranulation of neutrophils, supports chemotaxis of leukocytes, modifies cellular 
proliferation and triggers pro-inflammatory responses (Jampilek et al. 2006).  Leukotrienes 
are involved intimately in asthma and other allergic reactions.  Anti-leukotrienes, drugs that 
block leukotrienes synthesis or antagonize their binding sites, were once heavily researched 
but their negative effects on the liver has curtailed their research (Reinus et al. 2000).   
Currently anti-leukotrienes are used only for psoriasis medication and asthma (Jampilek et al. 
2006). 
 
2.6.2 Cyclooxygenase Pathway 
 Arachidonic acid can be metabolized by cyclooxygenase enzymes to form 
prostanoids.  The rate limiting step of prostanoid synthesis is driven by the three isoforms of 
cyclooxygenase to oxidize free arachidonic acid into PGG2.  Peroxidase then immideately 
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reduces the PGG2 into PGH2.  Then several synthases, specific to cell types, convert the 
PGH2 into the various prostanoids: thromboxanes, prostacyclins and prostaglandins. 
 The cyclooxygenase enzyme has two established isoforms (COX-1 and COX-2), and 
a third, recently described isoform (COX-3).  All three catalyze the identical reaction, with 
the same kinetic rates, however their active sites are distinct and independent (Claria and 
Romano 2005).  COX-1 is the constitutive form and is produced at low levels by most cell 
types.  COX-2 is the inducible form that is not found in most resting cells, but is heavily 
expressed in the presence of cytokines, growth factors, endotoxins and other external 
stimulations.  COX-3 is a variant of COX-1 isoform, in which the first intron is not spliced 
during transcription. The isoforms share nearly 80% homology, and their major difference is 
the amino acid at position 523: isolucine in COX-1 and valine in COX-2 (Claria and Romano 
2005).    
 Following the action of the cyclooxygenases and peroxidase to convert arachidonic 
acid into PGH2, specific synthases, convert the PGH2 into thromboxanes, prostacyclins, and 
prostaglandins D, E and F.  Thromboxanes are produced only in platelets, while prostacyclins 
are produced only by endothelial cells.  Thromboxanes and prostacyclins are antagonist, 
homeostatic agents that control blood flow and clotting.  However, prostaglandins are 
produced in most cell types.  The opening of the endoperoxide ring of PGH2 at c-9 and c-11 
and subsequent attachment of functional groups at those sites produce the prostaglandins.  A 
ketone at C-9 and hydroxyl at C-11 produces prostaglandin E2, while the converse hydroxyl 
at C-9 and ketone at C-11 produces prostaglandin D2.  Reduction with NADPH leads to 
hydroxyl groups at both C-9 and C-11 and produces prostaglandin F2α.  The nomenclature of 
the subscript 2 signifies the two double bonds (C-5/6 and C-13/14) and the alpha signifies 
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stereochemistry of O-9.  Prostaglandins primary role lies in mediating inflammation, but they 
are also known to facilitate calcium movement, hormone regulation and control cell growth. 
 All prostanoids have short life spans and are immideately transported out of the cell 
through prostanoid transporters.  Their autocrine and paracrine responses are conveyed 
through G protein coupled receptors and somtimes PPARs.  Nine specific GPCRs have been 
identified: DP-1 and DP2, EP1 through EP4, FP, IP and TP for PGDs, PGEs, PGFs 
prostacyclins and thromboxanes, respectively.  Depending on cell type, receptors may inhibit 
or stimulate cAMP formation, or may activate a phosphatidylinositol signal pathway leading 
to intracellular calcium release (Narumiya et al. 1999).   
 
2.7 Clinical Treatment  
 The pathogenesis of tendon overuse injury is still unknown, leading to a debatable 
treatment methodology.  Further debate ensues because chronic cases are treated as 
inflammation even though histopathology clearly reveals a lack of inflammatory cells 
(Astrom and Rausing 1995).  Few studies have thoroughly examined the efficacy of 
empirically based treatment protocols, even though most treatments are based on these 
observations (Jozsa and P. 1997; Khan et al. 1999).  The most common treatment methods 
are rest, controlled exercise, pharmaceutical agents, a host of physical modalities and 
surgery. 
 
2.7.1 Rest 
 The first treatment option is to discontinue the overuse, or rest because tendinosis is a 
degenerative condition brought on by overuse.  There is likely structural damage in the form 
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of collagen fiber tears and cross-link breaks at this stage (Khan et al. 1999; Wang et al. 
2006).  Rest is intended to allow the tendon time to heal itself because until now, the damage 
rate has been greater then the repair rate.  However, the slow metabolic rate of tendon, almost 
1/10 the oxygen consumption of muscle, means it will likely require a much longer healing 
time than most doctors prescribe or patients allow.  If the clinical condition is not severe, 
sometimes reduced activity level is prescribed when rest should always be prescribed first. 
Rest is meant as the cessation of the exercise, and not immobilization which causes atrophic 
conditions. 
 Treatment of tendinosis is usually sought after the occurrence of pain or performance 
loss.  Because tendinosis is a largely asymptomatic degenerative condition, the first 
indications of pain is likely observed well into the degenerative state (Leadbetter 1992).  In 
mild cases, that is without other compounding injuries, pain is therefore not a good indicator 
of damage and tissue repair may require months, instead of the weeks (Khan et al. 1999).  
Tenocytes are suggested to require roughly 2 to 3 weeks to fully initiate a tissue response 
(Jozsa and P. 1997), therefore it is advised that at least this amount of rest be afforded the 
tendon before gradual exercise is introduced again. 
 
2.7.2 Exercise 
 It has been suggested that extrinsic factors such as improper training and equipment 
can cause overloading of tendons, leading to tendinopathy.  Before resuming exercise, these 
factors should be checked, and if necessary, corrected with proper braces, equipment or 
shoes.  After a few weeks of rest to initiate the repair process, it is suggested that 
strengthening and stretching exercises, particularly eccentric exercise be performed (Clement 
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et al. 1984; Stanish et al. 1986).  Various clinical studies have shown aggressive loading to 
relieve symptoms, as well as effectively help in healing (Clement et al. 1984; Alfredson 
2003).  While the exact mechanism that facilitates this healing is not know, it has been 
suggested to be a result of increased load magnitude and frequency inducing an increase of 
tenocytes metabolism (Kannus et al. 1997).   
Controlled stretching is likely to increase collagen synthesis and improve fiber 
alignment, resulting in better mechanical strength of the healing tendon.  Collagen unstressed 
during the proliferative and remodeling phase are less organized and weaker (Sharma and 
Maffulli 2005).  Furthermore, repetitive motion has been shown to induce a host of cellular 
responses such as DNA increase, protein synthesis and cellular proliferation, even at low 
loading rates.    
 
2.7.3 Pharmaceutical Treatments 
 Often, if rest and controlled exercise aren’t sufficient or the pain is too severe, 
pharmaceutical treatments are pursued.  The most common pharmacologic agents used in the 
treatment of tendinosis are non-steroidal anti-inflammatory drugs (NSAIDS).  Other 
pharmaceutical treatments, not all currently used, include corticosteroids, aprotinin, heparin, 
sclerosing agents and ground substance. 
 2.7.3.1 NSAIDS 
 The oldest synthetic drug, and the one often given credit for beginning the 
pharmaceutical industry is Aspirin, an NSAID.  The history goes back as far as the 5th 
century BC when Hippocrates noted the use of willow bark extract to ease aches and pains 
and reduce fever.  Over time this was extracted and isolated, but side effects such as gastric 
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problems and even death made this drug unsafe.  German scientists at Bayer managed to 
change a hydroxyl group to an acetyl group which instantly reduced the side effects.  It has 
proceeded to become the oldest and one of the most successful drugs, but the mechanism of 
action did not become apparent until the 1970s (Vane and Botting 1992). 
 Studies by Vane (Vane and Botting 1992) showed that Aspirin and other anti-
inflammatory medications worked by inhibiting cyclooxygenase.  A host of drugs with 
similar roles existed or were then manufactured, including other salicylates (like Aspirin), 
arylalkonic acids (like Indomethacin) and profens (such as Ibuprofen).  More potent versions 
like oxicams (Pirixocam) soon were manufactured, but these drugs began to show side 
effects of Dyspepsia, gastric ulcers and diarrhea.  It was later discovered that there were 
many isoforms of COX and that these NSAIDs blocked all of them. The discovery of COX-2 
led to the development of COX-2 specific NSAIDs (COXIBS) such as Celecoxib, Rofecoxib, 
Valdecoxib and others.  As long term clinical trials with these drugs became available, many 
years after the drugs were already being prescribed, they tended to show a potential risk of 
heart attacks when taken chronically.  Certain Coxibs have been both banned and voluntarily 
withdrawn amidst pending litigation.  Finally, acetaminophens, long known to have fever 
reducing and analgesic effects are labeled NSAIDs but their ability to inhibit COX-1 or 
COX-2 has not been shown.  Recently discovered COX-3 however has been shown to be 
effectively inhibited by acetaminophens (Chandrasekharan et al. 2002).  
Prostaglandins have many effects, one of which is to play an extensive role in the 
inflammation driven remodeling and repair process of musculoskeletal tissue such as bone 
(Radi and Khan 2005).  It is blocking this action that makes NSAIDs anti-inflammatory, and 
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combined with the fact that inflammatory mediators are seen in tendonitis as well as 
tendinosis is the basis for NSAID use in tendinopathy.  
Theoretically, these should have no affect on tendinosis, a non-inflammatory 
condition.  NSAIDs also have analgesic effects that may make patients ignore pain and 
further damage the tissue, suggesting many to call for more investigation of their use 
(Almekinders 1990).  Furthermore, the effects of NSAIDs in tendinosis have not been 
systematically evaluated, and the few studies that have examined it have found no beneficial 
effects (Jozsa and P. 1997; Almekinders and Temple 1998).  However, even though an 
inflammatory cell cascade is not present, there are several load induced inflammatory 
mediators, cytokines and growth factors expressed by the intrinsic fibroblast in tendinosis 
(Almekinders et al. 1995; Wang et al. 2006).  Affecting alternate mechanisms such as these 
remains a likely method of action for NSAIDs (Khan et al. 1999).  In one such example, 
NSAIDs block PGE2 which has been shown to increase collagenase production, increase cell 
death and create tendinopathy (Khan et al. 2005).  
2.7.3.2 Other Pharmaceutical Agents 
Other pharmaceutical agents used include corticosteroids, aprotinin, heparin, 
sclerosing agents and ground substance.  Corticosteroids are quite controversial and not used 
as much currently because tendinosis is a non-inflammatory condition and they have been 
shown to inhibit collagen synthesis and decrease the strength of the tendon (Clement et al. 
1984; Jozsa and P. 1997; Wang et al. 2006).  Corticosteroids work further upstream than 
NSAIDs, and their full effects are even less understood.  Furthermore, they have been 
established to cause cell death and atrophy in injection studies (Nirschl 1992; Khan et al. 
1999).  Other pharmaceutical agents used include the protease inhibitor aprotinin and the 
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anticoagulant heparin.  Injections of ground substance, mainly glycosaminoglycans, as well 
as sclerosing agents have shown some positive results (Alfredson 2003). 
 
2.7.4 Physical Modalities 
 Phyisiotherapists have also employed a wide range of physical modalities such as 
ultrasound, laser photo-stimulation, deep heat, pulsed magnetic/electromagnetic fields and 
electrical stimulation.  The intended purposes of these modalities are similar to those seen in 
various other tissues such as to disrupt the affected region and promote remodeling through 
the mechanical effect of high-frequency sound waves or increase local blood flow and heat 
(Wang et al. 2006).   
Ultrasound has been shown to increase collagen synthesis by tendon fibroblasts and 
increase the tensile strength in animal models (Jackson et al. 1991; Enwemeka et al. 1992).  
Laser photostimulation has been shown to significantly increase collagen concentrations, 
which combined with ultrasound and electric stimulation was shown to increase the 
biomechanics of rabbit tendon (Gum et al. 1997; Reddy et al. 1998).  Bipolar radiofrequency 
treatment has been suggested because of its ability to stimulate blood vessel formation and 
regulate vascular endothelial growth factor (VGEF), α-V-integrin and other growth factors 
while not compromising the strength of the tendon (Tasto et al. 2003; Silver et al. 2004).   
Because NSAIDs are thought to provide mainly analgesic effects and may have 
unintended side-effects, extracorporeal shock-wave treatment has been suggested because it 
too has established analgesic effects but little reported side-effects (Speed 2004; Wang et al. 
2006).  All physical modalities of treatment are controversial because they are mainly 
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adaptations from other tissues and their long term effects have not been clinically established 
in tendon (Rivenburgh 1992). 
 
2.7.5 Surgery 
 In most cases of tendinosis, surgery is not recommended because its benefits have not 
been systematically documented.  Chronic cases of tendinosis which are not responsive to 
non-operative treatments and still exhibit pain and performance loss are the majority of cases 
accepted for surgery.  The goals for surgery include inducing scar repair, removing affected 
portions of the tissue, encourage revascularization, relieve excess pressure and overload and 
repair/replace if there is rupture.  
The main method utilized is to excise the affected sites on the tendon after a 
longitudinal tenotomy (Nelen et al. 1989; Leadbetter et al. 1992; Alfredson 2003).  Another 
common method is to make multiple percutaneous incisions to promote blood circulation, 
enhance oxygen uptake and induce macrophage migration (Wang et al. 2006).  Grafts and 
tendon transfer are always options for severe cases.  The main hope of the surgery is to 
induce an inflammatory healing response.  This inflammatory response would induce 
macrophages which remove damaged cells and matrix as well as release growth factors.  The 
resulting fibroblast proliferation and collagen synthesis likely drives the repair process 
(Wang et al. 2006).  Even though there is a prevalent surgery history, good results of surgery 
are poorly documented histologically and little data exists to suggest that normal tendon 
properties are ever reached (Burks et al. 1990; Leadbetter et al. 1992).  It has been suggested 
that the postoperative healing response and careful rehabilitation, and not the surgery itself is 
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the cause of the tendon improvement (Leadbetter et al. 1992; Khan et al. 1999).  Therefore, 
in most cases tendinosis (barring rupture), non-operative measures are the gold standard. 
 
2.8 Overuse models 
To better understand the etiology of overuse tendinopathy many models have been 
examined.  Various in vitro and in vivo animal models, as well as a human model have been 
developed.  The various models offer great insights into the possible factors affecting overuse 
tendinopathy, however they also contain some shortcomings.  Improvements to existing 
models or an improved model, specifically in controlling loading, would be beneficial in 
better understanding tendon overuse injuries (Archambault et al. 1995; Jozsa and P. 1997). 
 
2.8.1 In Vitro Overuse Models 
Understanding overuse injuries of tendons first requires the understanding of the 
basic effects of cyclic load on tendon. To this effect, the most basic model of overuse injuries 
is that of the time-dependant response of tendon to load.  In the same manner all basic 
material properties of tendons were developed, isolated specimens are cyclically stretched by 
external force on material testing systems while the specimen deformation and applied force 
are recorded. This model has adequately demonstrated the accumulation of fatigue 
microdamage by verifying the existence of time dependant properties of stress-relaxation, 
creep and mechanical hysteresis in tendon (Rigby et al. 1959; Viidik 1973; Butler et al. 
1978; Schechtman and Bader 1997; Ker et al. 2000; Schechtman and Bader 2002).  
However, the biggest limitation of this model is the use of tendons devoid of cellular activity, 
a potentially significant contributor to overuse injuries. 
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The converse model of tendon overuse injury is that of cyclically loading cells in 
culture.  Because cells likely play a significant role in overuse injuries through the 
modulation of repair and remodeling, their response to cyclic load must be examined.  The 
cellular model consists of stretching fibroblasts on deformable substrates in culture and 
examining their response.  This model has demonstrated that cells express mRNA and 
proteins of various agents in response to cyclic load.  Some common expressions that likely 
play a role in the development and modulation of injury are cytokines, inflammatory 
mediators, growth factors and proteases (Banes et al. 1995; Banes et al. 1999; Tsuzaki et al. 
2000; Archambault et al. 2001; Tsuzaki et al. 2003; Yang et al. 2004).  The biggest 
limitation of this model arises from the lack of an extracellular matrix.  The equivalent tissue 
strain cannot be determined, nor can the effects of the cellular responses on the matrix. 
The last in vitro model, tissue explants, attempts to bring together the effects of cyclic 
loading on the tissue as well as the cellular response.  This model incorporates the use of a 
tissue loading device, usually custom designed, to cyclically load viable explants.  This 
model allows for the examination of loading and stress deprivation on various cellular 
expressions and matrix composition (Slack et al. 1984; Hannafin and Arnoczky 1994; 
Hannafin et al. 1995; Tanaka et al. 1995).  Because the loading is controlled, the various 
features of loading, that is, magnitude, frequency and duration can be controlled and their 
effects on tendon strength, matrix composition and cellular responses can be observed 
(Arnoczky et al. 2002; Lavagnino et al. 2003; Arnoczky et al. 2004).  The main limitation of 
explant models thus far is the inability to mechanically damage tendons through sufficient 
loading.  This is a limitation of existing devices, not of the explant model in general. 
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However, a limitation of all explants is the inability to account for damage and responses 
associated with in vivo motion such as those around joints and pulleys.  
 
2.8.2 In Vivo Overuse Models 
The models used most often however are animal exercise models, usually consisting 
of treadmill exercise.  Such models have been used for the Achilles, patellar, digital flexor, 
digital extensor and supraspinatus tendons of either rats, rabbits or swine.  As discussed 
earlier, such models have been used to show atrophy-like disuse characteristics, as well as 
exercise induced hypertrophy in the form a collagen, GAG, MMP and stress change (Viidik 
1969; Tipton et al. 1975; Woo et al. 1980; Amiel et al. 1982; Sommer 1987).  The Achilles, 
patellar and flexor tendons are suitable for overuse studies from the knowledge that, 
anatomically, the rat is very similar to humans. However, extensive work to detail the 
kinematics of rat tendon during free locomotion for comparison has not been made and most 
of these models are not quantifiable (Archambault et al. 1995).  
 The first quantifiable model examined the controlled motion of an anaesthetized 
rabbit Achilles tendon on a kicking machine (Backman et al. 1990).  Degenerative changes 
were seen visibly in the form of nodules, increased vascularization, edema, and infiltration of 
inflammatory cells.  Models of this type are beneficial because the loading can be indirectly 
controlled and the animal will not have the ability to distribute its weight to compensate.  
Another model is that of the rat supraspinatus tendon, determined thorough a comparative 
examination of rat and human anatomy (Soslowsky et al. 1996).  The importance of this 
model is that it is the first such model for a tendon that is susceptible to injury by intrinsic 
factors such as pinching, making it suitable for rotator cuff overuse studies.  This model is 
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however, a treadmill exercise model of the rat and thus quadruped vs. biped differences must 
be noted.  
The final sets of animal models are those which use in-vivo measurement techniques 
to monitor tendon during overuse injury. The first set of these methods are invasive and 
include the implantation of a pressure-sensitive transducer, a buckle transducer sensitive to 
flexion, measuring intratendinous pressure with fiber optic cables, a length measuring device 
or a force transducer (Meyer et al. 2004).  These methods are good for direct measurement of 
forces, but questions have arisen about the damage incurred during the implantation and that 
they have not been successfully used for long (>24hr) term studies.  A second set of models 
are non-invasive and examine tendon properties ultrasonically just after exercise. This 
method is particularly good for determining the area change and detecting the onset of 
tendinopathy (Gillis et al. 1993). 
Because animal exercise models can be costly and are often inconsistent, an 
alternative approach studied has been animal injection models (Wang et al. 2006).  These 
models include the injection of collagenase, cytokines and inflammatory mediators. The 
collagenase injection studies create tendon degeneration, but seem to recreate the tendon 
healing response to traumatic injury, whereas tendinosis is a slow degenerative condition 
(Riley 2004; Sharma and Maffulli 2005).  Cytokine injections are usually done by injecting a 
mixture of cytokines, growth factors and other unknown agents that are derived from 
synovial fibroblasts in response to an inflammatory agent (Stone et al. 1999).  Tendon 
degeneration is observed, but the complete composition of agents injected is unknown and is 
derived from a process that is not repetitive loading, the cause of tendinosis.  The final 
injection model is that of prostaglandins.  Since these inflammatory mediators are load 
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induced and acts upstream to collagenase and other factors in tendinosis, it may be a good 
model.  Peritendinous rat Achilles tendon injection of PGE1 has shown fibrosis and intra-
tendinous degeneration (Sullo et al. 2001). Direct injection of PGE2 was shown to cause 
degenerative conditions in rabbit patellar tendons as well (Khan et al. 2005).  Of the injection 
models, the final approach of injecting upstream factors directly observed in tendinosis is 
likely the best approach, but it may be improved by adding other load-inducible factors such 
as IL-1β and TNF-α if micro-injuries undergo similar healing response to traumatic injuries 
(Wang et al. 2006). 
A final model that must be noted, though it has not been used for overuse studies yet, 
is the human model.  All animal model listed above are possible for application on humans, 
but are well beyond regulations for human subjects. One type of in vivo human studies that is 
currently being examined is that which measure the intratendinous fluid via a micro-catheter 
during specific exercises (Langberg et al. 1999).  There are limitations on the exercise that 
subjects can perform as well as the ability to collect only fluids and not tissue samples, but 
consistent results of increases in collagen turnover and PGE2 have been seen with this 
approach (Langberg et al. 2001; Langberg et al. 2003). 
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CHAPTER 3 
AIMS 
 
3.1 Aim 1 – Elastic Strain Limit 
 The elastic strain limit of tendons has long been established at 4% strain. This is the 
level beyond which irrecoverable damage occurs. However, these studies were performed 
with older methodologies that may have negatively influenced the results. To reassess the 
elastic limit more accurately with newer gripping and strain monitoring methodologies, 
tendons will be loaded to subfailure strains, allowed to rest for 5 minutes, and then loaded to 
failure. 
 Hypothesis:  
 Strain levels significantly greater than previously thought, will be required to 
cause irrecoverable damage to the tendons.  
 
3.2 Aim 2 – Tendinopathy Model 
 The effect of cellular responses on the extracellular matrix and the inherent 
complexities of in vivo loading require the development of an in vitro explant model to 
precisely model the cyclic loading level effect on tendon material and compositional 
properties such that tendon degeneration can be studied.  A new pneumatic tissue loading 
device (TLD) and a high-speed real time video strain analysis (VSA) system will be 
  
developed, calibrated, have their performance characteristics established and tested for the 
ability to create and monitor damage. 
 Hypothesis: 
1) The new TLD will be capable of applying repeatable, damaging cyclic loads 
while maintaining the viability of the tissue, allowing for short term overuse 
tendinopathy studies. 
2) The new VSA system will be capable of measuring midsubstance strain, giving a 
more accurate representation of tissue damage without compromising tissue 
viability. And, this can be done during cyclic loadings within tissue culture. 
 
3.3 Aim 3 – Tissue Response 
 With an overuse tendinopathy model established, the next aim is to utilize the model 
to perform a cyclic loading study and examine the biochemical and biomechanical response 
of tendon.  A fixed number of cycles (86,400) will be varied across two periods (Short – 
1day, Long – 12 days) at two loading levels (Low – 3 MPa, High – 12 MPa). Composition, 
sGAG and collagen, will be measured as well as cellular responses (LDH, PGE2 and 
collagenase). Strain analysis during loading, as well as failure testing after the loading will 
help in monitoring the mechanical properties of the tendons. 
 Hypothesis: 
1) Composition – The low loading groups will not cause any damage and thus will 
not exhibit compositional changes. The short duration will not cause measurable 
compositional changes, but the short-high group will cause damage. The high 
group across the longer period will cause increase in GAG and decreased collagen 
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content, signs of tendinosis, because of the extra time.  Minimal viability changes 
will be seen, possibly a decrease in the high-long group. 
2) Cellular responses – Again, the low loading groups will not cause significant 
changes in the cellular responses because the loading will not be damaging. The 
high groups however, will both exhibit increased PGE2, LDH and collagenase 
with the long period group exhibiting a greater response in each instance. 
3) Mechanical Properties – The low loading groups are not intended to be damaging 
and thus we expect minimal changes in any mechanical property in these groups. 
The high short group will exhibit increased damage in the form of reduced 
stiffness, increased strain as well as lower failure strength. Again, we expect the 
high long group to exhibit a similar but more pronounced response. 
 
3.4 Aim 4 – Magnitude Response 
 Having determined the tendon response to load and how this changes across time, the 
next aim is to establish the load magnitude effect of this response.  A similar loading model 
will be utilized to load tendons to the same number of cycles but across four loading levels (0 
MPa, 3 MPa, 12 MPa and 18 MPa). This study will be performed across a period of 3 days. 
This period should be long enough to allow time for responses, but yet short enough to 
eliminate any duration dependant effects. 
 Hypothesis: 
1) Composition – A magnitude dependant sGAG increase will be seen, while 
collagen decrease will be seen in the highly loaded groups (12 and 18 MPa) but 
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not the 3 MPa or unloaded groups. There will be no viability changes in the 0 and 
3 MPa groups with a possible decrease in the 12 and 18 MPa groups. 
2) Cellular Responses – PGE2 levels will be highly magnitude dependant as will cell 
death and collagenase levels. Overall, the 3 MPa group will be very similar to the 
0 MPa group, if not slightly better.   
 
3.5 Aim 5 – COX Inhibion 
 An expected consistent response in our tendinopathy model is the load-magnitude 
dependant PGE2 response. A known inflammatory mediator with both positive and negative 
affects, it is also a source of clinical focus as its inhibitors are prescribed for overuse 
tendinopathies.  Furthermore PGE2 may be linked to various other responses we monitor 
(GAG, collagenase, cellularity, collagen content).  NSAIDs are prescribed in tendinopathy 
even though a full inflammatory process does not exist.  To examine the their effects in 
tendinosis, selective and non-specific COX inhibitors, as well as exogenous PGE2, will be 
applied to cyclically loaded tendons.  This will be done with the same model with a fixed 
number of cycles, across six days and three loading levels (0 MPa, 3 MPa and 12 MPa). 
 Hypothesis: 
1) Composition – The groups with the COX inhibitors will see reduced changes in 
the sGAG content and collagen content relative to untreated but loaded groups. 
The converse will hold for the exogenous PGE2 groups, which will see a more 
pronounced magnitude dependant sGAG increase and collagen decrease than the 
untreated but loaded group. 
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2) Cellular Response – The COX inhibitor treated groups will decrease the PGE2 
levels in the media as well as the LDH and collagenase levels at all of the loading 
levels relative to control. Any magnitude dependant responses will be diminished. 
The converse will hold true in the exogenous PGE2 groups with the greatest 
effects seen in the highly loaded groups. 
3) Mechanical Properties – The COX inhibitor treated groups will show increased 
mechanical properties relative to the control groups. The exogenous PGE2 treated 
groups will show the converse, decreased mechanical properties relative to the 
control groups. 
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CHAPTER 4 
ELASTIC STRAIN LIMIT  
 
Devkota AC & Weinhold PS, 2003. Mechanical Response of Tendon Subsequent to Ramp 
Loading to Varying Strain Limits. Clinical Biomech (Bristol, Avon) 18, 969-974. 
 
 
4.1 Abstract 
Objective:  To determine the in vitro elastic limit of avian flexor tendons utilizing more 
current methodologies. 
Design:  Assess the mechanical changes between subfailure and subsequent failure ramps at 
various loading levels. 
Background: Currently accepted values of elastic strain limits were determined utilizing 
older methodologies.  Consequently, reported values are fairly small and imply matrix 
damage occurs with small strains. 
Methods: Flexor tendons were loaded in vitro, to various subfailure strain levels between 1% 
and 14%, allowed to rest for 5 minutes, then taken to failure.  Suture markers, across the 
midsubstance, and cryo-grip displacement were monitored for strain using a video strain 
analysis system and a linear variable displacement transducer, respectively.  The mechanical 
changes between the various subfailure and failure ramp loadings were assessed. 
Results: Varying strains of subfailure ramp loading did not influence (P>0.05) the ultimate 
tensile failure strength, elastic modulus, strain at failure, or strain energy density of tendons.  
  
In addition, residual strain after subfailure loading was not significant, nor was it influenced 
by the level of the subfailure loading. 
Conclusions:  Tendon behaves elastically under ramp loading to significantly higher strains 
(nearly failure) than previously reported (4%). 
 
Relevance 
This study has found strain thresholds required to cause matrix damage to be 
significantly higher than previously thought, implying that matrix changes to acute loading 
events are more a result of the cellular response to the loading event.  The clinical relevance 
is that the clinician may have a greater opportunity to prevent matrix changes than once 
thought by biochemically altering the cellular response.  
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4.2 Introduction 
Acute strains and cumulative trauma injuries to tendon are a common and growing 
clinical problem having debilitating effects on an individual’s activity level and quality of 
life.  While the pathophysiology following these injuries is complex, it is believed that 
loading of the tissue beyond specific mechanical limits can cause irreversible damage to the 
extracellular matrix, resulting in a permanent change in the mechanical characteristics of the 
tendon.   Furthermore, resident cells of the tissue and infiltrating cells must react to the 
damage of the tissue with a wound healing response in order to repair the injury (Leadbetter 
1992).    The specific mechanical limits that cause damage to tendon have been largely 
inferred based on single tensile loading tests conducted to failure, while few studies (Rigby et 
al. 1959; Abrahams 1967) have examined how the mechanical response of tendon changes 
with loading to subfailure levels.  Such information would help identify the mechanical 
thresholds (strain), at which matrix damage begins to occur in tendon.    In addition, with the 
increased interest in examining how cell viability and metabolism of cultured tissue explants 
or cells grown on deformable substrates are affected directly by controlled mechanical 
stimuli (Banes et al. 1995; Hannafin et al. 1995), it is important to understand how matrix 
damage strain thresholds relate to cell response strain thresholds. 
Classic tendon mechanics studies (Rigby et al. 1959; Abrahams 1967) have suggested 
that loading beyond 4% strain can cause permanent deformation and a reduction in strength 
and stiffness; factors indicative of matrix damage.   However, the methods used in these 
studies may have adversely influenced these results.   The contact extensometers used for 
deformation assessment and the mechanical techniques employed to clamp the tendons are 
susceptible to slippage and stress concentrating effects.  In contrast, recent studies of 
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ligament (Panjabi et al. 1996) where subfailure stretches of 80% of the failure deformation 
have been applied to bone-ligament-bone complexes, has shown an absence in reductions in 
strength, deformation at failure, and energy at failure, while an increase in stiffness was 
reported.  In addition, assessments of the deformation response at low load levels (Panjabi et 
al. 1996) found that such deformations were significantly increased in the ligaments treated 
with subfailure stretching. 
In an effort to reexamine the results of the classic tendon studies while utilizing more 
current testing methodologies, the following study was carried out to characterize mechanical 
changes in avian digital flexor tendon with subfailure ramp loading to varying strain limits.  
In this study, the more current methodologies of cryo-clamping (Riemersa and Schamhardt 
1982) and video strain analysis (VSA) (Woo 1982; Lam et al. 1992; Derwin et al. 1994) 
were employed to minimize grip slippage and stress concentrating effects.  The main 
objective of this study was to evaluate changes in permanent deformation, elastic modulus, 
ultimate tensile strength, energy to ultimate strength, and low load-level deformations after 
ramp loading is applied to tendon to the following strain limits: 1,2,3,4,6,8,10,12, and 14%.  
It is hypothesized that permanent deformation will increase while strength and stiffness 
measures will decrease with subfailure ramp loading, but that these changes will begin to 
appear at higher strain limits then previously reported. 
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4.3. Methods 
4.3.1 Specimen Information 
Freshly severed feet from unprocessed 45-day old Rock Cornish chickens were 
acquired from a local poultry processing plant, then subsequently cleaned and frozen at -
20°C.  The feet were thawed at a later date (1 – 2 months) and the flexor digitorum profundus 
tendon was isolated from the middle digit of each foot and frozen at -20°C (for 24 – 48hours) 
in saline soaked gauze prior to testing.  The rationale for this specimen comes from its 
anatomic similarity to human flexor tendons (Lindsay and Thomson 1960; Farkas et al. 
1974) and its prevalence in tissue explant studies of tendon injury (Manske and Lesker 1984; 
Hannafin et al. 1995; Tanaka et al. 1995). On the day of testing, tendons (average length 
85mm) were thawed and duplicate area measurements were made along the middle third of 
the tendon by an area micrometer after applying a 0.12MPa compressive stress for 2 minutes 
(Butler et al. 1984). The final reported area of the tendon is the average of the two 
measurements.  
4.3.2 Instrumentation 
Tendons were clamped by means of liquid nitrogen fed cryo-clamps similar in design 
to that previously described (Riemersa and Schamhardt 1982), and mechanically loaded by a 
servo-hydraulic materials testing system (8500 Plus, Instron Corporation, Canton, MA, 
USA).  Tendons were attached with the grip-grip displacement set at 38mm. Two black #5-0 
sutures were stitched transversely, approximately 13mm apart at the longitudinal center of 
the tendon for midsubstance strain analysis. The suture displacement was monitored by the 
VSA system (Devkota and Weinhold 2001) and the grip displacement was monitored by the 
LVDT within the actuator of the Instron system.  The load level, monitored by a 250lb load 
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cell (Sensotec Inc., Columbus, Ohio, USA), and the two displacements were collected 
simultaneously at 60Hz for all mechanical tests. 
4.3.3 Mechanical Testing (Elastic Strain Limit) 
Mechanical testing was preceded by first pretensioning the tendon at 0.25 N, then 
preconditioning with 10 cycles of a 0.5Hz, symmetric triangular waveform with amplitude of 
0 to 0.5% grip strain. The specimens were again pretensioned at 0.25 N, and then taken to a 
predetermined grip strain-level (1,2,3,4,6,8,10,12, &14) by a 1% strain/second linear ramp. A 
subsequent -1% strain/second ramp brought the tendon back to the original rest state, where 
it was wrapped in saline soaked gauze and allowed to rest for 5 minutes to recover from any 
viscoelastic effects.  After the rest period, the specimens were pretensioned at 0.25 N, and 
then taken to failure by the same 1% strain/second linear ramp. 
From the predetermined strain-limited and failure ramp loadings of each specimen, 
the following material and structural properties were evaluated based on suture marker 
(midsubstance) strains, grip strains and load: max load, max displacement, ultimate stress, 
strain at ultimate load, energy density at ultimate load, stiffness, elastic modulus by linear 
regression of data between load limits of 25-75% of the ultimate load, residual strain 5 
minutes after strain-limited ramp loading at 1MPa stress level, and change in strain between 
strain-limited/failure ramp loadings within a specimen at a 10MPa stress level. 
4.3.4 Statistical Analysis 
One-way analysis of variance (ANOVA) followed by Tukey’s mean comparison 
testing was utilized to evaluate differences in mechanical properties at each strain limit. Two-
way repeated measures ANOVA (the repeated factor being readings from the strain-limited 
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& failure ramp loadings within a specimen) was utilized to evaluate the residual strain and 
change in strain at 10MPa parameters.  A significance level of 0.05 was used for these tests. 
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4.4. Results 
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Figure 4: Ultimate tensile failure strengths of avian flexor digitorum profundus tendons 
subjected to varying strain-limits of a single subfailure ramp loading were not found to differ 
with strain-limit level (ANOVA, P>0.05). 
Figure 4
 
Varying the strain-limit (1-14%) of the subfailure ramp loading applied to the tendon 
did not influence (P>0.05) the ultimate tensile failure strength of the tendons ( ).  In 
addition, the elastic modulus based on midsubstance or grip strain (Figure 5) was not found 
to differ (P>0.05) with the level of the strain-limit applied.   The elastic modulus based on 
the midsubstance strain was found to be significantly stiffer then the modulus based on the 
grip strain (P<0.05).   Paired strain-limit/failure stress-strain curves (marker displacement) 
for individual specimens tested to strain limits of 1, 6, and 12% (grip strain) show the 
similarity between the strain-limit and failure curves ( ).  The average stress level 
achieved in the tendon with each strain-limited subfailure ramp loading is shown (Table 1).   
Figure 6
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Figure 5: Elastic moduli based on the midsubstance or grip strain of avian flexor digitorum 
profundus tendons subjected to varying strain-limits of a single subfailure ramp loading were 
not found to differ with strain-limit level (ANOVA, P>0.05).  Elastic moduli based on 
midsubstance strain were found to be significantly stiffer then the moduli based on grip strain 
(paired t-test, P<0.001). 
 
 
Figure 6: Examples of paired midsubstance strain-limit/failure stress-strain (VSA) curves for 
individual specimens tested to grip strain limits of 1, 6, and 12% (shown up to max stress). 
Strain levels of curves have been artificially shifted for clarity of presentation. Note, grip 
strain is greater than midsubstance strain. 
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The midsubstance residual strain 5 minutes after each strain-limited subfailure ramp 
loading (Table 1) was not found to differ from zero (P>0.05), and this strain was not found to 
differ with the level of the strain-limit applied (P>0.05).   However, there was a minor 
change (P<0.001) in midsubstance strain between the strain-limited and failure ramp 
loadings when 10MPa of stress was applied ( ), but this change in strain was not 
influenced by the level of the strain-limit applied.   The midsubstance and grip strains at 
failure (ultimate stress) were not influenced by the level of the strain-limit applied (Table 1).    
Finally, the strain energy density at failure was not influenced by the level of the strain-limit 
applied (Table 1). 
Table 1
All failures were fairly instantaneous (no subfailures) and occurred between the grips. 
Most failed in the midsubstance between the sutures, but some did fail in the other region 
(between suture and grip). No differences or patterns were observed in relation to the failure 
site and the strain levels. Overall averages at failure across all groups were 96.7 MPa for max 
stress, 16.4% for grip strain and 12.2% for midsubstance strain. One specimen did fail during 
the 14% ramp loading, and its data was discarded. 
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Table 1: Mechanical properties (mean (SD)) of tendon based on tensile ramp loading to a 
specific grip strain limit or on subsequent test to failure. 
 
Limit Values Mechanical Properties 
Strain 
Limit 
(%) 
Stress at 
Strain 
Limit 
(MPa) 
Midsubstance 
Residual 
Strain After 
Strain Limit 
Test (%) 
∆ Midsubstance 
Strain at 10MPa 
between Limit & 
Failure Test 
(%) 
Midsubstance 
Strain at 
Failure 
(%) 
Grip 
Strain at 
Failure 
(%) 
Strain 
Energy 
Density at 
Failure 
(mJ/mm3) 
1 (n=3) 2.9 (2.9) -0.3 (0.7) Not Available 13.5 (4.4) 16.8 (2.1) 8.9 (3.3) 
2 (n=5) 5.8 (1.8) 0.3 (0.4) Not Available 10.5 (3.1) 16.8 (2.4) 8.8 (3.2) 
3 (n=5) 16.0 (4.8) 0.1 (0.7) 0.6 (0.5) 13.7 (3.1) 16.8 (1.7) 8.7 (2.5) 
4 (n=7) 20.7 (7.1) 0.4 (0.8) 0.4 (0.7) 12.2 (3.8) 15.4 (2.5) 7.4 (2.7) 
6 (n=7) 30.9 (9.2) 0.3 (0.9) 0.6 (1.0) 12.3 (3.0) 16.4 (2.5) 8.8 (4.4) 
8 (n=7) 50.8 (13.3) -0.3 (0.5) 0.1 (0.4) 11.9 (3.1) 16.6 (2.2) 9.5 (3.2) 
10 (n=6) 62.6 (9.2) 0.6 (0.5) 0.6 (0.7) 12.2 (3.6) 15.7 (1.0) 7.8 (1.1) 
12 (n=7) 73.8 (10.2) 0.3 (0.4) 0.6 (0.4) 11.6 (3.6) 16.9 (1.8) 8.9 (2.9) 
14 (n=7) 87.7 (7.8) 0.3 (0.6) 0.1 (0.8) 13.0 (3.4) 16.2 (2.8) 8.2 (3.8) 
 
-None of the mechanical properties differed with strain limit level (ANOVA, P> 0.05). 
-Residual strain was not significantly different than zero (RM-ANOVA, P>0.05) 
-Change in midsubstance strain at 10MPa between limit & failure test differed from zero    
(Repeated Measures ANOVA, P<0.001) independent of strain level. 
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4.5 Discussion 
A study was carried out utilizing cryo-clamp and VSA testing methodologies to 
characterize mechanical changes to tendon with subfailure ramp loading to varying strain 
limits in order to better characterize the strain thresholds at which matrix damage occurs in 
tendon.   Contrary to our stated hypothesis, the current study was unable to demonstrate a 
decrease in the strength and stiffness properties (Figure 4 & Figure 5) or an increase in 
permanent (residual) strain ( ) with ramp loading to strain limits ranging from 1-14%.  
In addition, no change in failure strain or strain energy density (Table 1) was found with 
ramp loading to the specified strain limits.  These results are in contrast to classic early 
tendon biomechanical studies that have suggested that strength and stiffness decline with 
loading beyond a strain limit of 4% (Rigby et al. 1959) and permanent deformation can begin 
to occur with strains exceeding 4% (Abrahams 1967). 
Table 1
It is believed that the difference in results between this study and past studies is 
largely related to the mechanical clamping methodologies used in past studies that may have 
exaggerated damage to the tissue due to local stress concentration effects near the grips.   
While it is possible that these differing results may be due to species specific effects, this 
would appear to be unlikely due to the similarity in the mechanical properties of avian tendon 
to human tendon. The ultimate stress (96.7MPa), grip elastic modulus (735.7 MPa) and strain 
at failure (16.3 %) of avian tendon reported in the current study compare relatively well with 
human patellar tendon studies that have reported  values of 65-111 MPa, 612-660 MPa and 
13-26% for the ultimate stress, modulus and failure strain, respectively (Butler et al. 1984; 
Butler et al. 1986; Johnson et al. 1994). The inference that stress concentrating effects near 
the grips are the cause of the difference is supported by recent studies of ligament (Panjabi et 
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al. 1996) that have reported an absence of reductions in strength, deformation at failure, and 
energy at failure following subfailure stretches of up to 80% of the failure deformation on 
bone-ligament-bone complexes.  In addition, in this ligament study an increase in 
deformation was observed at low-level loads (5-50% of failure) in ligament receiving the 
subfailure stretch.  Similarly, in the current study we saw a minor increase (Table 1) in strain 
at 10MPa loading after the initial ramp loading.  However, as this increase in strain was not 
found to be dependent on the level of the strain-limited ramp loading, it would appear that 
this strain effect might be a tissue conditioning effect rather than a damaging effect.  In 
addition, due to the small size of this strain change and the more dynamic adaptability of the 
length of the myotendinous unit, it is questionable if this strain change has physiological 
significance. 
The current study has significance in that it suggests 1) tendon behaves as an elastic 
material to higher strains (i.e. nearly to failure) then previously reported and 2) a decline in 
mechanical properties due to matrix damage from a single loading stimulus is less likely to 
occur than previously thought.  Readers are advised however, that this does not imply in vivo 
tendons or their matrix cannot be damaged by subfailure stretches. Tendons in vivo wrap 
around structures such as bones and pulleys, and are therefore exposed to compressive and 
shear loads that this in vitro study does not take into account. These loads vary not only 
between species, but also across tendon sites, and would have a definite effect on in vivo 
damage. Therefore, the results should be used in analyzing the basic matrix tensile 
characteristics of tendons in general. 
A limitation of the current study is that it focuses on the mechanical changes of 
tendon alone while damage may also occur at the myotendinous and osteotendinous 
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junctions.   An additional limitation of the study is the form of the loading stimulus: a single 
ramp loading at a strain rate slower than that which occurs in many injury situations.  The 
selected strain rate was a compromise to achieve a fairly sensitive strain resolution within the 
dynamic capabilities of the VSA system.  Additionally, a preponderance of the literature has 
been performed at strain rates similar to that selected.  While mechanical changes of tendon 
with cyclical loading is likely of greater significance to the majority of clinical injuries to 
tendon, it was believed that a fundamental understanding of the mechanical changes as a 
result of a single ramp load was required to more fully investigate the response to cyclical 
loading.   The limited studies that have examined the effect of cyclical loading on tendon 
have shown declines in strength and stiffness with increasing load cycles (Wang et al. 1995; 
Schechtman and Bader 1997). 
The decision to utilize cryo-clamps for testing necessitated a compromise be made 
between how well the environmental conditions could be altered to mimic physiological 
temperature and hydration conditions.  In this study, spray irrigation and wrapping the tissue 
in saline-soaked gauze was utilized to maintain hydration during the rest period.  The 
temperature of the tissue near the grip edge was found to be approximately 10° C during 
testing.   While temperatures effects on the viscoelastic properties of the tissue are debatable, 
most studies have observed no significant differences in the load elongation curve for a 
single loading for temperature ranges between 0°C & 55°C (Rigby et al. 1959; Hasberry and 
Pearcy 1986; Lam et al. 1990).  In addition, the tendons were frozen twice before testing for 
practicality purposes.  Effects due to this were examined by evaluating the mechanical 
properties of once versus twice frozen specimens in our lab and no significant differences 
were found. In addition, past studies (Smith et al. 1996) have found little difference in 
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properties between samples frozen once and up to five times before testing. A final 
consideration in examining the lack of differences in mechanical properties is in reference to 
the number of specimens tested per strain-limit group.  While the power of statistical tests 
may be improved with additional specimens per group, it is unlikely that this would uncover 
any physiologically significant differences in the strain-limit groups due to the proximity of 
the means of the mechanical properties of each group. 
Limitations withstanding, these results suggest that a single tensile subfailure 
stretching does not directly cause significant matrix damage.  These results also suggest that 
the cellular response to a loading stimulus may not be due to damage of the matrix, but due 
to tendon cells directly responding to the loading stimulus itself such that their cellular 
response causes a decline in the mechanical properties of the matrix.  The clinical 
significance of this is that a loading event may not instantaneously cause damage to the 
matrix, and therefore the clinician may have a greater opportunity to prevent matrix changes 
by biochemically altering the cellular response to a loading event. 
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CHAPTER 5 
OVERUSE TENDON EXPLANT MODEL 
 
Devkota AC & Weinhold PS, 2005. A Tissue Explant System For Assessing Tendon 
Overuse Injury. Med Eng Phys. 27(9), 803-808. 
 
5.1 Abstract 
Tendon overuse injuries are common athletic and occupational problems.  When 
studying mechanisms that cause these injuries, inherent complexities associated with 
controlling in vivo loading necessitates alternative approaches such as in vitro organ culture. 
Current devices for loading explants in organ culture, whether custom-built or commercial, 
have various deficiencies in their loading capability, control mechanism and strain 
assessment. To overcome these shortcomings, an advanced tissue loading device with video 
strain analysis capabilities was developed for investigating overuse injuries and its 
performance/calibration were evaluated. Two tests were used to assess the ability of the 
system to create and monitor mechanical changes with overuse. Overuse loading 
significantly increased strains and decreased strength, showing the ability of this system to 
create and monitor tissue damage. Furthermore, the device design allows for its use in a 
standard incubator.  Coupled with custom loading and data collection programs, this system 
is suitable for long-term overuse injury studies. 
  
5.2 Introduction 
The etiology of tendon overuse injury is such that repetitive loadings considerably 
below failure levels is believed to cause micro-damage that exceeds the basal repair ability of 
the tissue.  To better understand the mechanisms of tendon injury, many models have been 
studied. Original studies examined the effects of force on tendon healing in vivo after acute 
injury (McDowell and Snyder 1977; Woo et al. 1981), while more recent animal model 
studies have been successful in creating overuse-like injuries (Soslowsky et al. 2000).  A 
common difficulty in these models has been in controlling the in vivo loading. 
Because of the inherent complexity of controlling loading in an in vivo environment, 
additional studies have exposed cultured tendon cells to controlled substrate strains as a 
means of studying overuse injury (Almekinders et al. 1995).  The main deficit of this 
approach lies in its’ inability to account for the interaction between the cells and the 
extracellular matrix.  The native matrix’s role on the cellular response and the cellular role in 
matrix modification cannot be assessed through such models. 
An attractive alternative approach to determine how particular loading characteristics 
contribute to overuse injury is to apply controlled cyclical loads to tissue segments 
maintained in culture (explants).  Early studies using this approach have used custom-built 
displacement controlled devices to examine the influence of load or stress-deprivation on cell 
proliferation and matrix synthesis (Slack et al. 1984; Hannafin and Arnoczky 1994). Recent 
studies using such devices have examined effects of amplitude and frequency on various 
biochemical expressions (Lavagnino et al. 2003).  A deficit of these displacement-controlled 
devices is that grip slippage can adversely influence the application of controlled strains to 
the tissue. Furthermore, the method does not fully allow for tissue creep, a factor that has 
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been suggested to be an important mechanism of overuse injuries (Goldstein et al. 1987).  
Commercial load-controlled devices used to load tendon in culture (Tanaka et al. 1995) have 
been limited by the amount of force they could produce.  Studies examining higher levels of 
cyclic loads have been performed on nonviable tendons (Wang et al. 1995; Schechtman and 
Bader 2002; Wren et al. 2003), while tissue culture studies have largely focused on the 
response of tendon to low-level loading(Slack et al. 1984; Tanaka et al. 1995). 
In an effort to investigate a tissue explant model for tendon overuse injuries, a 
portable load-controlled tissue loading device (TLD) with video strain analysis (VSA) 
capabilities was developed to be used within a standard incubator ( ). The objective 
of this paper is to describe this device, its performance, calibration and preliminary tests. 
Figure 7
Figure 7: System Diagram of Tissue Loading Device (TLD) and Video Strain Analysis 
(VSA) System.  The TLD sits in an incubator while a dedicated laptop controls the load 
waveform applied to the tissue. A mobile computer operates the video strain analysis system 
with the digital camera capturing tendon strain and the DAQ board capturing loading, as the 
motion controller rotates the six faces of the device in front of the camera for analysis. 
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5.3 Methods 
5.3.1 Tissue Loading Device (TLD): 
The TLD is one of two identical, hexagonal, 6-station pneumatic apparatuses (
).  Filtered air is supplied to fifty-psi servo-valves (QB Series, Proportion-Air, 
McCordsville, IN) to produce pressure waveforms from input voltage waveforms. Air 
manifolds on each device distribute pressure to six air-cylinders (E16D1.0N, Airpot Corp, 
Norwalk, CT) through individual on/off valves.  The piston rods of the air-cylinders extend 
into 50ml conical tubes filled with media, which house the tissue. The tissue, secured in 
stainless steel serpentine grips, attaches to the piston rod at the top and fixed posts at the 
bottom.  A single thumbscrew fixes the tube to the device, expediting media replacement.  
Figure 
8
A custom LabVIEW (Version 6.0, National Instruments, Austin, TX) program on a 
dedicated laptop-computer generates input voltage waveforms by selection of the peak and 
trough pressures (MPa) and frequency (Hz) which are positive, sinusoidal and include an 
offset for the combined weight of grips and connectors.  Waveforms correcting for 
differences between expected and observed loads, as measured directly by a load cell in 
series, have been pre-programmed for common loading regimens.  Duration and average 
cross sectional area values complete the waveform selection.  Three regimens (peak, trough, 
frequency and duration), time delay between them, and how often to repeat them are 
independently selectable for each device, allowing for automatic, complex loading scenarios. 
The voltage waveform is transmitted to the servo-valve by a 12-bit National Instruments (NI) 
card (DAQCARD-6062E).  The range of the system is limited by the servo-valve at 0 – 
61.384 N and the accuracy is limited by the air-cylinders at <0.245 N. 
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Figure 8: Close-up of gripped tendon with midsubstance suture markers, and tissue loading 
device on rotating stage. 
Figure 8
 
The TLD sits on a platform connected to a stepper-motor (IS23002, MCG, Inc, Eden 
Prarie, MN) which allows rotation of the device for VSA of each specimen.  A NI motion 
controller (FW-7344) supplies the command signal, also generated from LabVIEW. 
5.3.2 Video Strain Analysis (VSA) System: 
Midsubstance VSA assesses mechanical changes in explants during cyclic loading by 
measuring the displacement of sutures ( ), stitched transversely approximately 13mm 
apart, at the longitudinal center of the tendon using a high-speed digital camera (Megaplus 
ES310, Roper Scientific, San Diego, CA) and an 8-bit NI image acquisition board (PCI-
1422). 
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Image preprocessing, consisting of selecting a minimal region-of-interest and a binary 
look-up-table to threshold markers based on lighting (Figure 9), greatly increases overall 
speed. Tracking the first and last edges of the markers along a longitudinal user-drawn line of 
action allows real-time strain collection synchronously with load data.  The optical zoom 
applied limits overall system resolution. 
 
Figure 9: Image of tendon with calibration ruler from a failure test, and subsequent VSA 
thresholding of midsubstance suture markers. 
 
5.3.3 Calibration of Tissue Loading Device: 
The range and performance were determined by testing the static and dynamic 
capabilities of the servo-valves and air-cylinders with a load cell connected in series.  
Variability in the output signal with changes in the waveform or its individual parameters 
separately (frequency, peak load, trough load) were examined with nylon strings gripped in 
place of tendons. Frequencies of 0.25, 0.5 and 1 Hz, peak loads from 3 to 24 MPa and trough 
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loads of 0.25 and 1.0 MPa were assessed, as well as three waveforms: low load (0.25 – 3.0 
MPa, 1.0 Hz), moderate load (0.25 – 12.0 MPa, 1.0 Hz) and high load (0.25 – 24 MPa, 1.0 
Hz). Loads from 1 to 30 MPa were tested for the static condition. Furthermore, because all 
twelve air-cylinders have individual valves, the variability caused by altering the number of 
concurrently operating cylinders was also examined. 
Once the range and performance capabilities of the TLD was determined, tendon was 
gripped and the input signal was manually modified until the output values reached the 
desired values for waveforms to be used. Frequencies from 0.25-2.0 Hz, a trough of 1.0 MPa 
and peaks from 1 to 30 MPa were tested. This process was repeated and the manually 
modified values required for the desired output values were averaged and recorded as preset 
values for common waveforms.  
5.3.4 Calibration of Video Strain Analysis System: 
VSA calibration is performed by placing an object with marks of known separation in 
the same plane as the tissue. A pattern-matching algorithm locates the tick marks, and the 
average distance, in pixels, between successive centroids divided by the known distance 
between them (mm) is the calibration factor (pixels/mm) for the square pixels of the system.  
To validate VSA performance, static and dynamic tests were performed using a digital 
caliper (CD-6CS, Mitutoyo, Japan; accuracy 0.02mm) and the linear variable differential 
transformer (LVDT), accuracy 0.05mm, of our materials testing system (8500+, Instron 
Corp., Canton, MA). Static testing was performed by zooming maximally at 50mm, then 
incrementally decreasing the caliper by 5mm (to 20mm) while recording the distance 
between caliper edges at each interval. Repeated trials with sutures (black, silk 9-0) affixed 
on each caliper edge were performed. Dynamic validation was performed by the VSA 
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measuring grip-to-grip displacement during a displacement-controlled ramp test on the 
Instron. Repeated trials with an initial gauge length of 13mm (average midsubstance gauge 
length) displaced 8% and 20% (expected failure range of tendon) at 1, 2 and 5% strain/sec 
were performed with VSA collection at 30Hz, the common range of typical systems (Woo 
1982; Lam et al. 1992).  
5.3.5 General Tests: 
To characterize the system’s ability to create and monitor mechanical changes with 
overuse loading, two tests were performed. The first was to determine the extent to which the 
system could alter the mechanical properties of tendons with overuse loading, and the second 
to demonstrate the ability of the VSA systems to measure strains accumulating throughout 
such experiments. Previously isolated avian flexor digitorum profundus tendons were 
thawed, mechanically gripped and placed in the TLD in saline.  The gauge lengths (grip and 
midsubstance) were determined with 3.0 MPa tension after preconditioning for five minutes 
(0.25 – 3.0 MPa, 0.25Hz). Tendons were then loaded for 24-hours (0.25 – 12 MPa, 1.0Hz), 
after which final gauge lengths were measured with 3.0 MPa tension.  Dynamic strains 
[(trough-peak)/trough] were monitored at 0, 4, 20 and 24 hours. Control tendons sat gripped 
in the TLD for 24 hours with no loading. Following the 24-hour periods, tendons were 
removed from the grips and frozen in saline-soaked gauze. 
For failure testing, performed on the Instron, tendons were thawed and duplicate area 
measurements were made along the midsubstance (avoiding vascularizations) utilizing an 
area micrometer similar to that described elsewhere (Butler et al. 1984).  The tendons were 
cryogenically gripped (Riemersa and Schamhardt 1982) just inside of where they were 
mechanically gripped by the TLD to ensure midsubstance failure. Failure testing was 
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preceded by pretensioning at 0.25N, preconditioning with 10 cycles of a 1% strain/sec 
havertriangle waveform at 0.50 Hz, and then pretensioning again at 0.25 N before applying a 
1% strain/sec ramp until failure. 
 
5.4 Results 
5.4.1 Tissue Loading Device: 
With one servo-valve controlling no more than six air cylinders at once, the 
variability in the output were minimal with changes in peak load, trough load, frequency and 
number of air-cylinders open in both the static and dynamic conditions. The difference in 
output from device one, with all six vs. zero cylinders open on device two, was less than 1% 
for both static and dynamic conditions.  During static loading, the difference between 
observed and expected output changed steadily as the loading level increased, with a 
maximum difference of slightly less than 6%.   The same characteristic was observed under 
dynamic conditions for the peak load, again with <6% difference.  The same magnitude 
changes were observed in the trough load as well, but the small magnitude of the trough 
made percentages large (50-1500%).  Changing the frequency (0.25 and 0.5 Hz) caused 
output changes of less than 1% throughout the loading range.  At 1 Hz, the differences were 
slightly larger, but remained below 5% at 24MPa. 
Holding the first device at one of three waveform while varying the waveform to the 
second device across all three waveforms, showed differences of <1% in the observed load 
on the first device.  Finally, manually adjusted input signals produced repeatable (<1% error) 
output for load levels up to 24 MPa at the tested frequencies and waveforms. Load levels of 
30 MPa or greater were possible only with the low frequency (0.25 Hz) signals. 
 80 
5.4.2 Video Strain Analysis: 
Static validation tests determined the average percentage error in length 
measurements across all 5mm increments to be within 0.26%, while individual errors across 
all trials ranged from 0 – 1.59%.  The average coefficient of variance of the repeated 
measurements at each gauge length was 1.45% (range: 1.29-1.6%).  Dynamic tests saw 
percentage errors rise to 51% at the smallest strain values, but decrease substantially 
thereafter as strain values increased (Figure 10). Overall, a raw strain error of 0.25% strain or 
less was maintained for 99% of all data points collected which coincides with the theoretical 
resolution of the VSA system (1/400 pixels = 0.0025 strain) for the number of pixels 
typically defined across the strain markers at expected zoom. 
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Figure 10: Dynamic calibration of VSA system showing VSA error across actuator strain. 
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 5.4.3 General Tests: 
The results of the damage assessment ( ) experiment showed the treated 
tendons, 24 hours at (0 - 12MPa, 1.0 Hz), had a decreased (P<0.05, t-test) ultimate failure 
strength  (104.04 ± 29.98MPa) compared to unloaded controls (126.04 ± 19.26MPa). The 
results of the grip and midsubstance strain measurement assessment experiment (Figure 12) 
showed a significant increase in the both the midsubstance (P = 0.007) and the grip (P < 
0.001) gauge lengths after 24 hours of loading.  The strain accumulated between the grips 
was also significantly (P = 0.007) greater than the strain accumulated between the suture 
markers as determined by paired t-tests. One-way repeated measures ANOVA across time 
showed dynamic suture strain to be different between 0 and 24 hours, and the grip strain at 
time 0 to be different from 4, 20 & 24 hours. 
Figure 11
Figure 11: Significant difference in failure strength of tendons loaded with a cyclic waveform 
of 0.25 – 12.00MPa at 1.00Hz for 24 hours (N=16) versus unloaded controls (N= 11). 
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VSA Strain Measurement
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Figure 12: Dynamic [(Peak-Trough)/Trough) and static [(Post-Pre)/Pre] measurement of 
midsubstance and grip strains across a 24-hour, 12 MPa sinusoidal waveform. Note: * 
Significance from time 0; + Significance between midsubstance and grip. 
 
 
5.5 Discussion 
Much of the research on tendon overuse injuries has focused on the biochemical 
activity in response to cyclic loads while few studies have examined fatigue of viable tendons 
with sufficiently large loads. Existing studies were performed on large materials testing 
systems with non-viable samples (Schechtman and Bader 1997; Schechtman and Bader 
2002; Wren et al. 2003) due to the unavailability of an appropriate device to load tendons to 
sufficient magnitudes in an in vitro tissue culture environment (Tanaka et al. 1995).  Current 
devices, mostly displacement control, were designed for low load applications and usually 
operate off a single displacement actuator, which requires all tendons to be gripped at the 
same length and slip equally to achieve uniform loading.  Furthermore, displacement 
controlled devices do not fully allow for creep, a substantial part of overuse injury (Wang et 
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al. 1995). The device described in this paper operates under load control, which is 
independent of grip slippage or tendon length and is capable of applying damaging loads that 
allow for creep to tendons in a tissue culture environment.  Furthermore, tendons are bathed 
individually in media, allowing for intra-experiment comparisons while eliminating potential 
cross-contamination. 
Calibrations of the device showed the difference between expected and observed 
output load changed with the level of loading and frequency in a complex manner.  Due to 
this complexity, the input signal was manually adjusted until desired outputs were observed 
for the waveforms to be utilized.  This step is required again only if changing the tissue of 
interest. This process, when repeated, showed low variability (<1%). These values were 
inputted into the waveform generation program and are used to load the tendons precisely.  
With the ability to apply controlled load levels up to 61 N, roughly 30 MPa, the ability to 
physically damage the tendon is in place. 
To measure the tissue response to load throughout testing, a video strain analysis 
system was developed. The VSA system negates grip slippage issues in strain measurement, 
providing a more accurate representation of the tissue damage from the cyclic load. Our 
validation tests (Figure 10) demonstrated superior performance relative to commercially 
available systems(Lam et al. 1992).  Additional advantages include the ability to operate at 
higher speeds, flexibility in programming and interfacing other control systems and reduced 
equipment costs. Other custom-developed VSA systems (Derwin et al. 1994) have reported 
higher resolutions and lower errors utilizing alternative image processing strategies, however, 
these systems could not process data in real-time. 
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Validation of the device required damage assessment tests.  The failure tests 
demonstrated that the 24-hour cyclically loaded specimens were significantly weaker than 
unloaded tendons. These results attest to the device’s ability to damage the tendon matrix, 
making it suitable for overuse injury studies. 
A second validation was performed to evaluate mechanical changes during overuse 
loading by strain analysis. Measurable mechanical changes, in terms of accumulated strains 
and an increase in gauge length across both the midsubstance and the grips were seen. In 
addition, these two strains were significantly different, indicating the existence of stress 
concentrating effects from the mechanical grips.  Some of this difference could be due to a 
change in geometry across the length of the tendon, but we believe this to be negligible 
because of the similarity of the two area measurements. This indicates that midsubstance 
strain, collected by the VSA system, should be measured when performing any damage 
assessment in the future because grip-to-grip strains include damage caused by gripping as 
well as slippage. If position control devices were used for loading, these gripping effects 
would effectively decrease the loading on the tendon. Without VSA analysis, this effect 
would be inaccurately expressed as overuse damage. Furthermore, the dynamic creep 
associated with repetitive loading is another factor that position controlled devices cannot 
account for, further reducing the loading. With load control, slippage and stress concentration 
effects do not decrease the loading level. 
One limitation of the TLD is the gripping methodology.  The difference in strain 
between the grips and midsubstance markers may be due to stress concentration effects at the 
grip edges or grip slippage.  However, the significant midsubstance strain increase from the 
beginning to the end of the experiment indicates that fatigue damage or creep has occurred.   
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In failure assessment, cryo gripping was done just inside the TLD grip zones such that the 
area damaged by the original gripping was not tested, and no further stress concentrating 
effects were present. 
It is believed that the described tissue loading device and video strain analysis system 
are valuable devices that will assist in studying tendon overuse injury.  The ability to operate 
easily and efficiently within the confines of an incubator allows for long term viable tests, 
while the load control mechanism assures no reduction of applied load due to stress 
concentration or slippage at the grips. Furthermore, midsubstance strain analysis will 
measure damage resulting from the loading only and the replaced media can be individually 
analyzed for biochemical responses. It is believed that biochemical and biomechanical 
analyses gathered with the use of this system will provide useful information on the 
mechanisms of overuse injury in tendon. 
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CHAPTER 6 
TISSUE RESPONSE TO CYCLIC LOAD 
 
  
6.1 Abstract 
 Purpose: Tendon overuse injuries continue to be a major source of clinical concern, 
both athletically and occupationally.  Studies have shown cyclic loading to cause material 
damage as well as induce biochemical responses in tendon.  The purpose of this study was to 
examine the tissue response of tendon after applying a fixed amount of cyclical loading over 
varying durations.  
 Methods: Avian flexor digitorum profundus tendons were loaded (3 MPa or 12 MPa) 
to a fixed number of cycles across either one or twelve days in vitro. Biomechanical data 
were gathered during the loading, as well as during the subsequent failure testing.  Cellular 
viability and death, as well as proteoglycan, collagen, collagenase and prostaglandin E2 
(PGE2) activity measurements were obtained from tissue specimens and media samples.  
 Results: Significant strain accumulated during loading.  Loading tissues at 12 MPa 
significantly reduced material properties at both 1 and 12 days as expected. The 3 MPa 
loading group also caused a reduction in properties, but only when applied across the 12 
days. Cell death and collagenase activity increased significantly with increasing loading as 
well as with increasing duration.  However, no differences were seen in cell viability or 
collagen content. Glycosaminoglycan content increased with load magnitude, while PGE2 
  
production was highly dependent on the magnitude of the loading as well as the duration 
across which it was applied. 
 Conclusions: Mechanical fatigue-induced material property changes were exhibited 
by the tendons in response to increased loading magnitude.  However, as the same loading 
was applied over a longer period, most outcomes were magnified substantially, relative to the 
short duration regimens. This is presumably due to a complex cellular response to loading. A 
key contributor may be the inflammatory mediator, PGE2, which exhibited large magnitude 
and duration dependent increases to cyclic loading. 
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6.2 Introduction  
 Overuse injuries comprise a significant portion of orthopaedic cases, both athletically 
and occupationally.  Overuse injuries are believed to be caused by the accumulation of 
micro-damage to individual collagen fibers(Archambault et al. 1995; Maganaris et al. 2004). 
While the etiology is likely more complicated than simple material fatigue, micro-damage 
due to fatigue has been suggested to play a significant role in tendon overuse injuries(Slack 
et al. 1984; Maganaris et al. 2004). Conversely, inflammatory mechanisms have also been 
suggested(Archambault et al. 1995; Khan et al. 1999; Fu et al. 2002), as overuse injuries are 
often termed tendonitis. However, confusion arises because histological studies have not 
shown the presence of  inflammatory cells such as leukocytes one would expect with classic 
inflammation(Astrom and Rausing 1995). However, in vitro studies of tendon fibroblasts in 
monolayer have shown substantial increases in levels of inflammatory mediators, such as 
prostaglandin E2 (PGE2), with mechanical loading(Almekinders et al. 1993; Almekinders et 
al. 1995; Tsuzaki et al. 2003; Wang et al. 2003; Li et al. 2004).  The etiology of overuse 
injuries is likely comprised of a combination of both material fatigue and cellular responses 
which result in cytokine release, matrix metalloproteinase (MMP) production and matrix 
degradation(Ireland et al. 2001; Riley et al. 2002; Alfredson 2003; Tsuzaki et al. 2003; 
Tsuzaki et al. 2003).  
 Early studies of overuse injuries established relationships between various material 
parameters and the amount of damage accumulated in tendons(Goldstein et al. 1987; Wang 
et al. 1995; Schechtman and Bader 1997; Schechtman and Bader 2002). However, most of 
these studies were performed with non-viable tendons, which neglects a potentially 
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significant factor, the cellular response to loading.  The cellular responses can aid the 
remodeling and repair, as well as exacerbate the damage (Archambault et al. 1995).  
Studies investigating the cellular response to mechanical loading have predominately 
utilized an alternative approach involving application of mechanical loading to deformable 
substrates upon which cells have been seeded. While a variety of important biochemical 
responses such as PGE2(Almekinders et al. 1993; Almekinders et al. 1995; Tsuzaki et al. 
2003; Wang et al. 2003; Li et al. 2004), protein kinases(Arnoczky et al. 2002; Skutek et al. 
2003) and MMPs(Archambault et al. 2002; Tsuzaki et al. 2003) production have been 
observed utilizing this approach, this model neglects the cell-matrix interaction. Furthermore, 
it may not be possible to accurately produce physiologic cellular strains.  To address these 
issues, animal models have been proposed (Soslowsky et al. 1996). These in vivo models 
apply loads externally by means of treadmill exercise.  With such approaches, potential 
external and internal adjustments such as weight shifting and load-redistribution may cause 
variability in the tendon loading.   
 To selectively study the effect of loading as a single causative or inductive factor for 
overuse injury these previous methodologies are inadequate. The use of live tissue explants 
however,  would help fill the gap caused by the limitations of the in vivo models and cell 
culture studies(Slack et al. 1984). A device, capable of maintaining tissue viability and 
applying damaging cyclical loads was recently fully developed(Banes et al. 1999; Devkota 
and Weinhold 2005; Flick et al. 2006). To study the influence of the duration of cyclical 
loading on tissue mechanical properties and biochemical expressions, tendon explants were 
subjected to cyclical loading over varying periods.  Since tendon overuse injuries are most 
likely due to both mechanical damage and the cellular response during loading and damage, 
 92 
it was hypothesized that if a damaging loading of a fixed number of cycles were distributed 
across a longer period, the cellular responses would exacerbate the decline in mechanical 
properties relative to the same loading applied across a shorter period. 
 
Figure 13: Methods Flowchart- The loading and assaying scheme for the flexor digitorum 
profundus tendons is shown.  The main steps are isolation, preconditioning, loading, resting 
and processing. 
Isolate, Grip, Suture (Day -3) 
Precondition (Days -2, -1) 
Short Load (Day 0) Long Load (Day 0 - 11) 
Continuous 24hrs 2 hrs/day, 12 days 
High: 12.0 – 1.0 MPa High: 12.0 – 1.0 MPa 
Low: 3.0 – 1.0 MPa Low: 3.0 – 1.0 MPa 
Wait 24 hours Wait 24 hours 
(Day 12) (Day 2) 
Whole Tissue Sectioned Tissue Media 
Failure Testing Composition Analysis Cellular Activity 
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6.3 Methods 
 Avian flexor digitorum profundus (FDP) tendons were isolated from the middle toes 
of 45-60 day old Rock Cornish hens. The complete middle FDP, from the distal insertion at 
the 4th phalanx to the union with the remaining flexor tendons just proximal to the claw, was 
isolated with average length of 85mm and area of 2mm2.  Tendons were mechanically 
gripped proximal to the most proximal vincula, exposing a 35mm (average) section 
superficial to the first three phalanges. Suture markers were stitched across the midsubstance 
for video strain analysis (VSA).  Tissues were allowed 24 hours of rest (Figure 13) in tissue 
culture medium consisting of phenol-red free DMEM-H media supplemented with 20mM 
Hepes, 100IU/ml penicillin, 100µg/ml streptomycin, 2µg/ml amphoteracin B, 100µM 
ascorbate, 1mM sodium pyruvate, 4mM L-glutamine and 2% fetal bovine serum. The final 
media additive was 2µM arachidonic acid, a supplement to insure adequate substrate for the 
production of prostaglandins.  
 Following the rest period, two days of preconditioning ensued, with 2 hours of a 
sinusoidal waveform (3MPa peak, 0.5Hz) and 22 hours of rest applied each day. The loading 
regimen commenced the following day.  All loading regimens consisted of equal cycles 
(86,400) of a sinusoidal waveform with a peak magnitude of either 12 MPa (High) or 3 MPa 
(Low) at 1.0 Hz. The loadings were applied for two durations: either 12 days (Long) or 1 day 
(Short).   Following loading, tendons were afforded 24 hours of rest before some were 
sectioned for compositional analysis, while the others were frozen in saline-soaked gauze for 
failure testing at a later time.  The loading regimens were applied via a custom-built load-
controlled tissue loading device within an incubator(Devkota and Weinhold 2005).  Fresh 
media were replaced one day before the loading regimen, the initial day of loading, and every 
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third day during the loading. A final media collection was performed after the 24 hours of 
rest, post-loading. All media were stored at -20ºC and analyzed later. 
 Midsubstance strain analysis was performed during the cyclic loading within the 
incubator. Both dynamic strains ((peak– trough)/ displacement) throughout loading and static 
strains, before and after loading, were measured.  Static strains were measured with a 1.0 
MPa tension load applied. All measurements were performed on midsubstance suture 
markers with a custom built VSA system(Devkota and Weinhold 2005).   
 The mechanical properties of the tendons were analyzed by performing failure testing 
on a servo-hydraulic materials testing system (Instron 8500+, Instron Corp, Canton, MA).  
The tendons were cryogenically gripped in custom-developed, liquid nitrogen-cooled grips 
similar to those described previously(Riemersma and Schamhardt 1982). Tendons were pre-
tensioned with a 1.0 N load, and then preconditioned with 10 cycles of a 1% strain haversine 
waveform.  The tendons were pre-tensioned again with 1.0 N, and then taken to failure with a 
1% grip strain/second linear ramp.  During this ramp loading, the load data and both 
displacement data (midsubstance and grip) were collected for structural property 
calculations. The grip and midsubstance displacement at time 0 (with 1.0 N pretension) were 
used as reference displacements for all strain measurements. Prior to failure testing, an area-
micrometer(Butler et al. 1984) was utilized for material property calculations. As a control 
for the failure property evaluation, a separate group consisting of tendons frozen at -20ºC 
immediately following isolation was added.  One-way and two-way analysis of variances 
(ANOVA) were utilized to determine significant differences within the groups for each of the 
properties investigated (P<0.05). 
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 The sectioned tendons were assessed for their viability, collagen and proteoglycan 
contents. Viability was evaluated immediately following loading by the modification of an 
MTT assay(Klein et al. 1996).  Briefly, tendon sections were incubated for 4hrs at 0.5mg/ml 
MTT. The tendons were then transferred to 2-methoxyethanol solution and shaken for 12 
hours at which point the resulting supernatant fluid was assessed for absorbance at 570nm 
with background subtracted at 690nm. For compositional analysis, the remaining sections 
were digested with Papain (0.5mg/ml).  The resulting digest was aliquoted and stored at -
80ºC for collagen and proteoglycan content analysis. 
 A modified hydroxyproline content assay was performed on the digest to measure 
hydroxyproline, a collagen constituent of known proportions (Bergman and Loxley 1963; 
Riley et al. 1994).  Briefly, digests hydrolyzed in 6M HCl at 105 ºC were treated with an 
oxidant and reagent combination and allowed to incubate, and then had their absorbance 
measured at 540nm. Hydroxyproline standards were also performed and the values were 
normalized by the wet weight of the tissue prior to digest. 
 A modified sulfated glycosaminoglycan (sGAG) content assay was performed on the 
digest to measure sGAG, the covalently attached glycoprotein chains of proteoglycans 
(Farndale et al. 1986; Riley et al. 1994).  Briefly, digest samples were treated with 200µl of a 
color reagent (DMMB) and the resulting absorbance was measured at 540nm. Chondroitin 
sulfate was used for standards and the data were normalized by the wet weight of the tendon 
prior to digest. 
 Media were analyzed for cell death, PGE2 and collagenase content.  Cell death was 
quantified through a commercial kit (Cytotox 96, Promega, Madison, WI).  The kit 
quantitatively measures lactate dehydrogenase (LDH), an enzyme released upon cell 
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lysis(Decker and Lohmann-Matthes 1988) through an enzymatic assay and is read on a 
platereader at 490nm. Cell death data are represented as percentage of total death, with 100% 
death being a group of fresh, unloaded tendons treated with a liquid nitrogen freeze-thaw 
process. 
 The levels of the inflammatory mediator, PGE2, were quantified through a 
competitive immunoassay kit (PGE2 - Monoclonal, Caymen Chemical, Ann Arbor, MI).  
Free PGE2 in the media competes with supplied PGE2 tracer for a limited amount of PGE2 
antibody. This antibody- PGE2 complex binds to a plate pre-coated with goat anti-mouse 
IgG, and following washing and development, is read at 492nm in a platereader.  
 The amount of total collagenase in the media was measured by a modified Azocoll 
procedure(Chavira et al. 1984). Briefly, azocoll, a dye impregnated collagen complex was 
suspended at 5mg/ml in buffer with aminophelylmercuricacetate (APMA), an agent 
supplemented to activate latent collagenase. The insoluble Azocoll was transferred while 
stirring to samples and given 24hrs to process. The supernatant of the resulting mixture had 
its absorbance measured at 520nm. 
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6.4 Results 
 Significant static strain accumulated in all loading groups except the low short group 
( ). The accumulation was significant with respect to both magnitude and duration, 
as measured by a two-way repeated measures analysis of variance (RM-ANOVA). Dynamic 
strains increased by 0.01% (short) and 0.46% (long) for the high groups only. A two-way 
RM-ANOVA of these data showed significant magnitude and duration dependent strain 
increases, indicating a decrease in stiffness.  
Figure 14
Figure 14: Strain, relative to time 0, is shown for the groups across cycles of loading with 
86,400 cycles being completed in 1 or 12 days, for the short or long groups, respectively. 
Asterisks on points denote difference from time zero, while asterisks on brackets indicate 
difference between two groups. Note the dashed lines for the short groups, as they were 
continuously loaded and did not have intermediate measurements. Significance of P<0.05, as 
measured by a 2-way RM ANOVA. 
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Table 2: Mechanical failure data of control 
tendons and those subjected to one of four 
regimens. Within each test category, groups that 
do not share a common letter are significantly 
different as determined by a one-way ANOVA 
(P<0.05). Those categories marked with an 
asterisk (*) were measured at max load. 
Table 2
 
 Maximum stress was highly dependent 
on magnitude with the high groups being 
significantly weaker than the control group. The 
grip strain (LVDT) was highly dependent on 
duration with the long groups enduring 
significantly less strain before failure than the 
control. The energy density, the amount of 
energy the tendons can absorb before failing, 
was significantly reduced relative to control, in 
all groups except the low/short.  A list of all 
mechanical failure properties (Mean ± St.Dev.) 
of the tendons, both structural and material, as 
compared by one-way ANOVA are presented in 
.  
The levels of PGE2 in the media 
increased significantly in all groups, relative to 
time, as measured by a two-way RM-ANOVA 
(Figure 15). The data are normalized relative to 
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levels at day 0 within the individual specimen.  A large duration-dependent increase was seen 
as both the high/long and low/long groups released more PGE2 into the media than their 
respective short groups. Magnitude dependence was also seen, as the high/long group was 
significantly greater than the low/long group. 
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Figure 15: Relative increase in media PGE2 levels, normalized by day 0 values, are shown 
across cycles of loading with 86,400 cycles being completed in 1 or 12 days, for the short or 
long groups, respectively. Asterisks on points denote difference from time zero, while 
asterisks on brackets indicate difference between groups.  Note the dashed lines for the short 
groups, as they were continuously loaded and did not have intermediate measurements. 
Significance of P<0.05, as measured by a 2-way RM ANOVA. 
 
Cellular turnover was indirectly measured by determining the tissue viability at the 
end of the experiment and comparing it to LDH levels, an indirect measure of cell death. Cell 
death increased significantly with the magnitude of the load, and the duration across which it 
was applied (Figure 16), as measured by a two-way RM-ANOVA.  However, the total tissue 
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viability, as measured by the MTT assay, did not change (Figure 16). Both high groups 
showed more cell death than their respective low groups, while both long groups exhibited 
more cell death then their respective short groups. 
 
Figure 16: Significant magnitude and duration dependent increases in cell death were 
observed, but no differences were seen in the total live cell count following loading. (a) Cell 
death, as measured by LDH released in media, is reported as the percentage of dead cells 
upon completion of loading. Normalization is relative to 100% death reported as LDH levels 
of tendons treated to a liquid nitrogen freeze-thaw process. (b) Cellular viability, as measured 
by a MTT assay, is reported as the absorbance of tissue segments immediately following 
loading, relative to the tissue weight. Letters beside normalized absorbance values denote a 
significant difference between groups without a common letter (Note: All “A’s” represent no 
difference in viability). Significance of P<0.05, as measured by a 2-way RM ANOVA. 
 
 Collagen turnover was also assessed indirectly by measuring hydroxyproline and 
collagenase content. The amount of total collagenase increased significantly, with time, in all 
groups (Figure 17) with a large magnitude and duration dependent increase (two-way 
ANOVA). However, the hydroxyproline content did not change (Figure 17). The amount of 
proteoglycans, as measured by sGAG in the tissue segments, was not affected by duration of 
loading, but significantly increased with the level of loading (Table 3). 
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 Figure 17: Significant magnitude and duration dependent increases in collagenase levels 
were observed, but no difference was seen in the total collagen content following loading. (a) 
Total collagenase in the media, as measured by an Azocoll assay, is reported as the relative 
increase in collagenase levels, normalized by values at day 0.  (b) Collagen contents 
following loading, as measured by hydroxyproline quantification of digested tissue segments, 
are reported relative to the dry weight of the tissue segment. Letters beside hydroxyproline 
measurements denotes a significant difference between groups without a common letter. 
(Note: All “A’s” represent no difference in collagen content between the groups). 
Significance of P<0.05, as measured by a 2-way RM ANOVA. 
 
 
Table 3: Sulfated glycosaminoglycan content, as measured from digested tissue segments 
following loading, normalized by the dry weight of the tissue segment. Groups without a 
common letter are significantly different as determined by a 2-way ANOVA (P<0.05). 
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6.5 Discussion 
 Current descriptions of tendon overuse injuries have emphasized the role of the 
accumulation of fatigue micro-damage with cyclical overuse loading.  However, how the 
cellular response to this cyclical load contributes to or lessens the fatigue-based decline in 
tissue properties is less clear.  In the current study, it was hypothesized that the cellular 
responses would exacerbate the mechanical property changes with cyclical loading.  
In support of this hypothesis, it was found that strains, PGE2 production, cell death, 
collagenase production and various mechanical property measures at a given magnitude of 
loading displayed a duration dependent effect.  
The larger accumulation of static strains in the high/long versus the high/short 
regimens would suggest that a cellular response contributes to the observed tissue strains. A 
similar effect observed in the low loading regimens would suggest that a general effect 
related to the time in tissue culture may contribute to this response. However, the greater 
changes observed in the higher loading regimens would suggest that this is not the dominant 
factor.  Additionally, there were no differences in cell viability between groups. The extra 
time for strain recovery during the unloading portions of the long regimens would suggest 
that observed differences in accumulated strain were also not a result of passive viscoelastic 
effects.  
Dynamic strain assessments also support this concept of cellular response-induced 
property loss as the tissue was found to display decreased stiffness with the high/long 
regimen, compared to high/short.  This decrease may be indicative of increased micro-
damage or remodeling in the high/long regimens.  Furthermore, the lack of differences in 
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dynamic strains between low/long and low/short would suggest this is not merely a time of 
tissue culture effect. 
 The failure mechanical property data were less definitive in providing evidence of a 
cellular response contributing to the decline in material properties.  Various properties were 
either load-magnitude or duration dependent and not both. The high/long regimen did not 
consistently produce the most inferior properties as anticipated.  However, this lack of 
difference may be related to a statistical difference in the area between tendons of the short 
and long duration loading regimens. A limitation to the methodology used in this study was 
that the area and gauge lengths used in failure material property calculations were measured 
after the cyclical loading regimens were applied. This was a design criterion elicited by the 
risk of contamination.  
 It is believed the further decline in mechanical properties with the longer loading 
regimens is due to the cellular responses to cyclical loading. A key factor in this cellular 
response may be the production of the inflammatory mediator, PGE2. In agreement with 
previous studies(Almekinders et al. 1993; Almekinders et al. 1995; Tsuzaki et al. 2003; 
Wang et al. 2003; Li et al. 2004), load-induced PGE2 production was observed. The PGE2 
levels increased in all groups and exhibited load-magnitude and duration dependence. 
Traditionally it has been suggested that this type of loading profile would put an individual at 
increased risk of clinically developing overuse tendinopathy. Previous studies have shown 
that high concentrations of PGE2 can increase collagenase production in uterine cervical 
fibroblasts(Goshowaki et al. 1988) and inhibit collagen production in human tendon 
fibroblasts(Cilli et al. 2004).  Furthermore, PGE2 has been used clinically to promote cervical 
ripening, a process in which the extensibility of the collagen matrix of the cervix is increased 
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due to apparent collagen reorganization (Shi et al. 2000). Finally, recent studies have 
demonstrated that repeated exogenous administration of PGE2 in vivo in the rabbit patellar 
tendon can lead to a tendon that appears degenerative under histological examination(Khan et 
al. 2005). 
 LDH measurements showed a steady, significant increase of cell death across all 
groups.  Like PGE2, the long groups displayed significantly more cell death than their 
respective short group. It is believed this difference is due to the lack of a response time for 
the short groups. The cell viability analysis showed no differences between the groups at the 
end of the experiment. Because cell death increased across time and the viability measures 
remained unchanged, a possible interpretation is that tendon fibroblasts proliferated 
accordingly in order to maintain live cell numbers.  Previous studies have provided evidence 
that PGE2 can stimulate fibroblasts to proliferate (Uribe et al. 1989; Martinez et al. 1997; 
Khan et al. 2005).   In addition, the profile of cellular turnover paralleled the profile of PGE2 
production, suggesting a possible link between these responses.   
Though high levels of collagenase were found (increase in all groups), no differences 
in the amounts of collagen were seen.  It must be noted that the collagen measured can 
include both degraded and healthy collagen. Because total collagenase was measured (both 
active and latent) this overall response may be interpreted as the opportunity for high 
collagen turnover being present, if not occurring. The collagenase results agree with previous 
studies on the effects of prostaglandins, which have shown increases in MMP  expression 
(Goshowaki et al. 1988; Ito et al. 2004; Kim et al. 2005) and coincide with our PGE2 
expression profile.   
 105 
There are a few limitations in the present study however.  For basic tissue 
maintenance, the media were replaced every three days.  While this is a standard period, a 
majority of the responses exhibited duration dependence, suggesting that the accumulation of 
cellular responses in the media were likely highest just prior to change. Greater tissue effects 
are likely if the tissue were exposed to these higher cellular response concentrations for a 
longer period.  Furthermore, the cellular responses may have been larger if more response 
time was provided. For the short groups, the media were collected after just two days (one 
day loading, and one day rest).  This short time may not have been sufficient for the tissue to 
fully respond, and could partly explain why some of the high/short groups did not exhibit 
greater cellular responses.  A further limitation may lie in dilution of the cellular responses in 
the media. While cell culture studies have volumetric cell to media ratios of roughly 1:50, the 
current study has a 1:500 tissue to media ratio.  This is a design criterion that could be 
changed. Altering these factors would likely cause increases in cellular responses and 
concentrations which could potentially have had greater effects on the tissue, and thus failure 
mechanical properties, as well as collagen and sGAG content. 
Overall, a large dependency in loading duration was observed in most of the 
responses. This is not expected for the mechanical measures with simple material fatigue, 
and is likely due to the cellular response of the living tissue. A key contributor in this 
response is likely PGE2. Though debate is ongoing about the presence of inflammation with 
overuse tendinopathy, a large increase of this particular inflammatory mediator was 
measured. PGE2 may contribute to the pathology of tendinopathy by stimulating cellular 
proliferation, partially decreasing collagen synthesis and increasing collagenase 
activity(Goshowaki et al. 1988; Uribe et al. 1989; Martinez et al. 1997; Khan et al. 1999; Ito 
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et al. 2004; Khan et al. 2005). In the loading regimens where PGE2 production was 
increased, the profiles of observed responses seem to coincide with the reported cellular 
effects of PGE2.  The greater PGE2, cell death and collagenase levels in the longer duration 
groups, especially the high/long group, suggest the potential significance of these cellular 
responses to overuse tendinopathies. To definitively assess if the cellular responses to 
cyclical loading are acting by way of a PGE2 pathway, future studies will focus on applying 
inhibitors. 
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CHAPTER 7 
MAGNITURE RESPONSE TO CYCLIC LOAD 
 
7.1 Abstract 
 The purpose of this research was to examine the biochemical response of avian flexor 
digitorum profundus tendon to repetitive cyclic loadings of various magnitudes.  An in vitro 
explant model was utilized to apply four levels of sinusoidal load (0, 3, 12 and 18 MPa) at 
1.0 Hz, 8 hrs/day for three days.  The loading caused minimal compositional changes as 
collagen content did not change, but a trend for a load-magnitude based increase of 
glycosaminoglycan content was observed.  Load-magnitude dependant increases (P<0.05) in 
collagenase, cell death and prostaglandin E2 were observed.  These data indicate that elevated 
cyclical mechanical loading of tendon quickly results in enhanced biochemical tissue 
responses indicative of tissue injury.  More sustained cyclical loading over time may be 
required for these initial responses to induce more dramatic tissue changes as observed in 
clinical tendinopathy.  
 
7.2 Introduction 
 Tendons are collagenous structures that transmit muscle force to bones across joints 
to provide motion.  Similar to other connective tissues, tendons adapt their structure and 
composition in response to mechanical and biochemical stimuli.  Tendon overuse injuries 
account for 30% of all running injuries and 40% of all tennis injuries (Sharma and Maffulli 
  
2005).  Though originally labeled tendonitis due to clinical symptoms of inflammation, 
histological studies have not shown classic inflammatory cells (Chard et al. 1994; Astrom 
and Rausing 1995).  Cases of inflammatory cell infiltration in tendon are rarely observed 
without acute damage or inflammation of the surrounding tissue.  Surrounding tissue 
inflammation and concurrent tendon degeneration are often separate entities (Backman et al. 
1990; Leadbetter 1992).  Tendon overuse injuries result from an accumulation of 
degeneration, or tendinosis (Archambault et al. 1995; Khan et al. 2002).  The major causative 
factor of overuse tendinopathy is suggested to be mechanical loading, however the most 
detrimental aspect of this loading (magnitude, frequency, duration, etc) has not been 
established (Archambault et al. 1995; Wang et al. 2006). 
The lack of mechanical load has detrimental and atrophic effects.  Load deprivation 
causes tenocyte necrosis, hypoxia, increased collagen breakdown, reduced cross-linking, 
collagen disorganization and decreased glycosaminoglycan (GAG) content (Akeson 1961; 
Jozsa and P. 1997; Maganaris et al. 2004).   Load deprivation induces the release of matrix 
metalloprotienases (MMP), growth factors, cytokines and inflammatory mediators 
(Lavagnino et al. 2003; Uchida et al. 2005).  Animals models of stress deprivation have 
generally agreed with explant studies, showing decreased ultimate strength and modulus, 
however data on changes in collagen fibril size, density and organization are often 
contradictory (Yamamoto et al. 1993; Hannafin et al. 1995; Yamamoto et al. 2000; 
Lavagnino et al. 2005).   
Mechanical loading has both positive and negative effects on the mechanical and 
structural properties on tendons.  Histopathologic examination of degenerative horse tendons 
with overuse tendinopathy show GAG content increases (Birch et al. 1998; Kobayashi et al. 
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1999).  Exercise animal models show positive effects such as increased failure strength and 
elastic modulus (Woo et al. 1980; Woo et al. 1981), as well as negative effects such as lower 
failure strength and elastic modulus (Sommer 1987; Soslowsky et al. 2000).  It is proposed 
that up to a certain level exercise can be beneficial to the tendon, however if extended too 
long it begins to have negative effects especially in regard to fatigue damage accumulation 
(Archambault et al. 1995; Schechtman and Bader 1997). 
With an improper balance of loading, the tendon may slowly degenerate into a 
tendinosis state.  The precise etiology is thought to be due to several factors, chief among 
them are the nature of the loading and subsequent biochemical responses  (Sommer 1987; 
Khan et al. 2002; Kjaer 2004; Riley 2004).   Biochemical responses include apoptosis in 
degenerated tendons (Yuan et al. 2003) as well as immediately following high magnitude 
strain in healthy tendon (Scott et al. 2005).  However, increase in cellularity (Banes et al. 
1995; Soslowsky et al. 2000; Yang et al. 2004) and  growth factors such as platelet derived 
growth factor BB, insulin like growth factor I, interleukin -1β and transforming growth factor 
β1 (Jozsa and P. 1997; Archambault et al. 2002; Tsuzaki et al. 2003; Kjaer 2004) are also 
observed in stretched fibroblasts.  Mechanical loading induced over-expression of these 
growth factors as well as matrix synthesizing and degrading enzymes and inflammatory 
mediators such as prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) have been observed 
and hypothesized to be involved in the development of tendinopathy (Almekinders et al. 
1995; Wang et al. 2003; Li et al. 2004; Khan et al. 2005).  Furthermore, injection of 
collagenase, cytokines and inflammatory mediators into tendon or peri-tendinous space have 
all independently shown tendinosis-like degeneration (Stone et al. 1999; Li et al. 2004; Riley 
2004).   
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 To better understand tendinopathy, it has been proposed that tissue responses as a 
function of load level must be more closely monitored (Archambault et al. 1995).  Many load 
inducible responses such as growth factors, cytokines and inflammatory mediators have been 
characterized and proposed to play a role in tendinopathy, but their relationship to load levels 
have not been established.  The objective of this study is to examine how biochemical 
responses indicative of tissue injury (PGE2, collagenase and cellular viability, GAG and 
collagen content) are influenced by the magnitude of cyclical loading applied in a tendon 
explant model.  The hypothesis is that these biochemical responses will increase with loading 
magnitude. 
 
7.3 Materials and Methods 
 7.3.1 Specimen:  Avian flexor digitorum profundus tendons were harvested from the 
middle toe of 50 – 60 day old Rock Cornish hen.  All specimens were obtained from freshly 
severed feet from a local commercial poultry processing plant. 
 7.3.2 Loading Design:  Tendons were gripped and placed on a load-controlled tissue 
loading device (TLD) (Devkota and Weinhold 2005).  The TLD sits in an incubator and has 
the ability to produce significant fatigue damage through cyclic loadings while maintaining 
viability (Devkota and Weinhold 2005).  An equilibration period of 72 hours was afforded 
the tendon following isolation.  A preconditioning (3 - 1 MPa, 0.50 Hz sine wave) loading 
was applied for two hours at 24 and 48 hrs to discourage atrophic changes. After the 
equilibration period, tendons were loaded 8 hours, and allowed to rest for 16 hours each of 
the subsequent three days.  The loadings were 1.0 Hz, sinusoidal waveforms with peaks of 18 
MPa, 12 MPa, 3 MPa as well as an unloaded group (0 MPa).  
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7.3.3 Media Analyses: Media was replaced just prior to loading and sampled daily 
(5%).  Also, 24 hours before loading started (48 hours into the equilibration period), the 
media was replaced to remove/minimize surgery-induced cellular responses. All media was 
stored frozen (-80ºC) and analyzed at a later time. 
PGE2 levels in the media were quantified by a commercial immunoassay kit (PGE2 
EIA – monoclonal, Cayman Chemical, Ann Arbor, MI).  Cellular death was quantified by 
measuring the levels of lactate dehydrogenase (LDH), a membrane protein released upon cell 
lysis by a commercial colormetric assay (Cytotox 96, Promega Corp, Madison, WI).  Total 
collagenase protein levels were measured by quantifying the amount of dye released from a 
mixture of sampled media and Azocoll, a dye impregnated collagen (Chavira et al. 1984).  
Aminophelylmercuricacetate (APMA), a collagenase activating agent was added during the 
analysis.  All media comparisons were made by a two-way (load magnitude x day) repeated 
measures analysis of variance (RM-ANOVA, P < 0.05). 
7.3.4 Compositional Analyses:  Following the third day of loading, all tendons were 
sectioned for compositional analysis and viability.  Viability was evaluated immediately by a 
modified MTT assay (Klein et al. 1996).  Briefly, tendon sections were incubated for 4hrs in 
0.5mg/ml MTT, then transferred to a methoxymethanol solution and shaken to release the 
dye.  Absorbance of the resulting solution was read at 570nm with background subtracted at 
690nm.  The remaining sections were digested with Papain (0.5mg/ml) and stored at -80ºC 
for collagen and proteoglycan content determination. 
A modified hydroxyproline content assay was performed on the digest to measure 
hydroxyproline, a collagen constituent of known proportions (Bergman and Loxley 1963).  
Briefly, digests hydrolyzed in 6M HCl at 105 ºC were treated with an oxidant and reagent 
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combination and allowed to incubate, and then had their absorbance measured at 540nm.  A 
modified sulfated glycosaminoglycan (sGAG) content assay was performed on the digest to 
measure sGAG, the covalently attached glycoprotein chains of proteoglycans (Farndale et al. 
1986).   Briefly, digest samples were treated with a color reagent (DMMB) and the resulting 
absorbance was measured at 540nm.  Hydroxyproline and chondroitin sulfate standards were 
performed and all values were normalized by the wet weight of the tissue.  All comparisons 
were made by a one-way ANOVA (P < 0.05, n = 12+). 
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7.4 Results: 
  
7.4.1 PGE2 Analysis:  PGE2 was found to be load inducible as all loading levels 
tested caused elevated concentrations in the media as compared to concentrations present 
during pre-loading (Figure 18).  This increase from pre-loading levels was significant for the 
highly loaded groups (12 MPa and 18MPa) only.  Both highly loaded groups also exhibited 
significantly greater PGE2 levels than the low and unloaded groups at this time point.  Basal 
PGE2 levels (measured prior to loading) were in the range of 200 – 400 pg/ml.  
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Figure 18: Raw levels of prostaglandin E2 in the media of tendons cyclically loaded for three 
days were load inducible and load-magnitude dependant. Asterisks on bars indicate a 
significant difference from the pre-loading level, while asterisks above bars represent 
significant differences between groups (P < 0.05). 
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 7.4.2 Cellularity Analysis: Cell death, measured by LDH levels in the media, 
increased significantly in a time and magnitude dependant manner for all groups (Figure 2).  
A significant increase (relative to pre-loading) in the number of dead cells was seen by the 
end of the first day in the 18 MPa group, second day in the 12 & 3 MPa groups, and third day 
for the unloaded group.  A significant load magnitude dependant increase was seen by the 
end of the third day (18 MPa > 12 MPa > 3 MPa > 0 MPa).  
 Cell viability, as measured by the MTT assay, showed minimal differences in the 
number of live cells (Figure 19).  No groups were significantly different from the unloaded 
group. The only difference was the 18 MPa had greater viability than the 3 MPa group. 
 
Figure 19: Increase of LDH (cytotoxicity indicator) in the media of tendons cyclically loaded 
for three days and the relative similarity in cellular viability of tendons, indicating cellular 
turnover. Asterisks on bars indicate a significant difference from the pre-loading level, while 
asterisks above bars represent significant differences between groups. For viability, groups 
that do not share a common letter are significantly different (P < 0.05). 
 
7.4.3 Collagen & Collagenase:  Collagen content (Figure 3), measured from 
hydroxyproline, was not different between groups (P = 0.312).   Collagenase measurements 
showed a significant increase by day three in the 18 MPa, 12 MPa and unloaded groups 
relative to day zero ( ).  This difference became significant after the second day for 
the 12 MPa group, while no differences were observed in the 3 MPa group across time. 
Figure 20
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 Figure 20: Relative increase in collagenase levels in the media of tendons cyclically loaded 
for three days and the similarity of collagen content of the tissue.  Asterisks above bars 
indicate a significant difference from pre-loading levels (Post/Pre). For collagen content 
groups that do not share a common letter are significantly different (P < 0.05). 
 
 7.4.4 Sulfated GAG Analysis:  The sulfated glycosaminoglycan content in the tissue 
after loading showed a trend for load-magnitude dependence, as both highly loaded groups 
showed greater, but not significant (P = 0.062), GAG content compared to the low and 
unload groups (Table 4).  
 
Table 4: Sulfated glycosaminoglycan content of tendon explants cyclically loaded for three 
days.  Values were normalized by dry weight of tissue segment. 
 
. 
 
 
 
 
 120 
7.5 Discussion: 
 Tendon overuse injuries are a major clinical problem and their etiology is thought to 
be due to a combination of the loading applied and the resulting biochemical responses.  
Responses that are potential candidates in the development of tendinosis include 
inflammatory mediators, particularly PGE2 (Almekinders et al. 1995; Wang et al. 2003; Li et 
al. 2004; Khan et al. 2005).  The current study found PGE2 to be load inducible, which is 
consistent with results of past fibroblast and human micro-dialysis studies (Yamaguchi et al. 
1994; Langberg et al. 1999; Langberg et al. 2003; Li et al. 2004).  Though not directly 
comparable to the results of cell culture studies, the levels of PGE2 measured during loading 
in our model are consistent with in vivo micro-dialysis studies of human tissue (Langberg et 
al. 2003).  PGE2 was also load-magnitude dependant, as the higher loading levels produced 
more PGE2 than did the low and unloaded groups.  This effect has not been shown in tendon 
tissue, but has been shown in cell culture studies of stretched fibroblasts of tendon and 
ligament (Yamaguchi et al. 1994; Wang et al. 2003).  However, translating strains observed 
in cell culture models into tissue loads is difficult.  Thus, the physiologic relevance of the 
effects observed in such cell culture studies is less clear.  In particular, the established role of 
PGE2 as an inflammatory mediator coupled with its  increase with loading have prompted the 
consideration of excessive PGE2 production to play a role in the pathology of overuse 
tendinopathy (Wang et al. 2006).  This has led to several injection studies investigating the 
ability of PGE2 or PGE1 to initiate degenerative changes similar to overuse tendinopathy.  
While histological studies suggested these injections could initiate degenerative changes 
(Sullo et al. 2001; Khan et al. 2005), a recent study evaluating mechanical properties found 
structural strength and stiffness to increase after eight weeks (Ferry et al. 2006).  Seemingly 
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contradictory, this improvement in properties would be consistent if PGE2 plays a role in the 
activation of remodeling and the histological studies observed degenerative changes during 
this remodeling phase while the biomechanical study observed mechanical improvement at 
eight weeks, after some remodeling.  The concept of PGE2 having a role in activating tissue 
remodeling has precedence in studies of bone, where increased bone mass has been observed 
following prostaglandin injections (Jee and Ma 1997).  While the putative activation of 
tendon remodeling by PGE2 to repair load-induced microdamage would seem to be a positive 
effect,  researchers  have suggested that tendon may experience a transient period of 
weakness as the tendon remodels (Zamora and Marini 1988).  However, excessive activation 
of remodeling by PGE2 may actually make the tissue more susceptible to further injury when 
it is being repetitively loaded.  A potential clinical impact of the observed load dependent 
increase in PGE2 may be to alter the timing or dosage of NSAID administration in patients 
with symptoms of tendinopathy, based on their activity level. 
 The accumulation of glycosaminoglycans seen in the 12 MPa and 18 MPa groups is 
consistent with past studies which have seen such increases in degenerated tendons (Birch et 
al. 1998; Kobayashi et al. 1999), and decreases in immobilized tendons (Jozsa and P. 1997; 
Maganaris et al. 2004).  Though these results weren’t significant, a strong trend (p=0.062) 
was evident and may have been significant given more response time.  This GAG response 
may be linked to the levels of PGE2, as studies have shown NSAID treatment to decrease 
GAG content (Riley et al. 2001).  The amount of GAG accumulation after only three days in 
culture was not expected, but warrants further investigation.  Further examination of specific 
GAGs expressed may help elucidate the onset of tendinosis as increases in dermatan sulfate 
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may signify wound healing type response, while increases in hyaluronic acid or chondroitin 
sulfate may indicate a tendency for granulation (Kobayashi et al. 1999).   
 Though a trend for load-based GAG concentration increase was seen, no differences 
or trends were seen in the collagen content.  This may be due to the short response time (3 
days) afforded the tendons or the sensitivity of the collagen assay may not be sufficient.  
Reports on animal studies have shown differences in collagen density, organization and 
collagen content with loading (Woo et al. 1980; Woo et al. 1981; Astrom and Rausing 1995; 
Soslowsky et al. 2000).  The current procedure analyzed total collagen so increases in type 
III collagen seen in tendinopathy (Riley et al. 1994; Birch et al. 1998; Archambault et al. 
2001), may be balancing the decrease in type I, and resulting in no change in total collagen.  
To better gauge the current degenerative state of the tendon, assessment of organization and 
ratio of collagen type I to type III may be beneficial. 
The levels of collagenase were found to increase with the highly loaded (18 MPa and 
12 MPa) and unloaded (0 MPa) groups but not the low group (3 MPa).  The up- regulation of 
collagenase in the unloaded group is consistent with studies of immobilization (Lavagnino et 
al. 2003; Uchida et al. 2005).  MMP-1 has been found to be down-regulated with load 
(Lavagnino et al. 2003), while MMP-3 is up-regulated (Archambault et al. 2001; Tsuzaki et 
al. 2003) in past tendon studies. The 3 MPa group is likely the groups that best represents 
normal loading activity, or a non-damaging group (unpublished data), and this could explain 
the lack of collagenase or remodeling needed in the group.  Cyclic loadings at 12 MPa has 
been previously shown to be damaging in our tissue explant system (Devkota and Weinhold 
2005), therefore the highly loaded groups’ increase in MMPs may be of MMP-3, the MMP 
upregulated during remodeling.  However, like the collagen data, evaluating the specific 
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MMPs released would need to be performed to confirm this.  Also, the collagenase response 
may be linked to the PGE2 response as past studies have shown PGE2 to increase collagenase 
production in uterine cervical fibroblasts (Goshowaki et al. 1988) and PGE2 has been used 
clinically to promote cervical ripening, a process in which the extensibility of the collagen 
matrix of the cervix is increased due to apparent collagen reorganization (Shi et al. 2000).   
Large increases in cell death were seen in a magnitude and duration-dependant 
manner in our cyclic loading model.  Interestingly, the lack of change in  viability  between 
groups may suggests active cellular turnover.  This inferred cell turnover appears to occur 
especially in the highly loaded groups, and is consistent with past studies of stretched 
fibroblast (Banes et al. 1995; Yang et al. 2004).  This conjectured increase in cell turnover in 
the highly loaded groups could be linked to the load dependent PGE2 response as previous 
studies have indicated that PGE2 can stimulate cell proliferation in fibroblasts (Martinez et al. 
1997).  However, studies of tendon have previously shown increased apoptosis in 
tendinopathy as well as immediately following high magnitude loading (Yuan et al. 2003; 
Scott et al. 2005).  Cell death with cyclical loading of tendon may have a role in the 
pathology of overuse tendinopathy as the release of cytosol proteinases or proenzymes may 
induce degeneration of the surrounding matrix.  A limitation of the cell death and viability 
evaluations is that the assays used did not localize changes of these variables within the 
different regions of the tissue. 
Significant changes in the tendon responses were seen after only three days with a 
cyclical loading explant model.  Increases were observed in the collagenase levels, GAG 
content, cell death and PGE2 content.  Each of these biochemical responses are suggestive of 
tissue injury and have been  previously hypothesized to play a role in the development of 
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tendinopathy  (Akeson 1961; Archambault et al. 1995; Jozsa and P. 1997; Li et al. 2004; 
Khan et al. 2005; Wang et al. 2006).  PGE2, a response independently linked with the other 
responses and likely a key contributor to tendinopathy, was found to be inducible in a load-
magnitude dependant manner.  The clinical significance of these findings may lie in the 
potential modulation of NSAID administration during heavy exercise and rest for 
tendinopathy. 
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CHAPTER 8 
COX INHIBITION 
 
8.1 Abstract: 
 The following study was carried out to examine the hypothesis that chronic 
expressions of prostaglandin E2 (PGE2) plays a role in the development of overuse 
tendinopathy.  Avian flexor digitorum profundus tendons were cyclically loaded four 
hours/day in an explant model for six days with and without treatments of exogenous PGE2, 
SC-560 (COX-1 inhibitor at 0.01 & 0.10 µM) and Celebrex (COX-2 inhibitor at 0.1 and 1.0 
µM) across three loading levels (0, 3 and 12 MPa).  Both COX inhibitors decreased PGE2, 
strain accumulation, cell death and collagenase while maintaining collagen, sulfated 
glycosaminoglycan (sGAG), ultimate stress, and energy density, but increasing elastic 
modulus and stiffness.  Exogenous PGE2 treatment increased strain accumulation and 
collagenase while reducing stiffness, cell death and showing trends for decreasing collagen 
and sGAG.  These results suggest the pathology of overuse injuries can be accelerated by 
PGE2 potentially through the reduction of stiffness, resulting in increased strains, and thus 
increased cellular responses.  Finally, both SC-560 and Celebrex were effective at 
suppressing many of these changes while initiating no damaging changes, suggesting a 
potentially positive therapeutic role for COX inhibitors in preventing overused tissue from 
developing into tendinopathy.  
 
  
8.2 Introduction: 
 Overuse injuries account for significant time and productivity losses in both athletic 
and occupational settings.   Tendon overuse injuries comprise nearly 30% of all running 
injuries and 40% of all tennis injuries (Sharma and Maffulli 2005).  Though the exact 
etiology is not known, overuse injuries are believed to be caused by an accumulation of 
damage due to repetitive loadings and biochemical expressions (Jozsa and P. 1997; Sharma 
and Maffulli 2005; Wang et al. 2006).  In response to external stimuli such as loading, 
various biochemical factors such as cytokines, growth factors and inflammatory mediators 
are released.  One such load-inducible biochemical expression that is thought to play a key 
role in the development of tendinosis is the inflammatory mediator prostaglandin E2 (PGE2) 
(Almekinders et al. 1993; Almekinders et al. 1995; Li et al. 2004; Wang et al. 2006). 
 Blocking PGE2 is one of the main effects of non-steroidal anti-inflammatory drugs 
(NSAID), a common treatment for tendinopathies (Radi and Khan 2005; Mehallo et al. 
2006).  NSAIDs inhibit cyclooxygenase (COX), a catalytic enzyme responsible for the 
formation of all prostaglandins and thrombaxanes. COX has two main isoforms, COX-1 and 
COX-2, the constitutional and inducible isoforms, respectively.  
 Non-specific NSAIDs, those that block both isoforms of COX, are the oldest class of 
synthetic drugs and have been used for over 100 years.  In tendon, these drugs have both 
positive and negative effects.  Indomethacin has been shown to have both positive (Forslund 
et al. 2003) and negative (Cohen et al. 2006) effects on healing tendon through the 
increase/decrease of failure strength.  Negative effects have also been shown, such as 
decreased cellular proliferation in a fibroblast model (Almekinders et al. 1995), and both 
decreased cellular proliferation and glycosaminoglycan (GAG) synthesis in explant models 
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(Riley et al. 2001).  Ibuprofen has also been shown to inhibit both cellular proliferation and 
migration, effects negative to tendon healing (Tsai et al. 2004; Tsai et al. 2006).  Non-
specific NSAIDs been shown to decrease the levels of PGE2, however it is usually 
accompanied by a concurrent increase in LTB4 levels (Almekinders et al. 1995; Li et al. 
2004), making its usefulness questionable.  Furthermore, negative effects have been seen in 
vivo as they have been shown to decrease blood flow during exercise (Langberg et al. 2003). 
 NSAIDs that block COX-1 have side effects of causing gastrointestinal bleeding and 
ulcering.  Newer NSAIDs called coxibs have been developed that block predominantly the 
second isoform of COX.  No data exists on the effects of coxibs on overuse tendinopathy, but 
limited data does exist on ligament injury and acute tendon injury models.  In a treating acute 
ankle sprain, coxibs have been as effective as non-specific NSAIDs (Petrella et al. 2004).  In 
transected tendons, coxibs have shown negative effects in the early stages (Elder et al. 2001; 
Virchenko et al. 2004; Cohen et al. 2006), but beneficial effects later in the healing process 
(Forslund et al. 2003; Virchenko et al. 2004).  Also, a micro-dialysis study of peri-tendinous 
space has shown coxibs to decrease the normal increase of blood flow during exercise 
(Langberg et al. 2003).   
 The current data that exists on the efficacy of NSAIDS is, at best, contradictory but 
they are still routinely prescribed for tendinopathy treatment.  No benefits of COX-1 
inhibition from NSAIDs have been seen (Radi and Khan 2005),  however they possess great 
analgesic effects, justifying their use (Jozsa and P. 1997; Mehallo et al. 2006).  Because little 
data exists on the effects of NSAIDs on overuse tendinopathy the following study was 
carried out.  The objective of this study was to investigate the ability of COX inhibitors to 
modulate the biochemical and biomechanical response of tendon explants exposed to cyclical 
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loading in vitro. We hypothesize that the COX-2 inhibitors will decrease load induced PGE2, 
resulting in better mechanical properties and reduced biochemical expressions of tissue 
injury compared to the COX-1 inhibitor treated and control groups.  An additional objective 
was to examine the influence of elevated levels of exogenous PGE2 on the biochemical and 
biomechanical response of tendon explants exposed to cyclical loading.  We hypothesized 
that exogenous PGE2 exposure would result in inferior mechanical properties and increased 
biochemical expressions of tissue injury. 
8.3 Methods: 
8.3.1 Specimen & Treatment:  Avian flexor digitorum profundus tendons were 
harvested from the middle toes of freshly sacrificed 50 – 60 day old commercial, Rock 
Cornish hen.  Three loading levels (unloaded, 3 MPa and 12 MPa) and six treatments 
comprised 18 total groups with n = 12 per group.  Treatments consisted of high and low 
dosages of SC-560, a COX-1 inhibitor at 0.01 & 0.10 µM, high and low dosages of Celebrex, 
a COX-2 inhibitor at 0.10 & 1.00 µM, an exogenous PGE2 group (100 ng/ml) and an 
untreated group.  
8.3.2 Loading Design:  Following isolation, tendons were placed on a load-
controlled tissue loading device (TLD) (Devkota and Weinhold 2005). An equilibration 
period of 72 hours followed with preconditioning (3 MPa, 0.50 Hz haver-sine wave) for two 
hours at 24 and 48 hrs to minimize atrophic changes.  Then tendons were loaded 4 hours and 
allowed to rest for 20 hours the subsequent six days. Loadings were 1.0 Hz, haver-sine 
waveforms with peaks of 12 MPa, 3 MPa or 0 MPa. 
8.3.3 Loading Strain Analysis:  Sutures were stitched across the tendon 
midsubstance for video strain analysis (VSA) (Devkota and Weinhold 2005).  Distance 
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between the sutures was measured just prior to the first, third and after the sixth loading days 
at 3MPa of tension for static strain.  Dynamic strain was measured during the first, third and 
after the sixth loading days.  Static measurements are absolute strain values while dynamic 
strain values are (peak – trough)/ trough length.  Strain measurements were not performed on 
the unloaded groups. 
8.3.4 Media Analyses:  Media was replaced just prior to loading, and every 72 hours 
thereafter.  Furthermore, 24 hours before loading started (48 hours into equilibration period), 
the media was replaced to remove biochemical expressions released during surgery and 
setup.  All media was stored frozen (-80ºC) and analyzed at a later time. 
PGE2 levels in the media were quantified by a commercial immunoassay kit (PGE2 
EIA – monoclonal, Cayman Chemical, Ann Arbor, MI).  Cellular death was quantified by 
measuring the levels of lactate dehydrogenase (LDH), a membrane protein released upon cell 
lysis by a commercial colormetric assay (Cytotox 96, Promega Corp, Madison, WI).  Total 
collagenase protein levels were measured by quantifying the amount of dye released from a 
mixture of sampled media and Azocoll, a dye impregnated collagen (Chavira et al. 1984).  
Aminophelylmercuricacetate (APMA), a collagenase activating agent was added to half of 
the samples to distinguish active from total collagenase. 
8.3.5 Compositional Analyses:  Following loading, 3 of the tendons were sectioned 
for compositional analysis and viability.  Viability was evaluated by the modification of an 
MTT assay (Klein et al. 1996).  For compositional analysis, the remaining sections were 
digested with Papain (0.5mg/ml) and stored at -80ºC for collagen and proteoglycan analysis. 
Modified hydroxyproline (Bergman and Loxley 1963) and sulfated 
glycosaminoglycan (sGAG) (Farndale et al. 1986) content assays were performed on the 
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digest to measure hydroxyproline, a collagen constituent of known proportions and sGAG, 
the covalently attached glycoprotein chains of proteoglycans.  Hydroxyproline and 
chondroitin sulfate standards were performed to determine absolute levels and were 
normalized by the dry-weight of the tissue. 
 8.3.6 Failure Testing:  Following loading, 9 of the tendons were wrapped in saline 
soaked gauge and stored at -20ºC for failure testing.  An area micrometer (Butler et al. 1984) 
was utilized for two measurements on the midsubstance prior to failure testing.  Tendons 
were cryo-gripped (Riemersa and Schamhardt 1982) and pre-conditioned with ten cycles of a 
1% strain, 0.5 Hz haver-sine waveform prior to failure testing with a 1% strain/sec linear 
ramp.  Load, grip strain and midsubstance strain data were gathered during the failure 
loading for structural and material property analysis. 
 8.3.7 Statistical Method:  The exogenous PGE2 and COX treatment groups were 
analyzed individually (vs. control) because COX inhibition has wide ranging effects beyond 
reducing PGE2 production.  A two-way (Load x Treatment Concentration) repeated measures 
analysis of variance (2-way RM ANOVA) was performed for both COX treatments at each 
measure to determine if dosage effects existed.  Within each measure, if a main effect of 
treatment concentration was not observed, the specimens at each dosage were combined.  
Media and strain analyses were performed by a 2-way (Load x Treatment) ANOVA at each 
day (0, 3, 6) and a 2-way (Treatment x Day) RM-ANOVA at each load level (0, 3, 12 MPa).  
Failure testing and composition data were analyzed by a 2-way (Load x Treatment) ANOVA 
for each measure.  Interactions were assessed by the Holm-Sidak multiple comparisons 
method with significant set at P<0.05. 
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Figure 21: Media PGE2 levels (ng/ml) in cyclically loaded tendon explants. Five point stars 
represent difference from control at that load level, while four point stars represent difference 
from basal values within group (P<0.05). PGE2 levels were greater after six days in untreated 
and PGE2 treated groups relative to their pre-loading levels.  All treatments of the Coxib 
(Celebrex) and the 3 MPa treatment of the COX-1 inhibitor (SC-560) eliminated this 
increase.  Note different scale on right for PGE2 treatments (Dark bars). 
 
8.4 Results: 
8.4.1 PGE2 Analysis:  Levels of PGE2 in the media were found significantly increase 
in all untreated and PGE2 treated groups, relative to basal levels (Figure 21).  The increase in 
the exogenous PGE2 groups was an order of magnitude greater than the untreated groups.  
COX inhibitor analysis showed a significant dosage difference in the Celebrex group, but not 
the SC-560 group.   All Celebrex and the SC-560 treatments significantly reduced PGE2 at all 
load levels relative to the 12 MPa and 3 MPa untreated groups. The untreated, unloaded 
group was significantly greater than all Celebrex-High, 12 MPa Celebrex-Low and 3 MPa 
SC-560 Low groups.  Within the COX inhibitor groups, a main treatment effect of increased 
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PGE2 was observed (SC-560 > Celebrex), independent of load level.  All COX inhibitor 
treatments were able to abolish PGE2 levels (relative to basal levels) except for the 0 and 12 
MPa SC-560 groups.  A strong trend for a decrease in PGE2 levels, relative to basal levels, 
was observed in the 3 and 12 MPa Celebrex-High groups (P = 0.056 and 0.055, respectively). 
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Figure 22: Static strain measured during cyclic loading. Five point stars represent difference 
from control at that load level, while four point stars represent difference from basal values 
within group (P<0.05). Significant strain accumulated by day six in the highly loaded 
untreated as well as the PGE2 and COX-2 treated groups.  Day three values are represented 
for each group as light shaded bars.  
 
8.4.2 Loading Strain Analysis:  Static strain analysis showed untreated and PGE2 
treated groups to significantly accumulate more strain than the SC-560 group, which did not 
accumulate strain, with 12 MPa loading (Figure 22).  The Celebrex group also accumulated 
strain at this loading level, but it was not different from any other treatments. At the 3 MPa 
loading level, only the PGE2 treated group accumulated strain, but no inter-treatment 
differences were seen.  A trend for strain accumulation in the untreated group at 3 MPa was 
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also observed (P = 0.092). An overall duration dependant strain accumulation was observed 
(6 > 3 > 0), and at day six, a load-magnitude dependant strain increase was also noted (12 
MPa > 3 MPa). 
Dynamic strain measurements ((peak-trough)/trough) demonstrated no treatment 
effects of SC-560, Celebrex and PGE2 groups relative to the untreated groups. An overall 
significant magnitude (12 > 3 MPa) dependant increase was noted, however a duration 
dependant increase (6 > 3 > 0) was only noted for all 12 MPa groups (data not shown).  
 
8.4.3 Failure Analysis:  Midsubstance tissue strains at failure were found to be 
significantly increased in the PGE2 group, relative to the untreated group at 0 MPa (
).  A main treatment effect of decreased midsubstance stiffness was also seen in the PGE2 
groups, compared to the untreated groups, independent of load level.  Conversely, a main 
treatment effect of increased midsubstance stiffness was observed in the Celebrex groups, 
compared to the untreated groups, independent of load level. A main treatment effect of 
increased midsubstance elastic modulus, independent of load level, was noted for the 
Celebrex group relative to the SC-560 and untreated groups.  Main effects of load magnitude 
were demonstrated by the decreased max stress, energy and energy density of the 12 MPa 
groups relative to the 0 and 3 MPa groups, independent of treatment.  No other treatment 
effects were noted for any analysis parameter. 
Figure 
22
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Table 5: Biomechanics data from failure testing. Note COX inhibitors (A, B; Ω, Λ) and PGE2 
(a, b; λ, ω) were each analyzed separately against the untreated group (PGE2 and COX 
inhibitors cannot be directly compared).  Latin letters denote load-magnitude difference, 
while Greek letters denote treatment differences. Groups that do not share a common letter 
are significantly different. 
 
    COX-1 COX-2 Untreated PGE2 
0 MPa 133.0 A 137.7 A 131.3 A a 132.8 a 
3 MPa 128.4 A 140.2 A 132.1 A a 141.4 a Max Stress (MPa) 
12 MPa 117.9 B 110.7 B 105.8 B b 106.7 b 
0 MPa 282.4 B 269.4 B 249.9 B   252.9   
3 MPa 277.5 A 307.0 A 297.6 A   257.4   Max Load (N) 
12 MPa 252.4 B 252.0 B 243.0 B   233.9   
0 MPa 2.121 B 1.970 B 1.899 B b 1.942 a,b 
3 MPa 2.165 A 2.198 A 2.255 A a,ω 1.814 b,λ Area (mm2) 
12 MPa 2.139 A 2.275 A 2.295 A a 2.202 a 
0 MPa 0.132   0.137   0.130     0.122   
3 MPa 0.134   0.132   0.130     0.135   Grip Strain (mm/mm) 
12 MPa 0.131   0.119   0.113     0.122   
0 MPa 0.115   0.163   0.107   a, λ 0.250 a, ω 
3 MPa 0.152   0.120   0.152   a 0.126 b VSA Strain (mm/mm) 
12 MPa 0.128   0.115   0.103   a 0.131 b 
0 MPa 71.47 C 71.95 C 68.30 C b 69.47 b 
3 MPa 89.65 A 91.27 A 88.19 A a 75.77 a 
LVDT 
Stiffness 
(N/mm) 12 MPa 77.82 B 81.20 B 86.21 B a,b 73.46 a,b 
0 MPa 1129.9   1164.8   1130.4     1199.6   
3 MPa 1106.8   1206.8   1160.9     1231.8   
LVDT Elastic 
Modulus 
(MPa) 12 MPa 1060.1   1116.4   1141.1     1079.4   
0 MPa 223.4 Ω, Λ 265.9 Ω 198.9 Λ ω 161.9 λ 
3 MPa 227.1 Ω, Λ 243.4 Ω 181.9 Λ ω 153.6 λ 
VSA 
Stiffness 
(N/mm) 12 MPa 184.9 Ω, Λ 212.0 Ω 186.8 Λ ω 149.0 λ 
0 MPa 1479.5 Λ 1661.1 Ω 1362.5 Λ   1080.7   
3 MPa 1324.8 Λ 1661.4 Ω 1287.3 Λ   1498.2   
VSA Elastic 
Modulus 
(MPa) 12 MPa 1348.2 Λ 1460.2 Ω 1376.4 Λ   1227.4   
0 MPa 740.9 A 684.0 A 601.0 A   591.8   
3 MPa 641.0 A 700.5 A 677.6 A   626.6   Energy (mJ) 
12 MPa 574.2 B 534.4 B 471.7 B   521.5   
0 MPa 10.14 A 10.93 A 9.80 A a 9.18 a 
3 MPa 10.44 A 10.92 A 10.14 A a 11.26 a 
Energy 
Density 
(mJ/mm3) 12 MPa 9.05 B 7.58 B 6.76 B a 7.45 b 
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Figure 23: Cytotoxicity, as measured by LDH  levels in media. Five point stars represent 
difference from control at that load level, while four point stars represent difference from 
basal values within group (P<0.05). Celebrex and SC-560 tended to decrease the load based 
cytoxicity increase, while exogenous PGE2 eliminated it to sub-basal levels.  
 
 
8.4.4 Cell Death and Viability Analysis:  Exogenous PGE2 significantly reduced 
cell death at all loading levels, while all untreated groups displayed a significant increase 
relative to basal levels (Figure 23).  Celebrex and SC-560 significantly reduced cell death 
relative to untreated groups at 0 and 12 MPa. No differences were seen between the COX 
inhibitors and untreated groups at 3 MPa. Across days, all COX inhibitor and untreated 
groups increased significantly (6 > 3 > 0) while PGE2 decreased (0 > 3, 6).  A load-
magnitude effect was also present as the 12 MPa groups were significantly greater than their 
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3 MPa counterparts.  No such load-magnitude effects were seen in the exogenous PGE2 
treated groups.  
 Cell viability analysis demonstrated no significant difference between treatments, but 
a trend was observed (P = .091) for the Celebrex group to have more live cells than the 
untreated group (Table 6). A load-magnitude based response was seen, as the 12 MPa and 3 
MPa groups displayed significantly less live cells than the unloaded groups.  
 
Table 6: Composition data from tissue segments. Note COX inhibitors (A, B; Ω, Λ) and 
PGE2 (a, b; λ, ω) were each analyzed separately against the untreated group (PGE2 and COX 
inhibitors cannot be directly compared).  Latin letters denote load-magnitude difference, 
while Greek letters denote treatment differences. Groups that do not share a common letter 
are significantly different. 
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 8.4.5 Collagen and Collagenase Analysis:  Total collagenase levels increased nearly 
3 fold in the exogenous PGE2 treated group compared to the untreated group at 0 MPa 
(Figure 24).  A slight, but significant increase was also noted in the PGE2 group relative to 
the untreated at 3 MPa, while a slight significant decrease was observed at 12 MPa relative to 
untreated.  Total collagenase levels were not affected by COX inhibitor treatment at any load 
level.  For total collagenase, a main effect of loading duration was present as levels increased 
from day zero to six, independent of load level. At day six a main effect due to loading 
magnitude, independent of treatment, was present as the 0 MPa groups were significantly 
greater than the 3 and 12 MPa groups.   
 For active collagenase, a main effect due to load level was also seen, but in this case 
the 12 MPa groups produced more collagenase than the 0 MPa groups ( ).  Active 
collagenase increased significantly in the 12 MPa untreated and PGE2 treated groups relative 
to basal levels.  This increase was significantly reduced by both COX inhibitor groups.  
Hydroxyproline content analysis showed no treatment or loading effects in collagen content 
for COX inhibitors (Table 6). PGE2 treated groups displayed a trend (P=0.086) for a main 
effect of a decrease in collagen content, independent of loading level.  
Figure 24
8.4.6 sGAG Analysis:  PGE2 treated groups displayed a main treatment effect for a 
reduction in sGAG content relative to the untreated groups, independent of loading level 
(Table 6).  A main effect of load level to increase sGAG content was also noted (12 > 0 MPa) 
for COX inhibitors, exogenous PGE2 and untreated groups. 
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 Figure 24: Total collagenase levels measured from media samples treated with AMPA show 
an increase in unloaded groups and a significant PGE2 effect.  Active collagenase measured 
from media samples without APMA show highly loaded groups to increase in active 
collagenase. 
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8.5 Discussion:   
 Overuse injuries comprise a significant portion of all orthopaedic injuries.  Though 
the etiology is unknown, a common treatment modality remains pharmaceuticals such as 
NSAIDs.  NSAIDs inhibition of prostaglandin synthesis is believed to be the method of 
action and is thought to be beneficial to the healing tendon.  Because prostaglandins are 
produced in response to loading, repetitive loading has been hypothesized to causes chronic 
overproduction that could lead to overuse injury.   Selective COX-1 and COX-2 inhibitors 
(as well as positive and negative controls of exogenous PGE2 and untreated groups) were 
administered with our overuse tendinopathy model to examine the influence of 
prostaglandins on the biochemical and biomechanical response of tendon.  The loading levels 
selected (0 MPa, 3 MPa and 12 MPa) correspond to atrophic, normal loading and fatigue 
inducing levels of loading, respectively. 
 Cyclically loaded tendons exhibited a load-induced increase in PGE2 that was 
selectively inhibited by both COX-1 and COX-2 specific NSAIDs.  Exogenous PGE2 levels 
measured 10x that of endogenously created PGE2 in the untreated groups.  This PGE2 
concentration was chosen to balance our culture system, which maintains a 1/500 tissue to 
media volume ratio, while most cell culture studies maintain ratios near 1/50.  A trend for an 
increase of PGE2 with load-magnitude was observed in untreated groups.  This response has 
not been seen with tendon tissue, but is consistent with past cell culture studies of tendon and 
ligament fibroblasts (Yamaguchi et al. 1994; Wang et al. 2003).  The COX-1 inhibitor SC-
560, was able to reduce the PGE2 increase at the 3 and 12 MPa loading levels relative to the 
untreated groups, but not in the unloaded condition.  Because the unloaded, untreated group 
exhibited a PGE2 increase, and the SC-560 could not inhibit this, COX-2 would seem be the 
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dominant isoform for PGE2 production in this scenario, the atrophic condition.  Whether this 
inducible COX-2 pathway is driven by the lack of load or some other signal is not 
determinable from this study.  However, as hypothesized, Celebrex exhibited inhibitory 
effects for load induced PGE2 increase, as well as for the unloaded condition.  Celebrex was 
also found to be dose dependant with the higher concentration showing a strong trend to 
decrease PGE2 levels below initial basal levels in the proposed damaging (12 MPa) and non-
damaging (3 MPa) groups.   
 The hypothesized role of PGE2 treatment to cause the greatest decline in property 
changes was confirmed by failure analysis.  PGE2 treatment, in the 0 MPa group, caused a 
significant increase in the tissue strain at failure.  This increase in strain will result in the 
reduction of the tendon’s force generation capability, potentially leading to further atrophy 
and remodeling.  This lengthening also caused PGE2 treatment to make tendons less stiff.  
Stiffness loss alters a tendon’s ability to handle load, and is often used as an indicator of 
tissue injury.   Conversely, the Celebrex treated groups caused an increase in midsubstance 
stiffness and elastic modulus, compared to the unloaded controls independent of load level.   
This effect has potential therapeutic benefit in clinically strained tendons, as PGE2 is strain 
inducible and known for causing soft tissue laxity (Shi et al. 2000), coxib treatment may 
directly alleviate this. 
 Though failure stiffness, elastic modulus and strain were affected by treatment, 
maximum stress was not.  The proposed damaging group (12 MPa) exhibited significant 
decreases in maximum stress, energy and energy density.   Statistical analysis showed this to 
be dependant on loading magnitude level and independent of treatment, implying the damage 
is a result of mainly material fatigue due to accumulated fibril damage.   
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Material fatigue was also evident in the strain accumulation during loading.   The 
dominant parameter was load-magnitude as a main effect for load existed.  Significant strain 
accumulated at 12 MPa, and this was reducible by SC-560 treatment unlike in the failure 
material properties where Celebrex reduced this increase.  Strain accumulation at 12 MPa 
was greatest with PGE2 treatment, and at 3 MPa, the only group with strain accumulation 
was the PGE2 treated group.  PGE2 has been shown to increase the extensibity of the cervix 
(Shi et al. 2000) and the failure testing showed consistent findings of increased strain and 
decreased stiffness. 
PGE2 treatment also increased total collagenase levels significantly (3x) versus the 
untreated levels within the unloaded groups.  Increase in MMP-1 expression of unloaded 
tendons (Lavagnino et al. 2003) has been previously observed and could partly explain the 
onset of tendinosis in sedentary people.  Total collagenase also exhibited a tendency for a 
load-magnitude based reduction, which has been seen in past studies (Lavagnino et al. 2003).   
This stocking of collagenase is likely a remodeling response, however, because no 
differences were noted in active collagenase in the unloaded condition, further signals or 
factors are likely required before changes that may lead to tendinopathy occur.  The opposite 
effect, a load dependant increase was seen for active collagenase as the 12 MPa PGE2 and 
untreated groups were significantly greater than their 3 and 0 MPa counterparts.  This 
increase in active collagenase was inhibitable by both COX inhibitors.  Whether this 
inhibition is positive or negative is debatable because though the collagenase can damage the 
matrix, they are required to remodel damaged matrix.  With tendinosis, before or during the 
onset of injury it is likely beneficial to inhibit collagenase, but later in the remodeling and 
repair phase it is likely detrimental.  This is supported by collagen content data which 
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exhibited a trend for a load based collagen content decrease, with a trend for the treatment 
effect of PGE2 to decrease collagen content.  This likely contributed to the increased strain 
and decreased stiffness in the PGE2 groups. 
Consistent with clinical tendinopathy, a load magnitude based sGAG increase was 
observed.  This increase is thought to be indicative of remodeling associated with 
tendinopathy.  However, PGE2 treatment decreased sGAG content (independent of load 
level) relative to the untreated group.  This is contradictory to the clinical situation as well as 
previous studies of cox inhibitors (Riley et al. 2001).  GAG loss was likely a physical result 
of the collagen decrease (trend) with PGE2 treatment.  
Cyclically loaded tendons exhibited a high magnitude and time dependant increase in 
cell death, which is consistent with past studies (Scott et al. 2005).  Exogenous PGE2 
treatment completely eliminated this response.  This reduction of cell death by PGE2 is seen 
in lung, colon and various other cancers and is thought to be through the cessation of 
apoptosis (Cui et al. 2005; Grosch et al. 2006).  Apoptosis has been suggested to play a role 
in the hypocellularity noted in tendinosis (Yuan et al. 2003). While apoptosis is positive in 
cancer where there is an over-abundance of cells, it is negative in tendinosis where there is 
decreased cellularity, implying a positive effect of PGE2.  Paradoxically, COX inhibitor 
treatment did not have the opposite effect of increased apoptosis. Both SC-560 and Celebrex 
also reduced cell death (relative to untreated), but since they were effective in reducing PGE2 
production, the COX inhibitors decreased cell death via a different pathway than PGE2.  Past 
studies have also noted exogenous PGE2 and COX inhibitor treatments to have the same 
effect, decreased proliferation (Almekinders et al. 1995; Riley et al. 2001; Cilli et al. 2004; 
Tsai et al. 2004).  Though cell death was decreased, an increase in the live cell count (relative 
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to untreated) was not noted with any treatment, implying a reduction in cellular turnover by 
these treatments. 
 In conclusion, our study indicates potentially significant roles for PGE2 and COX 
inhibitors in the development of overuse tendinopathy.  COX inhibitors maintained tissue 
composition and properties as evident by a lack of change in collagen, sGAG, ultimate stress 
and energy density.  This was likely accomplished through reduced cellular responses such as 
collagenase and cell death.  Cellular responses are strain dependant, and the COX inhibitor 
effect of increased stiffness and modulus resulted in decreased strains, and thus decreased 
responses.  Both COX inhibitors had the same trends, but Celebrex was generally more 
effective.  Conversely, the PGE2 treatment resulted in decreased stiffness, and trends for 
decreased collagen and sGAG content, likely due to increased strains and collagenase.  The 
underlying pathology leading to the stiffness change could be due to increased/decreased 
cross-linking, and warrants further investigation. However, the changes noted in this study 
could lead a healthy tendon to overuse tendinopathy if allowed to progress.  These changes 
are accelerated by PGE2, but reducible by COX inhibitors, mainly COX-2, suggesting a 
potentially therapeutic role against the development of overuse tendinopathy. 
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CHAPTER 9 
SUMMATION 
 
 Overuse tendinopathy remains a significant clinical concern, yet the etiology remains 
unclear.  Most research on tendinopathy continues to focus on the healing response of 
tendon, usually following acute injury.  While clinically relevant and potentially able to offer 
treatment options, the pathology of the condition cannot be fully addressed without better 
understanding the basic tendon material properties, then systematically examining the effects 
of loading, then repetitive loading on tendon to isolate the causative factors.  The following 
studies took such an approach by first determining the absence of an elastic strain limit, then 
creating a tendon explant model which allows for short term overuse studies.  Several load 
induced biochemical expressions that reduce composition and mechanical properties were 
isolated.  A factor of particular interest proved to be PGE2, which appears linked to several 
factors that combine to cause property losses resembling overuse tendinopathy.  COX 
inhibitors proved effective at reducing the PGE2 linked property loss, suggesting COX 
inhibitors as potential therapeutic measures to impede PGE2 from driving repetitively loaded 
tendons into the tendinopathy state.  
 In an effort to reexamine a basic material property of tendon, the elastic strain limit, 
tendons were loaded to various subfailure strains, and then loaded to failure.  Surprisingly, 
even the highest subfailure strains tested (90% of failure) did not differ from any other 
subfailure strain level (1%) in terms of material properties ( , , ).  Figure 4 Figure 5 Table 1
  
These results are likely due to methodology of cryo-grips which reduce stress concentration 
at edges of grips that employ only pressure for clamping.  Cryo-gripping resulted in failure 
within the midsubstance for over 98% of tendons tested, while previous studies in this lab 
saw 95% failure at grip edges.  These findings are supported by the study of bone-ligament-
bone complexes (which do not require mechanical gripping of the soft tissue) which saw no 
effects of subfailure loading up to 80% of failure strain (Panjabi et al. 1996).   
These findings suggest tendons are not directly damaged by a single subfailure tensile 
loading.  Because tendons are rarely loaded near failure levels, an alternate pathway, 
mediated by cellular responses must be responsible for a significant portion of the damage.  
Furthermore, because minimal fibrillar damage occurred, cellular responses are likely 
predominately load-induced and not damage induced.  Therefore, if these damage inducing 
cellular responses are identified, pharmaceutical treatments may be effective in preventing 
cyclically loaded tendons from developing into tendinopathy.  
 To determine the cellular responses directly responsible for driving an otherwise 
healthy tendon into a degenerative state, overuse studies are required.  However, before true 
overuse studies are conducted, studies of the basic response of tendon to cyclic load must be 
examined.  For this reason, an explant model was developed and its performance was 
characterized.   The explant model consists of two hexagonal, load controlled tissue loading 
devices and a video strain analysis system.  The loading device is superior to existing devices 
in its ability to maintain tissue viability, cause fatigue damage and operate in load control.  
The video strain analysis component of the model is superior to existing systems in its high 
speed of operation, reduced cost and programmability.   
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The VSA system is able to quantify the fatigue damage produced by the loading 
device in terms of strain accumulation.  The necessity of this feature cannot be overstated, 
especially considering the method of loading.  Our tests confirmed significantly increased 
strain accumulation across the grips, versus across just the midsubstance.  This increase is a 
result of slippage and stress concentrating effects from clamping, the same effects that caused 
the elastic limit of tendons to be initially reported at 4%.  Furthermore, were the tissues 
loaded in strain control, as many existing devices do, this damage and slippage would result 
in decreased loads across the tissue. However, because compressive damage is occurring at 
the grip edge, cellular responses initiated by damaged cells must be considered.  Tests of 
control tendons (unloaded) have been performed with and without gripping, and shown no 
significant differences in material properties, composition or biochemical response. 
This damaging explant system nicely compliments in vivo animal models as well as 
cell culture models.  Cell culture studies lack the extracellular matrix and thus cannot 
determine the effects of the cellular responses while in vivo models are inherently difficult to 
control.  In order to directly, and independently assess the effects of the various parameters 
of loading on tendon tissue, explant models are required. The current model, being able to 
cause and monitor fatigue damage while maintaining tissue viability, seemed capable of 
producing the beginnings of overuse tendinopathy, but needed confirmation.  
Overuse tendinopathy is a result of damage induced by cyclic loading and fibroblast 
response. However, how the cellular response to this cyclical load contributes to or lessens 
the fatigue-based decline in tissue properties, that is, their interaction is less clear.  To 
establish the usefulness of our system in overuse studies, both of these factors, and their 
interaction needed to be established.  To assess this, a loading design consisting of a set 
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number of cycles of load, distributed across varying periods was undertaken.  The numbers 
of cycles selected (86,400) corresponds to the number of seconds in one day.   These cycles 
were either administered consecutively for 24 hours, or divided into twelve equal portions (2 
hours each) and distributed over twelve days.  The twelve days was arbitrarily selected to 
allow sufficient time for cellular response to be induced. 
The model was successful in inducing material fatigue, as evident by the decreased 
material properties (failure stress, failure strain, elastic modulus).  Fibroblasts also expressed 
many responses with these loadings, among them collagenase, PGE2, sGAG and cell death.  
In general, these responses were magnified when applied across the longer duration, and their 
interaction was statistically significant. When changes are observed across time, it is 
important to establish that they were not solely a function of time in tissue culture.  This was 
evident in most responses which, though increased over time, also increased by loading 
magnitude.  Though many cellular responses were observed, the compositional changes were 
minimal, reiterating overuse tendinopathy as a long term degenerative condition. However, 
load based changes in sGAG was observed indicating that changes were likely imminent, if 
not already in progress. The proteoglycans that GAGs attach to are involved in, among other 
thing, matrix reorganization.    
Overall, fibroblast and load based changes were observed in cyclically loaded tendon 
explants with our new model. However, the precise pathway by which the damage occurs is 
not clear.  Whether load induces cellular responses which then damage the tissue, or load 
causes damage which then induces cellular responses needed further clarification. A great 
effect for the cellular responses to cause damage was seen as the longer duration of the 
normal loading level caused marked cellular responses and material property damage relative 
 156 
to the same loading applied across one day.  Also load induced damage was noted as the 
aggressively loaded groups caused the same amount of mechanical damage, regardless of the 
duration across which the loadings were applied.  Though clinical tendinopathy wasn’t 
developed, changes that would likely lead to tendinopathy if allowed to progress are present.   
 A cellular response that likely plays a significant role in driving a cyclically loaded 
tendon into overuse tendinopathy is PGE2.  PGE2 is seen in bone to play a significant role in 
the modulation of osteoblasts and osteoclasts formation, thereby affecting bone formation 
and resorption.  Though inflammatory cells are not found in tendinopathy, inflammatory 
mediators such as PGE2 are frequently observed.  PGE2 is load inducible in vivo through 
microdialysis and animal exercise, in seeded fibroblasts, and now in animal explants. Though 
it is not directly ascertainable from our studies what cells caused this response, studies of 
tendon fibroblasts in culture suggest their role.  PGE2 has also been shown to be load 
inducible in a dose dependant manner, cause localized degeneration as well as affect cellular 
proliferation and collagen synthesis, implicating its likely role in tendinopathy.  In other 
tissue such as bone, these inflammatory mediators play a key role in general remodeling, as 
well as remodeling after damage however, their role in tendon has not been established. 
 We found tendon explants to exhibit a dose and duration dependant increase in PGE2.   
Though not directly comparable to the results of cell culture studies, the levels of PGE2 
measured due to loading in our model are consistent with in vivo micro-dialysis studies of 
human tissue. Also, PGE2 is load-magnitude dependant, as the higher loading levels produce 
more PGE2 than the low and unloaded groups.  PGE2 also may play a role in modulating 
other responses seen as, collagenase, cell death and collagen content have all been previously 
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linked to PGE2 or its inhibition. To establish these links directly, and simultaneously, in our 
model would help confirm PGE2’s role in tendinopathy.  
 To help determine PGE2’s role in tendinopathy, treatments of COX inhibitors and 
PGE2 were administered to our existing model.  The model consisted of three loading levels 
(0 MPa, 3 MPa and 12 MPa) which correspond to unloaded/atrophic condition, normal use 
condition and overuse condition, respectively.  The findings suggest that tendon may become 
damaged in the unloaded and overuse condition, but not the regular use condition.   
After six days of loading, as expected, load inducible PGE2 as well as various other 
factors were expressed in high quantities.  The COX inhibitors were able to reduce this PGE2 
increase in most cases and the exogenous PGE2 produced the greatest negative changes in the 
tendon. COX inhibitors maintained tissue composition and properties as evident by a lack of 
change in collagen, sGAG, ultimate stress and energy density.  This was likely accomplished 
through reduced cellular responses such as collagenase and cell death.  Cellular responses are 
strain dependant, and the COX inhibitor effect of increased stiffness and modulus resulted in 
decreased strains, and thus decreased responses.  Both COX inhibitors had the same trends, 
but Celebrex was generally more effective.  Conversely, the PGE2 treatment resulted in 
decreased stiffness, and trends for decreased collagen and sGAG content, likely due to 
increased strains and collagenase.  The underlying pathology leading to the stiffness change 
could be due to increased/decreased cross-linking, and warrants further investigation. 
However, the changes noted in this study could lead a healthy tendon to overuse 
tendinopathy if allowed to progress.   
The significant role of PGE2 in tendinopathy is further highlighted when correlated to 
the other responses.  Our earlier examinations saw the response to PGE2 to be identical to the 
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collagenase and cell death response, and similar to the sGAG response. This does not provide 
a direct link between the responses because they could all be load inducible in the same 
matter, however, their reduction with COX inhibitors and increase with exogenous PGE2 
suggests that PGE2 plays a significant role in their expression. However, not all PGE2 and 
COX responses were antagonistic, which suggests that COX inhibitors and PGE2 may act by 
different pathways to perform the same task (such as reducing cell death).  
The importance of our load controlled device is evident here as these response to 
PGE2 would not be seen in other position controlled devices. With the decreased stiffness, if 
in strain control, the loading would decrease and thus the responses would be different.  With 
our model, where the loading was constant, these changes were accelerated by PGE2, but 
reducible by COX inhibitors, mainly COX-2, suggesting a potentially therapeutic role against 
the development of overuse tendinopathy. 
The findings and conclusions provided are applicable under the assumption that the 
changes will continue to progress long term, under similar conditions. However, if they are 
not found to continue, then the actions of PGE2 can be observed as benificial.  Mechanical 
properties were expected to diminish significantly in the PGE2 treated groups, especially the 
ultimate strength. However, only certain properties decreased (strain, stiffness, modulus) 
while failure strength and energy density did not. This translated into lengthening of the 
tissue, not property loss and was supported by the lack of collagen content change. This is 
beneficial to tendon as it reduces overall load and thus reduces the possibility of failure. 
Decreases in GAG content of the PGE2 group demonstrate that this is likely not tendinosis, 
where GAGs increase.  Also, PGE2 reduces apoptosis rates which would be helpful in the 
tendinosis state where reduced cell numbers are seen.  Also, with no change in total cell 
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count, reduction of cellular turnover would be quite beneficial if tendon behaves like bone.  
These findings could suggest that PGE2 is actually beneficial in tendinopathy.  PGE2 did 
modulate collagenase, but again only for total collagenase and not active collagenase. Finally 
both existing studies of biomechanical properties for PGE2 in whole tissue have shown 
positive roles for PGE2 as an injection study found increased structural properties (Ferry, et 
al unpublished) and a second study saw no decrease in strength, but a trend (P=.06) for 
increased strain in with an internal pump of PGE2 (Wilkes, el al unpublished).  Overall, if 
PGE2 only lengthened tendons as these data might suggest, PGE2 would be beneficial in 
preventing damage. 
From this work many future studies are possible.  The device can be utilized to 
perform basic material properties of tendon that have not been done in such a model. They 
include basic creep, dynamic creep, fatigue as well as similar tests to determine the effects of 
frequency.  Expansions of the existing tests could also prove beneficial as histology and 
specific analysis of MMPs and GAG were not performed.  To induce tendinopathy however, 
more damage must be created. This could be achieved by either introducing more factors like 
PGE2 that could drive tendon to tendinopathy (collagenase, cytokines, etc) or by artificially 
creating injury.  This injury could be created by compression, hypo-thermally or through an 
incision.  Once clinical tendinopathy type injury in created, a series of rehabilitation studies 
can be performed that test all the mechanical characteristics of loading (magnitude, 
frequency, duration, rest period, etc.) with and without therapeutic intervention (COX 
inhibitors, PGE2, etc.) to determine the best course of action for recovery.  
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APPENDIX 1 
Loading Control Program 
 
The tissue loading device is controlled by the following waveform generation 
program (code not shown) written in LavView (Figure 25).  Six individual regimens (three 
per channel) can be programmed manually or selected from preset waveforms. The regimens 
can be repeated an indefinite number of times at a set interval.  All inputs are in MPa, 
calculated from a mean cross sectional area (default 1.713).  
 
 
 
Figure 25: Sample window of waveform generation program. 
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APPENDIX 2 
Video Strain Analysis Program 
 
The real-time video strain analysis (VSA) is performed with the following program 
(code not shown) written in LabView. The procedure is outlined below. 
 
 
Figure 26: VSA Step 1 - Define channels and input specimen information. 
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 Figure 27: VSA Step 2 – Position camera orthogonally such that both markers (including 
their intended path) and calibration marks are visible. 
 
 
Figure 28: VSA Step 3 – Select number of tick marks on the screen of a known distance and 
allow program to locate them to calibrate the system. 
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Figure 29: VSA Step 4 – Select threshold parameter such that the original image (on left) is 
converted to binary image (on right) with markers clearly visible and no extra noise. 
 
 
Figure 30: VSA Step 5 – Draw line of action across which to measure strain (first and last 
marks). Make sure to include full range of motion of markers. 
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 Figure 31: Run Test – Shown is a typical result after failure testing. 
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APPENDIX 3 
Biochemistry 
 
The biochemistry portion of this project consisted of the analysis of the media by two 
commercial analysis kits, as well as a third analysis procedure derived from literature. 
Furthermore, select tendons were cut with a special tool to gather sections used for either 
digestion or MTT analysis.  This tool provides an average of 7.11mm sections when cut with 
a slight bit of pretension.  For the future, it is suggested to shorten this section width by 
decreasing the size of the aluminum block between the scalpel blades so more sections only 
from the midsubstance may be utilized. 
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APPENDIX 4 
 MTT Cell Viability Assay 
 
 Immediately following loading, select tendons were sectioned (Appendix 6.0). One of 
these sections was analyzed for viability by a (MTT) protocol. The protocol used (Flick, 
2005) was developed by a former student Jason Flick, and is a modification of a common 
viability assay (Klein et al. 1996).  The chemicals used, MTT (3-(4,5-Dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium Bromide) and 2-methoxyethanol were purchased from Sigma 
(St Louis, MO), while the PBS (Phosphate Buffered Saline) and DMEM-H (Dulbecco’s 
Modified Eagle Medium, High Glucose) was manufactured by Invitrogen (Carlsbad, 
California) and purchased from the local tissue culture facility. The following is the protocol 
used: 
 
 
MTT Protocol 
Preparation: 
1. Weigh 50mg of MTT wrapped in aluminum foil. 
2. The 50mg of MTT will be transferred to the Tissue Culture hood where it will be 
dissolved in 10ml of sterile PBS in a sterile 15ml centrifuge tube. 
3. 1ml aliquots of the 10ml MTT solution will be sterilely transferred to 1.5 ml 
micro-centrifugation vials and labeled with the concentration (5mg/ml), medium, 
date, and stored frozen at –20C. 
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Protocol: 
1. Aliquot 900µl of DMEM-H media (37ºC) with no additives into micro-centrifuge 
tube (1 tube/sample to be analyzed). 
2. Add 100µl of MTT stock solution (5mg/ml), for final concentration of 1mg/ml 
3. Transfer sectioned sample into tube with MTT solution. 
4. Incubate tube with tendon for 4hrs in incubator (37ºC, 5% CO2) 
5. Transfer tendons into tubes with 1ml, 2-methoxyethanol (Keep one extra tube 
with 2-methoxyethanol only for background) 
6. On large orbital shaker, shake tubes (sealed) for 12 hrs at 120rpm 
7. Aliquot 200µl x 4 from each tube into 96-well plate 
8. Record absorbance in dual mode. 570nm with background (690nm) subtracted. 
9. Dry tendon segments in speed-vac (100mTorr) for 2hrs. 
10. Final value is average absorbance / dry weight (obs/mg) 
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 APPENDIX 5 
Papain Digest 
 
Immediately following loading, select tendons were sectioned (Appendix 6.0). One of 
these sections was stored frozen (-80ºC). At a later date, the section was digested with Papain 
from Papaya Latex for compositional analysis. All chemicals are listed below and were 
purchased from Sigma. The protocol was based on a modified procedure performed 
previously (Riley et al. 1994). The following is the protocol used: 
 
PAPAIN DIGESTION 
(Ref.: Riley et al., 1994) 
 Make phosphate buffer and store at 4 ºC. Each sample requires 250µl, i.e. you can do 
four samples/ml of buffer. You don’t want to store buffer too long b/c of degradation issues. 
Buffer is 0.1 M phosphate buffer (pH 7) with 10mM Cystine HCL & 2 mM EDTA. It’s 
sampled and brought to 0.5 mg/ml papain, this is the final working buffer which will digest 
the samples. 
Reagents: 
1. Monobasic   NaH2PO4·H20  137.99 g/mol Powder (Chemical Room) 
2. Dibasic   NaH2PO4·7H20 286.07 g/mol Powder (Chemical Room) 
3. L-Cysteine-HCl C3H7NO2S·HCl·H20 175.63 g/mol Powder (Chemical Room) 
4. EDTA   C10H14N2Na2O8 336.21 g/mol 0.5M Stock (Cold Room) 
5. Papain (Papaya Latex)   21 kDa  Powder (Freezer) 
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Stock Buffer Preparation: 
1. Make (100ml) 0.1M phosphate solutions 
a. 100ml ddH20 + 1.3799g (Monobasic) 
b. 100ml ddH20 + 2.8607g (Dibasic) 
2. Make buffer base – Final ratio of dibasic/monobasic will be close to 65:35. Add 70ml 
of dibasic solution and slowly add monobasic solution until pH is 7.0. (Total volume 
will be slightly > 100. This is not an error.) 
3. Add Cysteine HCL directly to make final solution 10mM (0.17564g for 100ml). 
4. Add EDTA to make final solution 2mM (400µl (.5M stock) for 100ml). 
5. This does not store well (precipitates). Store at 25C < 2 weeks. It’s the additives 
(Cysteine, or EDTA) that precipitates out, so don’t add these until ready to use. 
 
Working Buffer Preparation: 
1. Prepare 0.5 mg/ml working buffer  
2. Vortex well and warm to 37 ºC to completely dissolve Papain 
3. Use warm solution when assaying 
 
Protocol: 
1. Record dry weight of individual tendons (SpeedVac 4-hrs).  
2. Add 250 µl of Papain/Buffer Solution. (Ensure solution is warm before adding). 
3. Seal lids of microtubes with Teflon tape and the plastic snaps designed for microtubes.  
This is to prevent evaporation. (not required if o-ring capped microtubes are used) 
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4. Digest for 3 hrs. at 65 °C.  Use oven under bench in 2332 with test tube shaker/rotator to 
ensure complete digestion. 
5. Periodically (60min), flick the tubes to ensure mixing, as well as to loosen any pellet 
particle that may be sticking to the tube. 
6. Double check for evaporation (monitor volume of digest when finished). 
7. May have to add another 250 µl of Papain/Buffer solution (if not digested within 6hrs). 
a. Note calculation changes will be required 
8. Aliquot samples into three more tubes (µ-centrifuge w/O-ring cap). Separate aliquots in 
different boxes and store at -80C. 
a. Hydroxyproline –  40µL in 2.0ml clear o-ring tube 
b. GAG -   20µL in fliptop tube A 
20µL in fliptop tube B 
c. DNA -   40µL in 2.0ml clear o-ring tube 
40µL in 2.0ml clear o-ring tube 
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APPENDIX 6 
sGAG Content Assay 
 
 One set of aliquots from the papain digest (stored at -80ºC) was used for sulfated 
glycosaminioglycan (sGAG) assay. All chemical used are listed below and were purchased 
from Sigma. The protocol was based on a modified procedure performed previously (Riley et 
al. 1994) based on the original procedure of (Farndale et al. 1986).. The following is the 
protocol used 
 
 
Glycosaminoglycan Assay 
(Ref.: Riley et al, 1994 from Farndale et al, 1986) 
 
 The working solution is a DMMB reagent with the constituents listed below, brought 
to 1 L total volume with ddH20. Storage is recommended in a brown (or Al Foil covered) 
bottle at room temperature.  Standards/samples must be assayed immediately after combining 
with the reagent buffer, as the combination is very unstable. 
Reagents: 
 Usage Required (per sample) Stability 
Color Reagent Make stock 200µl Few Months  
(25ºC In dark bottle)
Chondroitin Sulfate Make fresh Daily 2 ml (per plate)  Few Weeks (4ºC) 
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Notes: 
1. Will do 8 standards (100, 50, 25, 12.5, 6.25, 3.125, 1.5625 and 0 µg/ml) 
2. Will be doing two dilutions of each sample (in duplicate) 
3. Can accommodate up to 20 samples per plate (Do not do much more than 10/plate) 
4. Timing is very important, but multi-pipetting consistency cannot be compromised 
5. Must use multi-pipettor to disperse buffer 
 
Working Solution: 
Color Reagent: 
a) 16 mg Dimethylmethylene Blue (DMMB)  
b) 3.04 g Glycine 
c) 2.34 g NaCl 
d) 95.0 ml HCl, 0.1 M 
    *    Total Volume = 1.0 L ddH20 
 
Standard: 
1) Stock Solution (0.5 mg / ml) 
• 5mg of Chondroitin Sulfate in 10ml of ddH20 
• This is to reduce weighing errors 
• Store this at 4ºC 
2) Bring stock solution to room temperature 
3) Temp Solution (100µg / ml) 
• 2ml of stock solution (vortex first) + 8ml ddH20 
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4) Make Standard Dilutions (Serially) 
• Fill 1 flip-top µ-centrifuge tube with 1000µl of ddH20 (1) 
• Fill 6 flip-top µ-centrifuge tube with 500µl of ddH20 (2-7) 
• Fill 1 flip-top µ-centrifuge tube with 1000µl of Stock (8) 
• Transfer 500µl from stock (8) to next tube (7) 
• Shake tube (7) and transfer 500µl to next tube (6) 
• Continue until 1000µl is in tube (2) 
 
 
Standard # Concentration 
1 0.00 µg/ml 
2 1.5625 µg/ml 
3 3.125 µg/ml 
4 6.250 µg/ml 
5 12.50 µg/ml 
6 25.00 µg/ml 
7 50.00 µg/ml 
8 100.0 µg/ml 
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Protocol: 
1) Set up Plate-reader and make it ready to go 
• Prepare template  
• Prepare protocol (Kinetic 2 reads/min, 30min) 
2) Prepare samples 
• Aliquot 20ul of digest samples into each (of 2) flip-top tubes 
• Dilute first samples 1/3 by adding 40ul ddH20 
• Dilute second samples 1/4 by adding 60ul ddH20 
3) Prepare standards serially as described above 
4) Prepare 96-well plate 
• Aliquot (double) 8µl of standards 
i. Start with 0 µg/ml, and end with 100 µg/ml 
ii. Use same pipet-tip 
• Aliquot 8µl of each sample to wells (in duplicate) 
5) Add 20ml of DMMB Reagent to multipipetting tray 
• Add 200µl of buffer to each well using multi-pipettor* 
6) Take immediately to Plate Reader 
7) Read absorbance at (525), but actually 540 b/c that’s what we got 
• Will kinetically read 2 reads/minute for 30 minutes 
*Timing important, But multipipetting consistency is more important… 
 So, MULTIPIPET CAREFULLY AND CONSISTENTLY!!!!!!! 
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APPENDIX 7 
Hydroxyproline (Collagen Content Assay) 
 
 One set of aliquots from the papain digest (stored at -80ºC) was used for the collagen 
content assay (measuring hydroxyproline). Hydroxyproline is an amino acid that is found 
primarily in collagen at known proportions. All chemical used are listed below and were 
purchased from Sigma. The protocol was based on a modified procedure performed 
previously (Riley et al. 1994) based on the original procedure of (Bergman and Loxley 
1963). The following is the protocol used 
 
Hydroxyproline Assay 
(Ref.: Riley et al, 1994 from Bergman & Loxley, 1961) 
Reagents: Usage Stability 
Chloramine T Make fresh as needed Few weeks 
Na Buffer Make stock Indefinite 
DAB Make fresh as needed Few weeks  (in dark bottle) 
Isopropanol Straight from bottle Indefinite 
Hydroxyproline Make fresh as needed Few weeks (at 4ºC) 
Notes: 
1. Will do 8 standards (100, 50, 25, 12.5, 6.25, 3.125, 1.5625 and 0 µg/ml) 
2. Will be doing two dilutions of each sample (in duplicate) 
3. Can accommodate up to 20 samples per plate 
4. Do not make working solutions in advance 
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Working Solutions: 
Amount Required 
0.4 ml + 0.1 ml / sample 
2.4ml max (Per Plate) 
1. 1:4 (20/80%) of Chloramine T and Buffer 
a) Chloramine T      
? 7 % w/v Chloramine T in H20 
? 7g Chloramine T per 100ml water 
b) Na Buffer        
? 57g  Sodium acetate trihydrate 
? 37.5g Trisodium citrate dehydrate 
? 5.5g  Citric Acid monohydrate 
? 385ml Isopropanol 
? ≈615ml Water (Bring to 1L Total) 
2. 1:3 (25/75%) of DAB and Isopropanol 
a) DAB (p-demethylamino-benzaldehyde)   
Amount Required 
2.4 ml + 0.6 ml / sample 
14.4ml max (Per Plate) ? 66.6% w/v DAB in 60% perchloric 
acid  
? 20g DAB per 30ml of 60% perchloric acid 
b) Isopropanol (Propan-2-ol)      
Standard: 
1) Temporary Solution (0.5 mg / ml) 
• 5mg of Hydroxyproline in 10ml of ddH20 
• This is to reduce weighing errors 
2) Stock Solution (100µg / ml) 
• 2ml of temporary solution + 8ml ddH20 
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3) Make Standard Dilutions (Serially) 
• Fill 1 flip-top µ-centrifuge tube with 1000µl of ddH20 (1) 
• Fill 6 flip-top µ-centrifuge tube with 500µl of ddH20 (2-7) 
• Fill 1 flip-top µ-centrifuge tube with 1000µl of Stock (8) 
• Transfer 500µl from stock (8) to next tube (7) 
• Shake tube and transfer 500µl (7) to next tube (6) 
• Continue until 1000µl is in tube (2) 
 Standard # Concentration 
1 0.00 µg/ml 
2 1.5625 µg/ml 
3 3.125 µg/ml 
4 6.25 µg/ml 
5 12.5 µg/ml 
6 25.0 µg/ml 
7 50.0 µg/ml 
8 100 µg/ml 
 
 
 
 
 
 
 
 
 
Protocol: 
1) Aliquot 40µl of digested sample into Clear 2.0ml tubes (screw cap) w/Black O-ring  
2) Hydrolyze sample 
• Add 200µl of 7.2 M HCl (Final conc. = 6.0 M) 
• Screw tightly & Incubate (105ºC ) in oven overnight (20hrs) 
3) Dry down in Speed-Vac (6 hrs) 
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4) Reconstitute with 1.0ml H20 and dry down in Speed-Vac (20 hrs) 
• (This is to reduce acidity of pellet which has liquid stuck under it) 
5) Make working solutions (4ml and 16ml max) 
6) Reconstitute sample with 1000µl ddH20 (Stock) 
• Dilute 1/8 ≈ 10 µg/ml 125µl sample + 875 µl ddH20    
• Dilute 1/4 ≈ 20 µg/ml 125µl sample + 375 µl ddH20 
7) Store Stock at -80ºC 
8) Prepare 96-well plate 
• Aliquot (double) 40µl of standards 
i. Start with 0 µg/ml, and end with 100 µg/ml 
ii. Use same pipet-tip 
• Aliquot (double) 40µl of sample (both dilutions) 
• Add 25µl of Working Solution 1 
• Wait 4 min 
• Add 150µl of Working Solution 2 
9) Apply parafilm seal and cover plate,  
• Incubate 60ºC for 40min 
• Cool 5 minutes to room temperature 
10) Scan at 540nm & 575nm (will use the 540) 
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APPENDIX 8 
 PGE2 
 
One set of media aliquots were analyzed for PGE2 content by a commercial, 
competitive enzyme immunoassay kit from Cayman Chemical (Prostaglandin E2 EIA Kit – 
Monoclonal, Catalog #514010).  The manufacturer recommended protocol was utilized with 
minimal changes.  The suggested plate layout was used with each sample measured in two 
dilutions, each in duplicate.  A summary of the procedure is outlined below. 
 
PGE2 Assay 
Cayman Chemical Part # 514010 
 
Pre assay: 
1) Make EIA buffer (Ultra-pure water source in MBRB 23 ) 
2) Make wash buffer 
 
Assay: 
1) Make two dilutions/samples (Chose from 1/10, 1/30, 1/60, 1/100, 1/200, 1/400) 
2) Prepare PGE2 standard, tracer and antibody 
3) Prepare Plate 
a) EIA Buffer – 100µl in NSB wells, 50µl in Bo wells 
b) PGE2 Standard - 50µl of each standard (8 concentrations, 0 – 1ng/ml) 
c) Samples – 50µl 
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d) Tracer – 50µl to all well except TA 
e) Antibody – 50µl to standards, samples, and Bo 
4) Incubate overnight (18 hrs) at 4ºC 
5) Reconstitute Ellman’s reagent 
6) Wash plate 5 times 
7) Add Ellman’s reagent (200µl) to every well  
8) Add 5µl tracer to TA well 
9) Develop (in shaker, protected from light) 60-90 min 
10) Read plate (405-410nm) 
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APPENDIX 9 
 LDH 
  
One set of media aliquots were analyzed for cellular toxicity by measuring LDH 
content by a commercial, competitive enzyme immunoassay kit from.  The manufacturer 
recommended protocol was utilized with minimal changes.  The suggested plate layout was 
used with each sample measured in two dilutions, each in duplicate.  A summary of the 
procedure is outlined below. 
 
LDH Assay 
Promega Part Number TB163 
 
Pre assay: 
1) N/A 
 
Assay: 
1) Aliquot 50µl of sample (in triplicate) to 96-well plate 
2) Make substrate mix 
3) Add 50µl substrate mix to each well  
4) Cover plate and incubate 30 min at room temp 
5) Add 50µl Stop solution to every well  
6) Read absorbance at 490nm 
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APPENDIX 10 
 Collagenase 
 
 During the loading portion of the experiment, the media was collected at various 
periods and stored. During Aim 3, the media was stored frozen at -20ºC, while it was stored 
at -80ºC for Aims 4 and 5. Of set of the media was analyzed for collagenase activity by the 
modification of an Azocoll procedure. This was done originally by Dr. Mari Tsuzaki in this 
lab, based on a previously described method (Chavira et al. 1984). Azocoll was purchased 
from EMD Biosciences (San Diego, CA). All other reagents were purchased from Sigma. 
The following is the procedure used: 
 
Collagenase Activity Assay (Azocoll) 
(Chavira et al 1984) 
 
 Media from the fixed cycles experiment will be analyzed for collagenase activity. The 
basic procedure of Chavira et al 1984 will be used as interpreted by Mari (her protocol also 
in directory).  APMA will be added to all samples and controls.  Media from each day, plus 
background and controls will be run.  Final concentrations of Azocoll and sample are 1:1.  
Pre Assay Preparation 
1) Make reaction buffer stock 
• 50 mM Tris-HCL 
• 1 mM CaCl2  
• pH 7.8 
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Samples for Assay 
1) Samples 
2) Background (Buffer, Azocoll) 
3) Controls (LDH +) 
 
Procedure 
1) Make Azocoll buffer 
a. Suspend Azocoll in buffer (5mg/ml) 
b. Incubate (25C) for 90min 
c. Aspirate supernatant and replace buffer 
2) Add AMPA, final conc. 1mM 
a. Already in warm buffer to help dissolve 
3) Prewarm tube at 37C for 15min 
4) Distribute 500µl sample to flip-top tubes 
5) Vortex azocoll buffer and add 500µl to samples  
a. Vortex again after every 2-3 tubes 
6) Incubate 24hrs, 37C while rotating slowly to reduce sedimentation 
7) Stop reaction by immersing in ice-water bath (10 min) 
8) Centrifuge tube and sample supernatant to 96-well plate (double aliquot) 
a. 30sec, 1000 RPM: 200ul 
9) Record absorbance at 520nm (subtract background) 
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